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Abstract 
Neural cell adhesion molecule (NCAM) is involved in neuronal migration, axon growth, 
fasciculation, and learning and memory. Its axon outgrowth-stimulating activity is 
prevented by use of the VASE exon encoding a 10aa insertion into the extracellular 
domain. Expression of NCAM-VASE transcripts increases during development but not 
in regions of continuing plasticity such as the olfactory bulb, suggesting a synapse-
stabilising or anti-plasticity role for VASE. This report has determined for the first time, 
the subcellular distribution and cell type specificity of NCAM-VASE protein in the adult 
rat CNS, to gain clues as to the function of VASE. In developing rat brain, NCAM-VASE 
protein expression is upregulated during myelination, and is at its highest in adult myelin 
and ependymal cells lining all ventricles except the lateral ventricle. It is notably 
excluded from highly NCAM positive neurons in the subventricular zone and also from 
the other major site of adult neurogenesis, the dentate gyrus subgranular layer. NCAM-
VASE is not expressed in brain astrocytes unless induced in vitro to become reactive, 
but is present in spinal cord astrocytes and at the dorsal root entry zone (DREZ). 
Interestingly, NCAM-VASE is also highly expressed in cardiac but not skeletal muscle. 
The distribution of NCAM-VASE indicates that it may be involved in CNS myelin 
formation/maintenance and contribute to the poor regenerative environment of CNS 
myelin. It also may add to the axon outgrowth inhibitory effects of astrocytic scars. This 
information can now be used to direct functional studies, such as a possible role for 
VASE in gap junction function and maintenance. 
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1.0 introduction 
Neural cell adhesion molecule (NCAM) is a hemophilic binding glycoprotein expressed 
on the surface of neurons, glia, muscle and many other tissues (Walsh and Doherty, 
1997), and has homologues in all higher eukaryotes investigated, including Drosophila 
melanogaster {HaW and Rutishauser, 1985) and Caenorhabditis elegans (Aurelio et al., 
2002). NCAM has been recognised as playing a part in the accurate development of the 
nervous system (Cremer et al., 1994) and muscle (Peck and Walsh, 1993), and 
increasingly has been found to play a major role in neurite outgrowth, neural migration, 
synaptic plasticity and in learning and memory (Maness and Schachner, 2007). NCAM 
in part owes its multifunctional qualities to extensive alternative splicing leading to a 
wide diversity of NCAM isoforms (Reyes et al., 1991) and also a number of 
posttranslational modifications (Friedlander et al., 1985; Niethammer et al., 2002). 
1.1 NCAIVI alternative splicing 
NCAM is encoded by a single gene located to band q23 of chromosome 11 in humans 
(Nguyen et al., 1986), however through extensive alternative splicing, a large number of 
NCAM isoforms can be theoretically generated (Nybroe et al., 1988). The three major 
isoforms of NCAM share identical extracellular domains consisting of five 
immunoglobulin (Ig) domains which convey hemophilic binding properties, and two 
fibronectin-type III (FNIII) domains which are involved in signalling via the fibroblast 
growth factor receptor (FGFR) leading to neurite outgrov\/th. They differ only at either the 
size of their cytoplasmic domain or mode of attachment to the membrane (Figure 1.1.1). 
These three NCAM isoforms are designated by their approximate RDa molecular weight 
- NCAM 180 (large cytoplasmic domain, also known as NCAM/d and NCAM/I), 
NCAM 140 (small cytoplasmic domain, also known as NCAMsdand NCAMS) and 
NCAM 120 (glycosylphosphatidylinositol-anchored, also known as NCAMssdand 
NCAMC) (Nybroe et al., 1988) (Figure 1.1.1). 
19 
VASE exon 
added in IglV^ 
Ig domain 
Fibronectin type III 
domain 
GPI anchor 
NCAM140 
NCAM120 
NCAM180 
Figure 1.1.1 - The three major isoforms of NCAM differ only in the size of their cytoplasmic 
domain or mode of attachment to the membrane. NCAMSO has the larger cytoplasmic domain, 
NCAM140 has the smaller cytoplasmic domain, and NCAM120 is glycosylphosphatidylinositol (GPI)-
anchored. 
NCAM180, 140 and 120 are expressed differently during development and in 
different cell types. NCAM180 is predominantly expressed in neurons, especially at the 
postsynapse (Persohn et al., 1989). NCAM140 is expressed predominantly in neurons 
but is also expressed in oligodendrocytes, astrocytes and muscle to varying degrees 
during early development (Walsh and Doherty, 1997). NCAM120 is primarily non-
neuronal, being mainly expressed in muscle (with additional exons making it the 
125kDa isoform), astrocytes and oligodendrocytes (Dickson et al., 1987), (Nybroe et al., 
1988), (Bhat and Silberberg, 1988). 
Microsplicing events in the immature NCAM transcript at two locations further 
add to the diversity of NCAM isoforms. The first microsplice site in NCAM is within Ig 
domain IV (Figure 1.1.2) and is a 30 base pair exon encoding a highly conserved 
sequence which has been named VASE (sometimes called TT) (see later) (Small et al., 
1988). The splicing of VASE into NCAM has been shown to be developmentally 
regulated, low during early development and high in adult and has been correlated with 
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a developmental loss of the ability of neurons to be stimulated to extend neurites in 
response to NCAM (Doherty et al., 1992a). In the adult brain, VASE transcripts have 
been found to be low in tissues associated with synaptic plasticity and regeneration 
such as the olfactory bulb and the dorsal root ganglion (Small and Akeson, 1990). The 
other microsplice site in NCAM is between the two FN III domains. Five exons can be 
spliced into this region: exons a,b,c - the "muscle specific domain" (MSD1), exon AAG, 
and the secreted NCAM exon. The MSD, unlike the name suggests is not necessarily 
restricted to muscle NCAM as mRNA containing the MSD have been found in the 
developing mouse cerebellum (Santoni et al., 1989). In mature muscle, MSD-containing 
NCAM predominates, giving NCAM isoforms of 185kDa, 145kDa, and 125kDa (the 
major isoform in muscle being 125kDa) (Suzuki et al., 2003). The MSD has high 
sequence diversity amongst species, the conserved factor being multiple O-
glycosylation sites in exon b and c which are thought to raise up and stabilise the NCAM 
hemophilic binding domains above the skeletal muscle glycocalyx (Walsh and Doherty, 
1991; Watanabe, 1998). Developing myoblasts contain mainly NCAM without the MSD, 
with splicing in of the MSD correlating with myoblast fusion and post-fusion myotubes 
contain predominantly NCAM with the MSD (Walsh and Doherty, 1991). It has been 
shown that mutating the 0-glycosylation sites of exons b and c diminishes myoblast 
fusion, and C2C12 mouse myoblast cells overexpressing NCAM125 (NCAM120 + MSD) 
have enhanced fusion (Suzuki et al., 2003). The MSD has been shown to have no effect 
on the homophilic binding strength of NCAM, or affect its neurite outgrowth-promoting 
properties (Pizzey et al., 1989). 
VASE Sequence 
ASWTRPEKQE 
NHr -COOH 
Igl Igll Iglll IglV IgV FNIII-1FNIII-2 TM Cytoplasmic domain 
Figure 1.1.2 - NCAM diversity is further increased by 1. Microsplicing events which can add 
various exon combinations generating NCAM-VASE, muscle-specific isoforms and a secreted 
NCAM isoform, and 2. Posttranslational modification, most notable being the addition of polysialic 
acid (PSA) to IgV. 
Exon a and the AAG exon have been found to be expressed in the brain without 
exons b and c, although the significance of this is unknown (Santoni et al., 1989). The 
AAG exon consists of only three base pairs (hence "AAG") and encodes the conversion 
of an Arg residue to Gin and Gly. AAG can be spliced Into NCAM by itself, however no 
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known function of this exon has been determined. The sequence for exon a is proline 
rich (in humans it is "HSPPP") and has been proposed to create a putative hinge domain 
between the two FNIII domains of NCAM (Reyes et al., 1991). The function of this is 
unknown but possibly could help or hinder accessibility of the FNIII domains to 
signalling partners such as the FGF receptor. 
The secreted NCAM (NCAMSec) isoform was originally misidentified as 
NCAM120 due to the fact that it encodes a protein of similar sequence and size. In fact, 
the secreted NCAM isoform lacks the final FNIII domain, terminating after the complete 
MSD sequence in a 21 aa unique sequence which neither encodes a transmembrane 
domain nor a GPI -anchor giving it an apparent molecular weight of about 115kDa 
(Gower et al., 1988). The precise function of NCAMSec has not been identified but it is 
developmentally upregulated in muscle along with NCAM 125 as part of myoblast fusion, 
and is also present in the brain (Gaardsvoll et al., 1993; Linnemann et al., 1993). It has 
been suggested that NCAMSec could play a part in nerve innvervation of muscle, as 
being secreted, it could diffuse away from the muscle producing a gradient of NCAM 
which could promote neurite growth into the target area. It could also embed itself into 
the muscle extracellular matrix and provide a similar permissive environment (Gower et 
al., 1988). Mice engineered to have their endogenous NCAM gene replaced with a 
constitutively secreted form were found to be embryonic lethal with severe growth 
retardation and morphological defects by E8.5-9.5 (whilst a complete NCAM knock out 
is viable (Cremer et al., 1994)). This severe phenotype was found to be dominant as 
heterozygotes displayed the same phenotype. The fact that homozygotes suffered an 
embryonic lethal phenotype in the absence of "normal" membrane - bound NCAM 
suggested that the soluble NCAM could perhaps be exerting its effects via a heterophilic 
interaction during the development of the mouse embryo (Rabinowitz et al., 1996). As 
well as a specific secreted NCAM isoform, it has been reported that soluble NCAM has 
been detected in the growth medium of newborn rat neuronal cultures with apparent 
sizes corresponding to NCAM 140 and 180 (Bock et al., 1987) although the processes 
involved in producing these full length soluble NCAM molecules is presently unknown. 
1.2 NCAM domain structure and homophilic binding 
The five immunoglobulin domains of NCAM have been shown to confer homophilic 
binding properties whilst the two fibronectin type III domains have been shown to be 
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important for NCAM signalling (Anderson et al., 2005; Wieland et al., 2005). The Ig 
domains of NCAM are highly conserved between species, with NCAM containing 
vesicles derived from any combination of mouse, canary, turtle, newt, salamander and 
shark being able to co-aggregate in an NCAM-dependent manner (Hoffman et al., 
1984). NCAM Ig domains are all predicted to be of the intermediate set (l-set) 
immunoglobulin folding (Harpaz and Chothia, 1994). This has been so far confirmed by 
the elucidation of the crystal structure of the first three Ig domains of NCAM (Soroka et 
al., 2003). Each NCAM Ig domain has two cysteine residues engaging in a disulphide 
bridge holding the hydrophobic core together (Walsh and Doherty, 1997). The exon 
arrangement of NCAM is such that each Ig domain is encoded by two exons and each 
of the Cys residues of the disulphide bridge falls into a different exon (Owens et al., 
1987). 
There is currently much controversy surrounding the mode of NCAM hemophilic 
binding which has yet to be reconciled. On one side, there is the "conventional" model 
of NCAM binding which proposes antiparallel reciprocal binding either between Igl + II 
or Igl-V (Figure 1.2.1a) which is currently championed by Rutishauser and Leckband 
(Johnson et al., 2005; Johnson et al., 2004) and is supported by the bulk of historical 
evidence (Ranheim et al., 1996). On the other side there is the "Zipper" model proposed 
by Bock in which firstly a double reciprocal binding occurs between Igl and Igll of two 
NCAM molecules on the same membrane (c/s-interaction) which then form an 
interaction between Igll and Iglll of two NCAM molecules on the opposing membrane 
(frans-interaction) (Figure1.2.1b-d) (Hinsby et al., 2004). The Zipper model is backed up 
by crystallographic data of the first three Ig domains of NCAM (Soroka et al., 2003) but 
currently has no definitive support published from outside sources. 
"Conventional Model" 
It was found that that vesicles coated in NCAM could self-aggregate (Hoffman 
and Edelman, 1983). Through the selective deletion of different Ig domains, Iglll was 
identified as essential for aggregation of NCAM-transfected L cells (Rao et al., 1992). 
Deleting the other Ig domains only minimally reduced transfected L cell aggregation. 
The putative NCAM Iglll hemophilic binding site was further refined by the discovery 
that a decapeptide from Iglll could inhibit aggregation of embryonic day 14 chick brain 
membrane vesicles - KYSFNYDGSE (bold = required residues) and that this 
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sequence was involved in reciprocal binding to the same sequence on another NCAM 
molecule (Rao et a!., 1992; Rao et a!., 1994). Single recombinant NCAM Ig domains 
coated to beads were tested against each other to determine aggregation properties. It 
was discovered that whilst Iglll could self-aggregate, Igl preferred to aggregate with IgV, 
Igll preferred to aggregate with IglV, and vice versa (Ranhelm et al., 1996). This 
suggested a situation In which an NCAM molecule could bind homophilically to another 
NCAM molecule on an opposing membrane in trans- via antlparallel Interactions 
between the Ig domains (Figure 1.2.1a). NCAM Igl and Igll were found to crystallise In 
an antlparallel dimer leading to the possibility that perhaps there also could be NCAM 
homophilic binding In which only the first two Ig domains participated (Kasper et al., 
2000) (Figure 1.2.1b). These two modes of binding were both found to be possible 
using a technique called surface force measurement (SF) which can measure the 
distance-dependence of attractive and repulsive forces between two membrane-bound 
molecules (Johnson et al., 2004). In effect, this apparatus allowed the strength of 
binding between membrane-attached NCAM molecules to be measured for different 
membrane separations. It was found that an NCAM Igl-V molecule had two distinct 
bound states - at close membrane separations, a stronger binding was observed 
corresponding to all Ig domains participating in homophilic binding, and a weaker 
binding at wider membrane separations corresponding to just Igl and Igll participating in 
homophilic binding. Deleting Iglll from the molecule removed the close, strong binding 
state whilst removing Igl and II removed the weaker, further apart binding state. It was 
also found that only Iglll contributes to the strength of the strong binding state (Wieland 
et al., 2005). The functional significance of NCAM having two binding states of differing 
strength has been suggested in the light of the addition of polysiallc acid (PSA) 
posttranslationally to NCAM IgV. PSA Is a large negatively charged polymer (>100 
sugars) of a2,3-llnked sialic acid (Rutishauser and Landmesser, 1996) added to NCAM 
IgV (Figure 1.1.2) which has been shown to reduce the adhesion strength of NCAM 
(Hoffman and Edelman, 1983). The steric and electrostatic repulsion of PSA has been 
suggested to interfere with the strong Igl-V homophilic binding, perhaps only allowing 
the weaker Igl and II interaction to occur, thus reducing the adhesion strength of NCAM 
(Johnson et al., 2005). 
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Figure 1.2.1 - Proposed models for NCAM homophilic binding, (a) The "Conventional" model in 
which two NCAM molecules on opposing membranes can either interact in an antiparallel manner 
via Igl-V interactions or just Igl-ll interactions, (b-d) The "Zipper" model in which cis- interactions 
between NCAM molecules on the same membrane form via reciprocal Igl - II interactions, which 
can then form multimers with NCAM dimers on an opposing membrane via (b) Igl - Iglll and Igll -
Igll interactions (= compact zipper), (c) Igll - Iglll interactions (= flat zipper), (d) or a combination 
of both zipper modes (= double zipper), (b-d) taken from figure 5, (Soroka et al., 2003). 
"Zipper Model" 
The "Zipper" model of NCAM homophilic binding is rather more complex than the 
"Conventional" model. It was established through crystallographic data which suggests 
that NCAM Igl-lll can form higher order cis- and trans- interactions (Soroka et al., 2003). 
The model firstly proposes that two NCAM molecules on the same surface associate in 
cis- via reciprocal interactions between Igl and II, in contrast to the "Conventional" 
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model which proposes that the Igl+ll interaction is in trans (Figure 1.2.1). This structure 
can then homophilically bind to a similar structure on an opposing membrane in trans-
via interactions between Igl and Iglll, and Igll and Igll on opposing diamers = "Compact 
Zipper" configuration (Figure 1.2.1b). Hemophilic binding can also be achieved in trans-
via Igll and Iglll interactions on opposing diamers = "Flat Zipper" (Figure 1.2.1c). It has 
been proposed that both zipper configurations could be combined to create a complex 
"Double Zipper" organisation (Figure 1.2.Id). Independent published evidence directly 
supporting the "Zipper" model is currently lacking, with the authors instead relying on 
outside data which contradicts the "Conventional" model but not their own. The most 
notable of these is data from an independent research group who could not find the 
previously reported self association between NCAM Iglll (Atkins et al., 2001) which 
would be necessary for Igl-V antiparallel hemophilic binding. However, the same 
research group also have published data showing that beads coated in NCAM Igl + II 
are sufficient to cause bead aggregation suggesting that NCAM Igl and Igll can bind in 
a trans- fashion (supporting the "Conventional" model) although perhaps the cis-
interaction can occur as well ("Zipper" model) (Atkins et al., 2004). In an attempt to 
reconcile data, proponents of the "Zipper" model have suggested that the decapeptide 
(KYSFNYDGSE) from chicken NCAM Iglll which inhibits aggregation of embryonic chick 
brain membrane vesicles (Rao et al., 1992) is homologous to the rat NCAM sequence 
KHIFSDDSSE in NCAM Iglll which maps to the NCAM Igl - Iglll hemophilic binding site 
in their model. Therefore they conclude that the inhibitory effect of the decapeptide is 
due to perturbation an Igl - Iglll interaction rather than Iglll - Iglll (Walmod et al., 2004). 
Presently the weight of evidence appears to fall on the side of the "Conventional" 
model however the conventional model has yet to take into consideration NCAM cis-
interactions which have been experimentally been shown to be important in activation of 
the NCAM-mediated signalling cascade leading to neurite outgrowth (Niethammer et al., 
2002). Additional evidence for a hemophilic NCAM cis- interaction apart from the crystal 
structure has been claimed by proponents of the "Zipper" model based on the ability of 
a peptide.corresponding to the NCAM Igll binding site for Igl (called p2 peptide) to 
promote neurite outgrowth of PC12-E2 cells in the absence of stimulation by an NCAM 
presenting cellular monolayer (Li et al., 2005). Their proposed mechanism is that the 
peptide interferes with NCAM cis- hemophilic binding, resulting in stimulation of neurite 
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outgrowth somehow. This is rather speculative, as equally the peptide could be 
mimicking NCAM trans- hemophilic binding which could possibly cause a 
conformational change in NCAM leading to neurite outgrowth, as they had originally 
envisaged. In all likelihood, NCAM hemophilic binding is probably a complex process, 
which, when taking into consideration the addition of PSA and the insertion of the VASE 
exon into IglV, could potentially have multiple modes of binding. 
The two fibronectin type III (FN!!!) domains of NCAM are not thought to play any 
part in NCAM hemophilic binding (Ranheim et al., 1996) but increasing evidence is 
showing their role in transduction of the NCAM-mediated signal leading to neurite 
outgrowth (Anderson et al., 2005; Kiselyov et al., 2003). 
1.3 Neurite outgrowth 
NCAM hemophilic binding stimulates neurite outgrowth (Doherty et al., 1989). 
Neurite outgrowth is the means by which neuronal cells put out and extend processes 
which will later develop into axons and dendrites (Larsson, 2006). Extension of neurites 
involves the reorganisation of the actin and microtubule cytoskeleton in response to 
both long and short range positive and inhibitory cues so that neurons can synapse with 
their appropriate target even when separated by considerable distance (Govek et al., 
2005; Tessier-Lavigne and Goodman, 1996). In vitro neurite outgrowth models are well 
characterised and study the outgrowth response of either primary neurons or cell lines 
of neuroepithelial origin (such as PCI2 cells or neuroblastomas) to various stimuli 
usually in a substrate, recombinant fibroblast monolayer, or in soluble form (Beggs et 
al., 1997; Doherty et al., 1989; Kiryushko et al., 2004). 
Fibroblasts Primary neurons/ Outgrowth response 
PC12/neuroblastomas determined by interaction 
with surface proteins overexpressed 
^ % # by the fibroblast layer 
_ . g g , # # 
V 16hrs 16hrs 
Figure 1.3.1 - Schematic of a fibroblast monolayer neurite outgrowth assay. Fibroblasts which can 
be transfected to express various cell surface proteins are plated as a dense monolayer overnight 
and then primary neurons or neuronal cell lines plated on top. After a fixed period of time, the 
outgrowth response of the neurons to the proteins expressed in the monolayer can be assessed. 
When presented to a neuron, NCAM is an outgrowth-stimulatory molecule. This 
response has been well characterised in an in vitro system in which NCAM is 
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transfected into non-NCAM expressing fibroblast cell lines such as NIH 3T3 cells and 
presented as a confluent monolayer to neurons growing on top. After 16-48 hours the 
neurons are assessed for neurite length (Figure 1.3.1) (Doherty et al., 1989). The 
advantages of this system over coating down purified NCAM as a substrate or applying 
soluble NCAM is that NCAM is displayed in a cellular context to the overlying neurons in 
a greater approximation to the in vivo situation. The outgrowth response of cerebellar 
granule neurons on monolayers expressing NCAM 140, NCAM120 and NCAM 125 has 
been shown to be dependent on NCAM expression level. Rather than dose-dependently 
increasing outgrowth, NCAM appears to have a critical expression level threshold value 
below which no stimulation of outgrowth occurs and above which the extent of 
outgrowth stimulation rapidly increases (Doherty et al., 1990b). Monolayers expressing 
secreted NCAM do not promote neurite outgrowth above basal levels (Doherty et al., 
1990b). Monolayers expressing NCAM 180 are not as good as NCAM 140 at promoting 
neurite outgrowth possibly as due to their cytoskeletal interactions, they are not so 
motile in the membrane which could potentially hinder any necessary NCAM 
reorganisations which might need to occur to promote outgrowth (Doherty et al., 1992b). 
As well as having different effects on neurite outgrowth when presented to a 
neuron, different NCAM isoforms also have different effects when transfected into the 
neuron itself. Transfecting NCAM120 into PCI2 cells inhibits their normal outgrowth 
response to an NCAM-expressing monolayer but not an N-Cadherin monolayer 
suggesting a dominant negative effect (Saffell et al., 1995). Outgrowth response to 
NCAM is restored by treatment with PIPLC (phosphatidylinositol-specific phospholipase 
C) which cleaves the GPI-anchored NCAM 120 from the cell surface, leaving 
endogenous NCAM free to act. Overexpressing NCAM 140 without its cytoplasmic 
domain also had the same outgrowth inhibitory effect suggesting that NCAM stimulated-
neurite outgrowth is dependent on an NCAM cytoplasmic domain (Kolkova et al., 2000; 
Saffell et al., 1995). Overexpressing the NCAM 180 cyoplasmic domain in PC12 cells 
had no effect on NCAM-stimulated outgrowth in one study (Kolkova et al., 2000), 
although an NCAM180 cytoplasmic domain also containing the transmembrane region 
actually greatly increased outgrowth in a more recent study (Buttner et al., 2004). The 
authors suggest that overexpressing the cytoplasmic domain of NCAM 180 anchored to 
the cell membrane could sequester cytoskeletal components and disarrange the 
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cytoskeleton in some fashion that is favourable to neurite outgrowth where as an 
expressed soluble cytoplasmic domain could not (Buttner et al., 2004). 
1.4 Tissue localisation of NCAM 
NCAM distribution in the nervous system of various organisms, both throughout 
development and in adult, has been characterised and revisited a number of times over 
the last 25 years (Beasley and Stallcup, 1987; Daniloff et al., 1986; Dolapchieva et al., 
2001; Filiz et al., 2002; Goldowitz et al., 1990; Persohn and Schachner, 1987). Many of 
these reports contain conflicting data but taken as a whole, a consensus can be 
constructed. It is important to note that in some reports, NCAM localisation has been 
achieved using NCAM intracellular-specific antibodies, and so NCAM 120 distribution is 
not observed (Daniloff et al., 1986). This may not be a problem for NCAM distribution in 
neurons, as NCAM 140 and 180 are their major isoforms (Keilhauer et al., 1985). 
However, NCAM 120 is the major NCAM isoform of glial cells, and so glia could be being 
neglected in these studies (Nybroe et al., 1988). 
Generally in the nervous system, NCAM expression early in development is fairly 
ubiquitous and highly expressed, and becomes restricted as expression decreases with 
maturity (Chuong and Edelman, 1984). The four main areas of the nervous system that 
have been focussed upon in previous investigations into NCAM expression are: 
cerebellum, hippocampus, spinal cord and sciatic nerve (Beasley and Stallcup, 1987; 
Daniloff et al., 1986; Dolapchieva et al., 2001; Filiz et al., 2002; Goldowitz et al., 1990; 
Joosten, 1994; Persohn and Schachner, 1987). 
NCAM Expression in the Adult Cerebellum 
The adult cerebellum is composed of four layers: the outermost molecular layer, 
Purkinje cell layer, granule cell layer, and the innermost white matter fibre tracts. The 
molecular layer is composed mainly of the axons of granule neurons (called parallel 
fibres), which synapse onto the huge dendritic trees of the Purkinje cells. The molecular 
layer also contains other lower-abundance neurons such as stellate and basket 
neurons. The Purkinje cell layer contains the cell bodies of Purkinje neurons - the only 
neuronal output from the cerebellum. The Purkinje neurons extend a huge dendritic tree 
up into the molecular layer and a single axon down into the white matter via the granule 
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cell layer. The cell bodies of Bergmann glia also reside in the Purkinje cell layer and are 
crucial for the correct migration and connectivity of the Purkinje and granule neurons 
during development. Bergmann glia extend processes up into the molecular layer to the 
pial surface. The granule cell layer is tightly packed with the cell bodies of granule 
neurons - the most abundant cell type in the cerebellum. It also contains the axons of 
the Purkinje cells leaving the cerebellum, and axons of mossy and climbing fibres 
entering the cerebellum from the pons, inferior olive and spinocerebellar pathways. The 
cerebellar white matter tracts contain tightly bundled and myelinated axons of the 
Purkinje neurons, mossy and climbing fibres. For a comprehensive description of the rat 
cerebellum both during development and adult, Altman provides a comprehensive 
analysis at the EM level (Altman, 1972a; Altman, 1972b; Altman, 1972c; Altman, 1975; 
Altman and Winfree, 1977). 
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Figure 1.4.1 - The reported distribution of NCAM in the cerebellum as reported by various studies 
(Beasley and Stallcup, 1987; Daniloff et al., 1986; Filiz et al., 2002; Goldowitz et al., 1990). Darker 
shades of red represent higher NCAM expression by antibody staining and darker shades of 
green represent higher NCAM expression by in situ hybridisation. White shading represents an 
absence of NCAM expression, and grey shading indicates that this area was not commented upon 
in the study. 
In chicken, NCAM staining in the adult cerebellum has been found in all four 
layers, with the molecular layer and white matter giving the highest immunoreactivity 
(Daniloff et al., 1986). In rat, Beasley and Stallcup also reported high NCAM expression 
in the molecular and Purkinje cell layer and that the granule neuron layer contained only 
scattered staining (Beasley and Stallcup, 1987). Again, Filiz and coworkers, reported 
that the rat cerebellar molecular layer contained moderate amounts of NCAM, and in 
addition that the Purkinje cells weakly stained (Filiz et al., 2002). By in situ hybridisation, 
Goldwitz and coworkers identified that in PND23 mouse (cerebellum considered to have 
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developed about PND30 (apart from a few minor refinements), but morphology is 
essentially adult at this age) Purkinje, stellate and basket neurons highly express NCAM 
mRNA, whilst granule neurons express a moderate amount (Goldowitz et al., 1990). 
The general consensus for all of the localisation studies is that the cerebellar 
molecular and Purkinje cell layer are NCAM-positive (Figure 1.4.1). Reports of NCAM 
staining in the granule cell layer varies from moderate staining (Daniloff et al., 1986), to 
scattered staining (Beasley and Stallcup, 1987), and no staining at all (Filiz et al., 
2002). This discrepancy is hard to reconcile. Perhaps the moderate granule cell staining 
that Daniloff and coworkers observed is chicken-specific and not found in rat. The 
scattered granule cell layer staining reported by Beasley and Stallcup could be due to 
them possibly using an NCAM antibody reactive to all NCAM isoforms (although this 
cannot be definitively confirmed from the literature), whilst the absence of this staining 
found by Filiz and coworkers could be due to them using an NCAM antibody only 
reactive to the 140 and 180 isoforms. Alternatively the discrepancy could simply be due 
to variation caused by using different NCAM antibodies. In situ hybridisation studies 
seem to confirm that Purkinje neurons highly express NCAM and also the granule 
neurons to some extent (Goldowitz et al., 1990). The absence of NCAM 
immunoreactivity from the granule neuron layer even though they express NCAM could 
be accounted for if NCAM is localised to their axons which mainly reside in the 
molecular layer. Cerebellar white matter has been shown by Daniloff and coworkers to 
be immunoreactive to NCAM (Daniloff et al., 1986), however none of the other antibody 
studies pass comment on the presence or absence of white matter NCAM staining. 
NCAM Staining in the Adult Hippocampus 
An area of interest for NCAM expression, especially NCAM with the PSA modification, 
is the hippocampus due to NCAM/PSA involvement in long term potentiation (see later) 
(Muller et al., 2000). NCAM has been found to stain throughout the hippocampus, 
however the main areas of staining are the inner molecular layer of the dentate gyrus 
and the hjlus. The mossy fibre tract (also called the stratum lucidum) connecting dentate 
granule cells to the CAS region via the hilus (Figure 1.4.2) has also been found to be 
highly NCAM positive (Miller et al., 1993; Seki and Arai, 1993). In adult, new neurons 
are generated from the subgranular layer of the dentate gyrus, which then migrate into 
the dentate gyrus granule layer. Their axons then extend into the mossy fibre pathway. 
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making this one of the two main regions for adult neurogenesis in the brain (Sohur et 
al., 2006). Moderate NCAM staining was found in the stratum lacunosum moleculare, 
CA1 pyramidal layer, and the boundary of the hippocampus, with an absence of cell 
body staining dentate gyrus granular layers (Miller et al., 1993). Another study has 
confirmed extensive NCAM staining throughout the hippocampus and contrastingly 
found NCAM staining in the dentate gyrus granular layer (Bonfanti et al., 1992). 
Cortical hemisphere 
Stratum lacunosum-
moleculare 
IVIossy fibre 
Dentate gyms Hilus(CA4) \ 
Figure 1.4.2 - Diagram of the rat hippocampus. Modified from "Brain IVIaps; Structure of the Rat 
Brain" (2"^ ^ ed.) L.W. Swanson. 
NCAM Staining in the Adult Spinal Cord 
NCAM expression in the spinal cord is mainly localised to the grey matter, particularly 
the substantia gelatinosa (also called lamina II) located towards the tip of the dorsal 
horn (Joosten, 1994). The substantia gelatinosa is divided into outer and inner layer 
(Cervero and Iggo, 1980). The outer layer contains small neurons and the synaptic 
terminals of unmyelinated dorsal root afferent fibres. The inner layer contains slightly 
fewer neurons and receives both myelinated and unmyelinated fibres from the dorsal 
root (Cervero and Iggo, 1980). The function of the substantia gelatinosa has not been 
fully determined, however it is postulated to have a role in the processing of pain stimuli 
from sensory neurons (Lu and Perl, 2003). The innermost layer surrounding the central 
canal (called lamina X) also is a site of NCAM expression (Joosten, 1994). In the ventral 
spinal cord grey matter, cell bodies of motor neurons were found to be highly NCAM 
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immunoreactive (Joosten, 1994). Another report has confirmed that NCAM staining is 
strong in the lamina X, and is expressed specifically by the ependymal cell layer of the 
central canal (Filiz et al., 2002). Ependymal cells are ciliated cells found in a one cell-
thick layer lining the ventricles of the brain and spinal cord (Bruni, 1998). Their function 
remains controversial, as classically they were thought to provide a permeable barrier 
between the cerebrospinal fluid (csf) and the brain, and beat their cilia, to create flow 
currents in the csf (Spassky et al., 2005). Lately however they have been suggested to 
possess stem cell-like properties under certain conditions (Bruni, 1998; Xu et al., 2005). 
Low levels of NCAM staining have also been reported in the spinal cord white matter 
(Filiz et al., 2002). 
NCAM Staining in the Adult Sciatic Nerve 
NCAM distribution in the peripheral nervous system (PNS) has mainly focussed on the 
sciatic nerve. The sciatic nerve is a large nerve running down the back of the hind leg 
containing both sensory axons from the skin and motor axons to the muscle. In the 
sciatic nerve, NCAM has a very restricted pattern, with the main region of 
immunoreactivity being found on non-myelinating Schwann cells (Dolapchieva et al., 
2001; Mirsky et al., 1986; Roche et al., 1997; Seilheimer et al., 1989). Axons in the 
sciatic nerve have also been found to express some NCAM in their membrane and 
axoplasm and also NCAM immunoreactivity has been localised to the ECM 
(Dolapchieva et al., 2001). Most reports claim NCAM is totally absent from compact 
myelin (Dolapchieva et al., 2001; Jessen et al., 1987; Mirsky et al., 1986; Roche et al., 
1997). Two reports from the same lab however detected weak NCAM expression in the 
compact myelin (Martini and Schachner, 1986; Seilheimer et al., 1989). NCAM 
expression in myelinating Schwann cells is thought to be inhibited by signals from the 
axon, as transecting the axon or removing the Schwann cell from the axon in culture 
leads to a dramatic upregulation of their NCAM expression (Jessen et al., 1987). 
NCAM Expression in Other Tissues 
Although NCAM is named neural ceW adhesion molecule, in adult it has been 
found to be also be expressed in neuroendocrine tissues in the intestine (Thor et al., 
1987), pancreas (Cirulli et al., 1994), and liver (Small and Akeson, 1990), as well as the 
testes and ovaries (Davidoff et al., 1993; Mayerhofer et al., 1994), lungs and kidneys 
(Filiz et al., 2002), skeletal muscle and heart (Small and Akeson, 1990). The function of 
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NCAM in these-non nervous system tissues has been characterised in some cases, for 
example, NCAM has been shown to be important in the proper segregation of cells 
within the pancreas during development of the islets of Langerhans. NCAM KO mice 
have a much more randomised distribution of cells in their islets although their pancreas 
appears to function normally (Esni et a!., 1999). 
NCAM expression in the heart is fairly ubiquitous during development, becoming 
more restricted in adult (Wharton et al., 1989). In the adult rat heart, NCAM has been 
localised to nerve fibres innervating the cardiac tissue, myocardial cells surrounding the 
coronary artery, intercalated discs (membrane separating adjacent cells) and the 
sarcolemma (muscle cell membrane) of myocardial cells from the ventriclar wall 
(Wharton et al., 1989). NCAM has been reported as absent from atrial myocardial cells 
(Wharton et al., 1989). During development, NCAM is also ubiquitously expressed in 
skeletal muscle, becoming restricted to around the neuromuscular junction (NMJ) by 
adulthood (Covault and Sanes, 1986). If the muscle is denervated, NCAM expression is 
transiently upregulated all over the muscle fibre until reinnervation is achieved (Covault 
and Sanes, 1985). 
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1.5 Posttranslational modification of NCAM 
NCAM Glycosylation 
N5 N3 
N4 
N2 N6 
Site Glycosylation 
N1 
N2 
N3 
N4 
N5 
N6 
Sometimes unglycosylated; non-PSA, non-HNK-1 glycan 
HNK-1; non-PSA, non-HNK-1 glycan 
HNK-1; non-PSA, non-HNK-1 glycan 
HNK-1; non-PSA, non-HNK-1 glycan 
PSA: HNK-1; non-PSA, non-HNK-1 glycan 
PSA ; HNK-1; non-PSA, non-HNK-1 glycan 
Figure 1.5.1 - (a) There are six N-glycosylation sites in the extracellular domain of NCAM. (b) 
Glycans identified at each glycosylation site. Note there are three N-glycosylation sites in NCAM 
IgV but only two of them receive the PSA glycan (Albach et al., 2004; Walmod et al., 2004). 
The extracellular domain of NCAM has six N-glycosylation sites (N1-6) (Figure 1.5.1). 
NCAM contains complex and varied glycans, however two significant carbohydrate 
epitopes have been identified - polysialic acid (PSA) and human natural killer cell 
glycan (HNK-1).(Albach et al., 2004; Hoffman and Edelman, 1983; Kruse et al., 1984). 
Polysialic Acid (PSA) 
The major posttranslational modification of NCAM is the addition of polysialic 
acid (PSA) to IgV. It is a linear homopolymer of a2-8-linked sialic acid consisting of 8 to 
100 monomers (Rutishauser and Landmesser, 1996) (Figure 1.5.2) and has been found 
to have extremely important roles during nervous system development, and in learning 
and memory (Bonfanti, 2006). 
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Figure 1.5.2 - (a) Glycan structure of NCAM polysialic acid which is developmentally added to N5 
and N6 N-glycosylation sites in NCAM IgV. Marl<ed is the endoneuraminidase (endoN) cleavage 
site, (b) Glycan structure of an N-glycan from the protein PO bearing the sulphated HNK-1 epitope 
which is thought to be similar to those found on NCAM. R = region of variability which can contain 
a number of different sugar residues. Based on diagrams from (Rutishauser and Landmesser, 
1996) and (Kleene and Schachner, 2004). 
PSA was first identified in the brains of young rats in the early 1980s and it was noted 
that PSA could not be observed in the adult brain, so was proposed to be 
developmentally regulated (Finne, 1982). Curiously, it was discovered that PSA is 
almost exclusively attached to NCAM, with the only other protein to be minimally 
polysialylated being the sodium channel a subunit (Finne et al., 1983; Zuber et al., 
1992). Confirmation of this came when an NCAM knock-out (NCAM KO) mouse was 
created which also showed virtually a complete loss of PSA in the brain (Cremer et al., 
1994). 
PSA is added to NCAM by two enzymes - polysialyltransferase (PST or 
STSSialV) and sialyltransferase X (STX or ST8Siall). STX is mainly active during 
embryonic and postnatal development. Its mRNA peaks in abundance at PND2 and is 
almost absent by 6 months. PST is expressed throughout development but mRNA 
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levels only slightly decrease during development and persist into adulthood, especially 
in areas of synaptic plasticity such as the subependymal layer of the lateral ventricle, 
the granule cell layer of the dentate gyrus and the glomerular layer of the olfactory bulb 
(Hildebrandt et al., 1998). Structurally, only the adjacent NCAM FNIII-1 and IgV 
domains are required for the addition of PSA to NCAM by either PSA transferase 
enzyme but it is thought that perhaps NCAM IglV might have a non-essential minor role 
in fine-tuning the process (Close et al., 2003). If a triple Ala substitution of the acidic 
residues Asp511, Glu512 and Glu514 from an a-helix in NCAM FNIII-1 is performed, 
PSA transferase enzyme addition of PSA to NCAM is eliminated (Mendiratta et al., 
2005). Deleting the a-helix altogether causes PSA to be mistakenly added as an 0 -
glycan to FNIII-1 instead of as an N-glycan to IgV (Mendiratta et al., 2006). 
The developmental downregulation of PSA addition to NCAM is dependent on 
the availability of PSA transferase enzymes rather than the cleaving of PSA from NCAM 
by endogenous glycosidase activity or the death of PSA-NCAM-expressing cells 
(Friedlander et al., 1985). The downregulation occurs at different times in different 
tissues, in rats the earliest being in the dorsal root ganglion which loses PSA by PND1 
and the latest being the tectum which never completely loses PSA expression (Chuong 
and Edelman, 1984). 
PSA can be specifically cleaved from NCAM by the enzyme endoneuraminidase 
(endoN) from bacteriophage K1F which cleaves a2-8-linked sialic acid homopolymers 
into oligomers of 3-4 residues (Rutishauser et al., 1985). This has been a powerful and 
versatile tool to probe both the effects of PSA and NCAM in vitro and in vivo. 
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Figure 1.5.3 - Through steric hindrance and electrochemical repulsion, negatively charged PSA 
on NCAM can increase the intermembrane distance between cells so that cell-cell adhesion can 
further be reduced by interfering with the binding of other cell adhesion molecules (CAMs). (a) 
NCAM with PSA prevents other CAMs binding, (b) NCAM without PSA allows close membrane 
contact needed for other CAMs to interact. 
Polysialylation can account for up to 30% of the relative molecular mass of 
NCAM and coupled with its negative charge, PSA has been shown to exert both a steric 
and an electrorepulsive effect on surrounding PSA-NCAM molecules (Bonfanti, 2006). 
This affects the hemophilic binding strength of NCAM. Early on, it was noticed that 
NCAM-coated vesicles aggregated four times faster if they didn't have PSA, and that 
removing PSA with endoN could speed up the aggregation rate (Hoffman and Edelman, 
1983; Rutishauser et al., 1985). In fact, PSA can block the adhesion of other cell 
adhesion molecules such as N-Cadherin and integrins (Fujimoto et al., 2001; Johnson 
et al., 2005) perhaps by simply by increasing the distance between opposing cell 
membranes so that the cell adhesion molecules cannot come into contact, as 
suggested by Yang et al {Yang et al., 1994) (Figure 1.5.3). It is interesting to note 
however, that even though PSA reduces the adhesiveness of NCAM, it actually 
enhances NCAM-mediated neurite outgrowth rather than abrogates it. EndoN removal 
of PSA from embryonic retinal ganglion cells caused a reduction in their neurite 
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outgrowth response stimulated by an underlying NCAM-expressing cellular monolayer 
(Doherty et al., 1990a; Walsh and Doherty, 1991). Two possible explanations have 
been put forward to account for this effect - one being that weaker, more transient 
NCAM interactions would be more favourable for the reorganisation and growth of the 
extending neurite (Doherty et al., 1990a), the other suggesting that in the "Zipper" 
model, PSA perhaps could disrupt some of the zipper modes of binding, allowing a 
looser NCAM configuration more accessible for an association with the FGF receptor 
leading to activation of neurite outgrowth signalling pathways (see later) (Kiselyov et al., 
2005). 
The correlation of persistent PSA-NCAM expression with areas of the CNS which 
undergo constant rearrangement or generate new neurons, such as the dentate gyrus 
and the olfactory bulb, has lead to the investigation of PSA as a potential mediator of 
synaptic plasticity. It has been found that injection of endoN into the hippocampus of 
adult rats specifically impairs their acquisition and retention of spatial memory whilst not 
affecting their visual or motor pathways. In fact, endoN treatment of hippocampal slices 
is enough to completely abolish long term potentiation (LTP) and long term depression 
(LTD) in vitro (Becker et al., 1996; Stoenica et al., 2006). In vivo, NCAM KO mice have 
impaired LTP. This can be rescued by injecting PSA or PSA-NCAM into the 
hippocampus but not NCAM without PSA, suggesting it is the loss of PSA not NCAM 
which is causing the impairment (Senkov et al., 2006). However other work has 
suggested the opposite, that NCAM not PSA is the important factor in restoring normal 
LTP (Stoenica et al., 2006). It is quite likely that both NCAM and PSA play a role in 
correct learning and memory responses. PSA has also been shown to be important in 
the storage of fear memories. The amygdala is involved in the processing of fear 
memories and 24 hours post fear-training, PSA has been shown to be upregulated in 
this region. EndoN treatment of the amygdala had no affect on the acquisition of the 
fear memory, but does increase the rate of its extinction (Markram et al., 2007). 
The role of PSA during development has also been shown to be important. In 
vitro, the enzymatic removal or antibody blocking of PSA has been shown to 
significantly reduce the number of neuronal progenitors present in culture. It was shown 
that this is not due to reduced proliferation of the progenitors, rather to their early cell 
death, suggesting PSA could be a neuronal progenitor survival factor (Vutskits et al., 
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2006). PSA is also important in the migration of neuronal and oligodendroglial 
precursors, and for the defasiculation of axons where its anti-adhesive properties are 
thought to allow for transitory interactions more favourable for cell migration and neurite 
outgrowth (Bruses and Rutishauser, 2001; Franceschini etal., 2004). 
NCAIVI KO mice surprisingly are not embryonic lethal, but have a relatively mild 
phenotype characterised most notably by a 36% smaller, but fully functional, olfactory 
bulb (Cremer et al., 1994). The reduced size of the olfactory bulb has been found to be 
due to the greatly reduced ability of neuronal precursors to migrate from the 
subependymal layer of the lateral ventricle to the olfactory bulb through the rostral 
migratory pathway via a process called tangential migration. A large accumulation of 
precursors can be observed stalled in the migratory pathway (Chazal et al., 2000). 
Despite a diminished olfactory bulb, NCAIVI KO mice perform equally well as wild type 
mice in odour discrimination tests (Schellinck et al., 2004). Interestingly, injection of 
endoN into the brains of newborn rat pups causes a similar failure of neuronal 
precursors to migrate along the rostal migratory pathway suggesting that it is the 
absence of PSA in the NCAIVI KO mice rather than the absence of NCAIVI, which is 
causing this effect (Ono et al., 1994). The NCAIVI KO also has been linked to deficits in 
spatial memory, whilst having no effect on motor nerve pathways (Cremer et al., 1994), 
and causes a behavioural phenotype resembling schizophrenia (Pillai-Nair et al., 2005). 
Unlike the relatively mild phenotype of the NCAIVI KO, mice that have had both 
PSA transferase enzymes knocked out (PSA double KO) and so only express NCAIVI 
without PSA, show a postnatal lethal phenotype with severe brain defects, 50% of the 
pups dying within three weeks of birth (Weinhold et al., 2005). PSA double KO mice 
exhibit all the major phenotypic brain defects of NCAIVI KO mice reinforcing the proposal 
that it is the absence of PSA not NCAIVI per se that is important in the NCAIVI KO 
mouse. In addition, PSA double KO mice have unique defects, including postnatal 
growth retardation; precocious death; massive hydrocephalus; and abnormalities of 
major brain fibre tracts (Weinhold et al., 2005). Creating triple knockout mice in which 
both the PSA transferase enzymes and NCAIVI have been deleted, was found to rescue 
the postnatal lethality and restored the mice to the much milder NCAIVI KO phenotype. 
From this finding it has been concluded that removing PSA from NCAIVI creates a gain 
of function mutation and that during development PSA acts to regulate the effects of 
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NCAM in a controllable fashion. Some aspects of the PSA double KO phenotype, such 
as hydrocephalus, resemble those of an L1 KO. L1 is another cell adhesion molecule 
and a known heterophilic binding partner of NCAM (see later). Weinhold etal suggest 
that removing PSA from NCAM allows a stronger interaction between NCAM and L1, 
leading to L1 being sequestered from its other binding partners and negating its function 
which would give phenotypic similarities between the KO mice (Weinhold et al., 2005). 
PSA has also been implicated in the sensitivity of cells in the CNS to respond to 
soluble growth factors. EndoN removal of PSA reduces the differentiation and survival 
of cultured rat cortical neurons in culture and reduces signalling activated by brain-
derived neurotrophic factor (BDNF). Adding exogenous BDNF can rescue these effects 
(Vutskits et al., 2001). Similarly PSA antibody blocking or endoN treatment of 
oligodendrocyte precursor cells (OPCs) have both been observed to reduce OPC 
chemotaxis response towards a source of platelet-derived growth factor (PDGF). OPCs 
with PSA removed migrated at the same rate as untreated OPCs but in random 
directions rather than towards the PDGF source suggesting PSA as important in the 
direction of migration in response to PDGF. Another OPC chemoattractant, basic 
fibroblast growth factor (FGF-2) was shown to be not affected by PSA removal (Zhang 
et al., 2004). In slice cultures of the rat paraventricular nucleus, survival of 
magnocellular neurons can be potently promoted by the addition of exogenous ciliary 
neurotrophic factor (CNTF) or leukaemia inhibitory factor (LIF). EndoN removal of PSA 
from the slice cultures causes increased cell death which can be rescued by LIF but not 
by low concentrations of CNTF. PSA has then been concluded to be required for 
magnocellular neuron response to low CNTF concentrations (Vutskits et al., 2003). 
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Figure 1.5.4 - The possible modes of action of PSA in mediating growth factor signalling, (a) 
Without PSA, the concentration of growth factor is not sufficient to elicit a signalling response, (b) 
PSA could bind and concentrate incoming low abundance growth factors "channelling" them to 
their receptors and enhancing the signalling response, (c) Alternatively PSA could concentrate 
the receptors and restrict their mobility in the membrane facilitating their dimerisation and 
activation of signalling cascades. Based on diagram from (Bonfanti, 2006). 
A possible mechanism for the role of PSA in BDNF, PDGF and CNTF signalling could 
be due to PSA acting as a "sponge" to soak up growth factors in low abundance and 
concentrate them at the membrane surface ready for their respective receptors to 
receive (Bonfanti, 2006) (Figure 1.5.4). Although this model is still speculative, CNTF 
contains a cluster of three arg residues on its surface which gives it a localised region of 
positive charge which could perhaps bind to PSA which has an overall negative charge 
(Vutskits et al., 2003). Alternatively perhaps the steric repulsion of PSA over the surface 
of the cell membrane repels growth factor receptors into close proximity. As BDNF, 
PDGF and CNTF all signal through tyrosine kinase receptor dimerisation, restricting 
receptor lateral movement through the membrane could create localised points of 
receptor concentration and so facilitate receptor dimerisation and signalling (Figure 
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1.5.4). However LIF signalling, which has been shown to be not affected by PSA 
removal, also acts through a receptor tyrosine kinase and so this model would appear to 
not fit every growth factor signalling pathway (Vutskits et al., 2003). 
In the nervous system, regeneration after Injury generally requires the 
recapitulation of processes and proteins involved in development and PSA-NCAM is 
one such protein (Bates et al., 1999). During development, the extending axons of 
motor neurons from chick embryos express only very low amounts of PSA when they 
are tightly packed together into fasicles. Upregulation of the expression of PSA in the 
motor neurons exactly correlates with the time point at which the axons defasiculate, 
and rearrange into target-specific nerve bundles (Tang et al., 1992). EndoN removal of 
PSA at the time of axon rearrangement causes axons to remain fasiculated and leads to 
axon projection errors (Tang et al., 1994). In an analogous situation in adult mice, 
transection of the femoral nerve causes the reexpression of PSA which has been shown 
to be important in enabling regenerating motor axons to reinnervate specific muscle 
pathways. EndoN removal of PSA causes misdirection of some of these axons from 
motor pathways into cutaneous pathways (Franz et al., 2005). Similarly, during 
development PSA has been shown to be an inhibitor of myelination, with myelination 
only occurring after PSA has been downregulated from axons (Charles et al., 2000; 
Franceschini et al., 2004). In adult, PSA has been shown to be present on demyelinated 
axons in multiple sclerosis lesions but not on axons that have successfully remyelinated 
(Charles et al., 2002). 
HNK-1 
The sulphated glycoside human natural killer cell glycan (HNK-1), unlike PSA is found 
on a wide range of cell recognition proteins such as NCAM, LI, MAG and PO (Kleene 
and Schachner, 2004; Kruse et al., 1984). Immunoprecipitating NCAM with a HNK-1 
antibody will not pull down all of the NCAM suggesting that only some NCAM molecules 
display the HNK-1 epitope (Kruse et al., 1984). Little is known about the significance of 
HNK-1 on NCAM in particular, however HNK-1 has been shown to have an important 
role during nervous system development binding several proteins such as laminin-1 and 
-2, amphoterin and chondroitin sulphate proteoglcan lecticans (Kleene and Schachner, 
2004). Similarly to PSA, HNK-1 appears to be important in learning and memory. Mice 
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deficient in a key enzyme in the synthesis of HNK-1 display defects in spatial memory 
formation (Yamamoto et al., 2002). 
Other NCAM Modifications 
NCAM can also undergo a number of other posttranslational modifications. 
NCAM 140 and 180 can be palmitoylated on cytoplasmic Cys residues close to the 
plasma membrane which enables their entry into lipid rafts which is important in the 
NCAM signalling cascade leading to neurite outgrowth (Niethammer et al., 2002). 
NCAM can be phosphorylated on its single intracellular tyrosine residue which in the 
case of NCAM 180 has been shown to interfere with NCAM stimulation of the fibroblast 
growth factor receptor (FGFR) signalling pathway (Diestel et al., 2004). In addition, 
intracellular Ser and Thr residues have been shown to be phosphorylated by glycogen 
synthase kinase 3 (GSK-3) and casein kinase 1 (CK 1) (Mackie et al., 1989). The 
functional significance of NCAM Ser and Thr phosphorylation has not yet been fully 
explored, however the differentiation of PCI2 cells into their neuronal phenotype by 
NGF also causes NCAM to be phosphorylated involving protein kinase C (PKC). In the 
same study NCAM was also shown to be dephosphorylated by protein phosphatase 
1 (Matthias and Horstkorte, 2006). 
To conclude, the posttranslational modifications of NCAM add another layer of 
complexity to NCAM function. PSA increasingly has come to be seen as more 
functionally significant than the NCAM on which it is attached to, and consequently is 
continuing to be a molecule of huge interest especially in the field of learning and 
memory. 
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Figure 1.6.1 - Heterophilic interactions of NCAIVI illustrating the role of NCAM in linking the extracellular matrix to the cellular cytoskeleton, as an extracellular 
receptor, and as a signal transduction molecule. HBD = heparin binding domain, LBD = lectin binding domain. An extended version of figure 2, (Walmod et 
al.,2004). 
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1.6 NCAM heterophilic binding 
Like other cell adhesion molecules, NCAM can contribute to the stability of a cell by 
linking the cellular cytoskeleton to the extracellular matrix (ECM) or to other cells. 
Extracellular interactions of NCAM 
L1 
NCAM has been shown to bind to another member of the immunoglobulin cell adhesion 
molecule superfamily - L1, in a cis- interaction involving a carbohydrate lectin binding 
domain (LBD) in NCAM IglV and oligomannosidic carbohydrates on L1 (Horstkorte et 
a!., 1993; Kadmon et al., 1990a). The LBD has homology to known carbohydrate 
binding sequences: c x x x x x x (v, i,L) x (s, T) (VI) XXXX (E, S) , and is located close 
to the insertion point of the alternatively spliced VASE exon (Horstkorte et al., 1993). 
Like NCAM, LI is a hemophilic binding molecule with a role in neural development and 
neurite outgrowth, and is structurally similar to NCAM however has an extracellular 
domain consisting of six immunoglobulin domains followed by five fibronectin type III 
domains (Maness and Schachner, 2007). Interestingly bead aggregation studies have 
shown that LI-LI hemophilic binding is actually enhanced by the presence of an 
interaction with NCAM also contained on one of the beads (Kadmon et al., 1990b). It 
appears that NCAM not participating in hemophilic binding is required for LI-stimulated 
neurite outgrowth as soluble NCAM lgl,ll or III completely inhibits LI-simulated 
outgrowth, presumably by binding to the "free" NCAM on the neuron (Kristiansen et al., 
1999). The physiological significance of NCAM-LI interactions has yet to be determined 
but as LI promotes neurite outgrowth via ppSOc®'"'^  rather than p59^" this cross-talk 
further adds to the potential complexity of NCAM signalling (see later) (Maness and 
Schachner, 2007). Another cell adhesion molecule, TAG-1/Axonin has also been shown 
to bind to both NCAM and L1 in cis although the importance of these interactions has 
yet to be determined (Malhotra et al., 1998; Milev et al., 1996). 
Heparin 
NCAM has been shown to bind to the heparin, and ECM proteoglycans containing 
heparan sulphate (HSPGs) and chondroitin sulphate (CSPGs) (Storms et al., 1996) via 
a heparin binding domain (HBD) in Igll (Kulahin et al., 2005). Soluble heparin is able to 
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abrogate NCAM-mediated aggregation of NCAM transfected 3T3 fibroblast cells (Pizzey 
et al., 1989) and NCAM mediated neurite outgrowth (Kulahin et al., 2005). The inhibition 
of NCAM homophilic binding by heparin can be accounted for by the fact that the NCAM 
heparin binding domain (HBD) in Igll overlaps with its Igl homophilic binding domain 
(Kulahin et al., 2005). 
RPTPC/p 
The phosphatase RPTP(/|3, and its alternatively spliced isoform phosphacan can bind to 
NCAM via a high affinity carbohydrate interaction with NCAM IglV lectin binding domain. 
Phosphacan is an ECM protein and is a potent inhibitor of neuronal and glial adhesion 
and neurite outgrowth (Milev et al., 1995). Another ECM protein found to bind to NCAM 
and inhibit NCAM homophilic adhesion is neurocan (Grumet et al., 1993). The precise 
function of neurocan is unclear, although its deletion in KO mice appears to not cause 
any adverse effects (Zhou et al., 2001). Other ECM and cell surface proteins that NCAM 
can bind to are laminin, via HNK-1 glycans (Hall et al., 1997), P- and L- select!n also via 
HNK-1 glycans (Needham and Schnaar, 1993), and collagen, thought to be via heparin 
sulphate (Walmod et al., 2004). 
Robo3 
Robo3, a member of the robo family of transmembrane receptors can also bind to 
NCAM, in addition to its usual ligand, slit (Camurri et al., 2005). The Robo3-NCAM 
interaction has not yet been investigated and its significance not understood, however 
Robo-slit interactions are well characterised and are an important repellent of extending 
axons away from the midline in Drosophila (Camurri et al., 2005). 
Cellular prion protein 
Cellular prion protein (PrP"^ ) binds to NCAM via NCAM FNIII-1 in a protein-protein 
interaction which can cause activation of the p59^" signalling pathways (see later) 
(Santuccione et al., 2005; Schmitt-Ulms et al., 2001). PrP° is GPl-anchored and so is 
mainly localised to lipid rafts. In PrP° KO mice, there is less NCAM localised to lipid rafts 
suggesting that PrP^ acts as a stabilising factor to keep NCAM in the rafts (Santuccione 
et al., 2005). NCAM is not thought to play any part in the infectivity of the scrapie form of 
PrP (PrP^^) as NCAM KO mice are still susceptible to scrapie prions (Schmitt-Ulms et 
al., 2001). 
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Rabies Virus 
Interestingly NCAM has also been shown to be a receptor for the Rabies virus. 
Transfection of rabies-resistant L cells with NCAM140 and 180 is sufficient to confer 
susceptibility to infection, and in vivo NCAM KO mice show a greater delay in mortality 
and much more restricted brain infectivity than wild type animals (Thoulouze et al., 
1998). NCAM120 can also act as a rabies virus receptor when transfected into rabies-
resistant cells, however the cells appear to have impaired virus replication. The 
impaired replication is thought to be caused by elevated IFN-|3 which has antiviral 
activity. A possible mechanism proposed for this effect is that the rabies virus binding to 
NCAM120 could elevate levels of IFN-(3 by blocking NCAM120 signalling through the 
glucocorticoid receptor, as the glucocorticoid receptor can act to repress transcription of 
IFN-p (Hotta et al., 2007; Krushel et al., 1998). 
ADAM Metalloproteases 
Metalloproteases of the ADAM (a disintegrin and metalloproteinase) family, such as 
TNFa converting enzyme (TACE/ADAM17) can cause the shedding of whole 
extracellular domains of NCAM 140 and 180 but not 120 (Hinkle et al., 2006; Kalus et 
al., 2006). Conflicting reports as to the effect of NCAM shedding on neurite outgrowth 
have been reported with two studies showing that inhibition of NCAM ECD shedding 
from primary hippocampal neurons, either by chemical metalloprotease inhibition or 
expression of a dominant negative metalloprotease, leads to a reduction in NCAM-
stimulated neurite outgrowth (with no effect on basal outgrowth) (Hubschmann et al., 
2005; Kalus et al., 2006), suggesting NCAM shedding is an important part of NCAM-
stimulated outgrowth. However another report indicates that chemical metalloprotease 
inhibition in primary cortical neurons actually promotes NCAM-stimulated neurite 
outgrowth and neurite branching (Hinkle et al., 2006), suggesting that NCAM shedding 
is an inhibitory process, blocking NCAM-stimulated outgrowth. Supporting this view, 
cortical neurons from embryonic lethal transgenic mice overexpressing a secreted 
NCAM isoform showed reduced NCAM-stimulated outgrowth and branching (Hinkle et 
al., 2006). These two sets of conflicting reports have yet to be reconciled but it does 
seem possible that both situations could be true as in (Hinkle et al., 2006), cortical 
neurons which were reported to shed "high levels" of NCAM. Presumably if NCAM is 
shed from the neuron membrane it can bind back to remaining NCAM and induce 
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signalling for neurite outgrowth, but if too much NCAM is shed from the surface of the 
neuron, then the neuron would lack enough surface NCAM to produce a signalling 
response and so neurite outgrowth would not be induced. 
Intracellular interactions of NCAM 
Function Reference 
Both NCAM 140 and 180 
a and (3 tubulin Components of microtubules (Buttner et al., 2003) 
a-actinin 1 Bundling of actin filaments (Buttner et al., 2003) 
PLCy Growth factor-induced cell (Buttner et al., 2005) 
motility, growth and development 
Syndapin Role in clathrin-mediated (Buttner et al., 2005) 
endocytosis of synaptic vesicles. 
cytoskeletal dynamics 
PKC(32 Phosphorylation of downstream (Leshchyns'ka et al., 
p59^" kinase 
cytoskeletal organisers 2003) 
Signalling leading to neurite (Beggs et al., 1997) 
outgrowth 
FGFR1 Signalling leading to neurite (Kiselyov et al., 2003) 
outgrowth 
Spectrin Binds to NCAM 140 and 180 but (Bodrikov et al., 2005; 
mainly 180. (Also somehow Leshchyns'ka et al.. 
associated with GPI-anchored 2003; Pollerberg et al.. 
NCAM120) 1987) 
NCAMIBO-specific 
Ankyrin Cytoskeletal linker protein (Pollerberg et al., 1987) 
(3-actin Actin filaments (Buttner et al., 2003) 
Tropomyosin Role stabilising actin filaments (Buttner et al., 2003) 
MAP-1A Stabilises microtubules (Buttner et al., 2003) 
RhoA-binding kinase-a Ser/Thr kinase that mediates (Buttner et al., 2003) 
stress fibre formation, growth 
cone collapse and inhibition of 
neurite outgrowth 
TOAD-64 Role in axon growth, signal (Buttner et al., 2005) 
transduction 
Table 1.6.1 - Intracellular binding partners of NCAM140 and 180 with roles in cytoskeletal 
structure or modulators of cytoskeletal organisation/dynamics. 
Inside the cell, many components and modulators of the cytoskeleton can bind to 
NCAM (Table 1.61). Due to the presence of an extra intracellular exon, NCAM-180 is 
able to bind to a wider range of cytoskeletal proteins resulting in a reduction the lateral 
mobility of NCAM within the membrane when compared to NCAM 140 (Pollerberg et al., 
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1987) (Table 1.61). In addition to introducing extra protein binding sites, the splicing in 
of the 180-specific exon introduces multiple Ser and Thr phosphorylation sites (Mackie 
et al., 1989) and a putative calpain protease cleavage site (Covault et al., 1991), as well 
as being a less favourable promoter of neurite outgrowth than NCAM140 when 
presented to cerebellar granule neurons in a 3T3 cellular monolayer (Doherty et al., 
1992b). NCAM180 is predominantly a neuronal NCAM isoform which is mainly 
expressed after neuronal migration and is localised to the postsynaptic density (Nybroe 
et al., 1988; Persohn et al., 1989; Pollerberg et al., 1987). The linking of NCAM180 to 
spectrin is thought to be very important in the maturation of synapses. Spectrin is 
associated with the surface of the trans-Golgi network (TGN) and so can link the TGN to 
the cell membrane via NCAM180. During synapse formation, neurites make tentative 
connections between each other which involves NCAM hemophilic binding between 
opposing neurite membranes. This has the effect of clustering NCAM180 at the site of 
cell-cell contact and so can localise the TGN via spectrin to the site of the forming 
synapse and aid the synapse maturation process (Sytnyk et al., 2004). Spectrin also is 
a scaffold for other proteins which make up the postsynaptic density such as NMDA 
receptors and calcium/calmodulin-dependent kinase II alpha (CaMKIIa - an enzyme 
very important in LTP) (Sytnyk et al., 2006). Assembly of the synapse complex is 
impaired in NCAM KO mice, with a reduced ability to recruit CaMKIIa to synapses in an 
activity-dependent manner (i.e interferes with LTP) (Sytnyk et al., 2006). 
1.7 NCAM signalling pathways 
As well as providing a physical link between neighbouring cells/ECM and the 
cellular cytoskeleton, NCAM can activate a number of signalling pathways which 
regulate cytoskeletal reorganisation necessary for cell motility, neurite outgrowth (Figure 
1.7.1), and pathways involved in cellular differentiation (Walmod et al., 2004). NCAM 
signalling pathways leading to neurite outgrowth have been intensely studied over the 
last fifteen years with a number of pathways being implicated, including the fibroblast 
growth factor receptor (FGFR) pathway (Doherty and Walsh, 1996), p59^" kinase 
pathway (Beggs et al., 1997) and the glucocorticoid receptor pathway (Crossin et al., 
1997). Although all the mechanisms of NCAM signalling are yet to be elucidated, 
recently the interdependency of the FGFR and p59^" kinase pathways has been 
elegantly demonstrated (Bodrikov et al., 2005) (Figure 1.7.3 - see later). 
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Figure 1.7.1 - General overview of intracellular signalling pathways leading to NCAM-stimulated neurite outgrowth. FGF receptor, fibroblast 
growth factor receptor; PLC, phospholipase C; PIP2, phosphatidylinositol 4,5-bisphosphate; DAG, diacylglycerol; AA, arachidonic acid; 2-AG, 2-
arachidonylglycerol; CB1, cannabinoid receptor 1; IPS, inositol 1,4,5-trisphosphate; IP3R, IPS receptor; PKC, protein kinase C; PKA, protein kinase 
A; GAP-4S, growth associated protein 4S; CaMK, calcium/calmodulin-dependent kinase; p59^", p59^" kinase; FAK, focal adhesion kinase. Based 
on figure 1 from (Povlsen et al., 2003). Additional information from (Williams et al., 200S). 
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NCAM and the FGF signalling pathway 
Fibroblast growth factor receptors (FGFRs) are a family of four receptor tyrosine 
kinases activated by fibroblast growth factors (FGFs) (Doherty and Walsh, 1996). 
Signalling is induced by ligand binding leading to receptor diamerisation and then 
autophosphorylation (Eswarakumar et al., 2005). As a result, several proteins can dock 
to the phosphorylated residues of FGFR including phospholipase Cy (PLCy). Docking 
activates PLCy causing it to act upon its substrate - phosphatidylinositol 4,5-
bisphosphate (PIP2), cleaving it into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol 
(DAG) (Walmod et al., 2004). DAG can be converted to arachidonic acid (AA) and 2-
arachidonylglycerol (2-AG) by DAG lipase, and AA can induce further accumulation of 
2-AG within the cell (Williams et al., 2003). 2-AG is a ligand for cannabinoid receptor 1 
(CB1) which can act upon cell membrane situated calcium channels, opening them and 
allowing intracellular Ca^ "" to increase (Doherty and Walsh, 1996; Williams et al., 2003). 
IP3 can also act to increase intracellular by acting upon IP3 -sensitive calcium 
channels to release intracellular stores (Walmod et al., 2004). Ca^ "" signalling acts 
upon a wide range of effectors, such as protein kinase C (which is also activated by 
directly DAG) and CAM kinase II, leading to neurite outgrowth (Doherty et al., 2000; 
Walmod et al., 2004). 
Initially it was observed that the cell adhesion proteins NCAM, LI and N-cadherin 
all induce neurite outgrowth via a signalling pathway which was similar, if not identical to 
fibroblast growth factor (FGF)-stimulated neurite outgrowth (Williams et al., 1994b). 
Further investigations revealed a region in the fibroblast growth factor receptor (FGFR) 
with homology to a sequence in N-Cadherin: "HAV" which is important for N-cadherin 
homophilic binding (Halbleib and Nelson, 2006), and from this, homology to LI and 
NCAM was found in flanking FGFR sequences. This region with homology to all three 
CAMs has been named the CAM Homology Domain (CHD) (Williams et al., 1994a) 
(Figure 1.7.2a + b). 
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(a) 
Cl omain 
EZI Tyrosine kinase 
domain 
Acid box 
CHD 
D1 D2 D3 
(b) 
Protein Sequence 
FGFR-1 CHD VAPYWTSPEKMEKKLHAVPA 
L1 AAPYW 
NCAM-VASE ASWTRPEKQE 
N-Cadherin RAHAVDI 
(c) 
Protein Sequence 
N-Caherin (putative 
HAV binding site) 
I N P I S G Q 
N-Cadherin (ECD4) KIDPVNGQITTIAV 
FGFR-1 SKIGPDNLPYVQILK 
L1 SVILSGLRPYSSYHL 
NCAM S-IDRVE-PYSSTAQ 
Figure 1.7.2 - (a) Domain structure of the fibroblast growth factor 
receptor (FGFR) highlighting the location of the acid box and CAM 
homology domain (CHD). (b)The cell adhesion molecules L1, NCAM 
(VASE isoform) and N-Cadherin all contain sequences homologous 
to the CAM homology domain (CHD). (c) The putative N-cadherin 
binding site to its HAV motif (causing homophilic binding) is 
homologous to motifs in N-cadherin (domain 4), the FGFR, L1 and 
NCAM. Full stop = conservative aa change, grey box = non-
conseravtive aa change. Based on figure 1 (Williams et al., 1994a) 
and figure 6 (Doherty and Walsh, 1996). 
The sequence in NCAM homologous to the FGFR CHD is the 10aa alternatively spliced 
VASE exon (Saffell et al., 1994), and in LI the sequence homologous to the FGFR is a 
region between the third and fourth L1 Ig domains whose significance has yet to be 
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determined (Doherty and Walsh, 1996) (1.72b). Antibodies directed against the FGFR 
CHD region completely inhibit neurite outgrowth by all three CAMs, and also antibodies 
directed against the FGFR acid box sequence also greatly reduce NCAM and N-
Cadherin-mediated neurite outgrowth and completely inhibit L1-mediated outgrowth 
(Williams et al., 1994a). This suggests that the acid box and CHD are important in 
eliciting FGFR signalling in response to CAMs possibly by blocking an interaction. The 
acid box is a continuous sequence of seven Asp residues found in the linker between 
D1 and D2 domains of the FGFR (Figure 1.7.2a). Deletion of this sequence completely 
abolishes an interaction between the FGFR and NCAM or N-Cadherin (Sanchez-Heras 
et al., 2006). A peptide known to block basic FGF (FGF-2)-mediated neurite outgrowth 
via the FGFR does not affect neurite outgrowth stimulated by the CAMs suggesting that 
the CAMs bind to FGFR at a different site from its conventional ligand (Williams et al., 
1994a). 
Again, through investigating the HAV hemophilic binding sequence of N-cadherin, 
it was noted that another complementary sequence on N-cadherin binds to the HAV 
sequence during hemophilic binding and that this sequence was duplicated at a 
membrane-proximal region. This membrane-proximal HAV-binding sequence is 
positioned at about the appropriate distance from the membrane to bind to the HAV 
sequence present in the FGFR CHD (Doherty and Walsh, 1996). A homology search 
found that this N-cadherin-FGFR putative binding sequence was also found in NCAM 
and LI at a complementary distance from the membrane to interact with the CHD, and 
was also present in the FGFR itself (Figure 1.7.2c). Therefore it has been proposed that 
these sequences form CAM binding sites to the FGFR CHD - a prerequisite to neurite 
outgrowth. In the case of NCAM, a peptide derived from this putative FGFR binding site; 
DRVEPYSSTA= FRM peptide (which maps to NCAM FNlll-1) has been shown to inhibit 
NCAM-stimulated neurite outgrowth at low concentrations, and at high, saturating 
concentrations promote FGFR-dependent neurite outgrowth, consistent with a role for 
this site in NCAM-FGFR binding and activation (Anderson et al., 2005). NCAM FN 111-2 
has been shown by surface plasmon resonance (SPR) and nuclear magnetic resonance 
(NMR) to interact with the FGFR and a peptide derived from this domain; 
EVYWAENQQGKSKA (called FGL) has been shown to have a similar neurite-outgrowth 
inducing effect to FRM. In addition, extensive work is currently being carried out to test 
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the viability of the FGL peptide as a potential therapeutic (http://www.enkam.corn/) as in 
vivo trials in rats have shown promising results in determining that FGL can enhance 
learning and memory (Cambon et a!., 2004), can accelerate early postnatal 
development of coordination skills (Secher et al., 2006), can prevent or greatly reduce 
the pathology and cognitive impairment produced by injection of preaggreagted A(3 
peptide (Rat Alzheimer's model) (Klementiev et al., 2007), and in gerbils can act in vivo 
as a neuroprotectant, significantly protecting hippocampal CA1 neurons from death in a 
transient global ischemia model when injected prior to injury (Skibo et al., 2005). The 
similar effects of the FGL and FRM peptides have lead to the proposal that both NCAM 
FNIII domains play a role in binding to and activating the FGFR (Anderson et al., 2005). 
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Figure 1.7.3 - Simplified FGF signalling cascade - PhospholipaseCv binds via a SH2 domain to 
phosphotyrosines on the activated FGF receptor leading to cleavage of PIP2 into IPS and 
diacylglycerol (DAG). DAG is further metabolised into arachidonic acid (AA) which binds to 
calcium channels, opening them and allowing intracellular [Ca^*] to rise. An increase in [Ca^*] 
allows spectrin to cross-link receptor-like tyrosine phosphatase alpha (RPTPa) to NCAM. NCAM 
activation induces NCAM to be palmitoylated which facilitates its redistribution to lipid rafts, 
taking RPTPa with it. This brings RPTPa into the same region as pSS'^ ", allowing p59^" to be 
dephosphorylated and so active, leading to the recruitment of focal adhesion kinase (FAK) and 
neurite outgrowth. 
NCAM and the fyn signalling pathway 
NCAM has also been found to signal through the non-receptor tyrosine kinase 
p59^" (Beggs et al., 1997). Fyn resides as an inactive phosphorylated form in lipid rafts, 
and within rafts it is constitutively associated with NCAM140. Fyn does not significantly 
associate with NCAM180 or NCAM120 in raft preparations from early postnatal mouse 
cerebellum, however fyn has been found to tightly associate with NCAM120 in cultured 
early postnatal oligodendrocytes although NCAM120 and fyn cannot physically interact 
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as they reside on opposite sides of the membrane (Beggs et al., 1997; Kramer et al., 
1999; Niethammer et al., 2002). Activation of NCAM by antibody clustering or addition 
of soluble NCAM is enough to activate fyn and cause the recruitment of focal adhesion 
kinase (FAK) to the complex and induce signalling leading to neurite outgrowth (Beggs 
et al., 1997). Palmitoylation of NCAM on intracellular Cys residues has been shown to 
be required for NCAM 140 redistribution to lipid rafts and requires the FGFR signalling 
pathway (Niethammer et al., 2002). Recently the interdependence of the FGFR and fyn 
signalling pathways and the pivotal role of receptor tyrosine phosphatase alpha 
(RPTPa) in this process has been elucidated (Bodrikov et al., 2005) (Figure 1.7.3). 
Initially NCAM 140 resides outside of lipid rafts and has a "loose" basal interaction with 
RPTPa. NCAM 140 can bind to spectrin in a Ca^'^-independent manner but RPTPa can 
only bind spectrin in the presence of Ca "^". Activation of NCAM, for example by NCAM 
clustering antibodies, activates the FGFR signalling cascade resulting in, amongst other 
things, an increase in intracellular calcium ion concentration leading to the crosslinking 
of NCAM and RPTPa in a stronger interaction via spectrin. Activation of NCAM 140 also 
causes intracellular NCAM Cys residues to be palmitoylated, facilitating the 
redistribution of the NCAM-RPTPa complex into lipid rafts where NCAM can associate 
with fyn. The phosphatase activity of RPTPa dephosphorylates fyn to an active form, 
allowing recruitment of FAK and induction of neurite outgrowth (Bodrikov et al., 2005). 
The ERK1/2 MAP kinase signalling pathway can be activated by both FGFR 
(Figure 1.7.1) and fyn signalling (Niethammer et al., 2002). NCAM180 is able to activate 
the ERK1/2 signalling cascade in an FGFR-dependent manner, but only gives minimal 
NCAM-mediated neurite outgrowth when transfected into hippocampal neurons from 
NCAM KO mice. This is possibly perhaps due to its other intracellular binding partners 
which could sterically block an association with fyn, or perhaps its reduced membrane 
mobility prevents redistribution to lipid rafts (Niethammer et al., 2002). NCAM 120 also is 
able to activate the ERK1/2 signalling cascade but FGFR signalling is not required, also 
giving only minimal neurite outgrowth. Presumably NCAM 120 and the FGFR never 
meet as NCAM 120 is within lipid rafts and the FGFR is outside (Niethammer et al., 
2002). 
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GDNF signalling via NCAM 
Glial-cell-line-derived neurotrophic factor (GDNF) can signal via NCAM using the fyn 
signalling pathway, which has been shown to be important for neural precursor 
migration along the rostral migratory stream (RMS) from the subventricular zone to the 
olfactory bulb (Paratcha et al., 2006; Paratcha et al., 2003). GDNF classically signals 
through the receptor tyrosine kinase RET, brought about by a complex formed by a 
GDNF dimer binding to and dimerising the GDNF-family receptor alpha (GFRa) and 
then this whole complex binding to RET (Sariola and Saarma, 2003). Cells which do not 
express RET can signal via NCAM in response to GDNF. GDNF has a low affinity for 
NCAM in the absence of GFRa but when GFRa is associated with NCAM, GDNF can 
bind with a high affinity and cause the fyn signalling pathway to be activated without the 
need for NCAM homophilic binding (Paratcha et al., 2003). If GDNF is not present in the 
complex, GFRa appears to reduce NCAM-NCAM homophilic adhesion and so could be 
a potential modulator of NCAM-mediated cell adhesion (Paratcha et al., 2003). The 
binding of GDNF to NCAM has been shown to be dependent on four acidic residues 
found in NCAM Iglll and mutating them abolishes binding (Sjostrand et al., 2007). 
Computer modelling of the GDNF-NCAM interaction suggests that a GDNF diamer 
could bind to two NCAM molecules which are in the cis- NCAM configuration from the 
"Zipper" homophilic binding model (Sjostrand et al., 2007). When two GFRa GDNF-
ligand binding domains are modelled into the complex, they do not appear to interact 
with NCAM Igl-lll suggesting that the GFRa-NCAM binding site is elsewhere (Sjostrand 
et al., 2007). GDNF signalling is dependent on heparin sulphates as treatment with 
heparinase III abolishes GDNF-NCAM-fyn signalling by somehow preventing NCAM 
from redistributing to lipid rafts, possibly involving the HSPG agrin which coprecipitates 
with GDNF/NCAM (Iwase et al., 2005). 
NCAM and the Glucocorticoid Receptor Signalling Pathway 
The least understood NCAM signalling pathway is via the glucocorticoid receptor. It was 
observed that injecting NCAM Iglll or the decapeptide representing the NCAM Iglll 
homophilic binding site into adult rat cortical penetrating lesions could reduce astrocytic 
proliferation by around 50%, the conclusion being that NCAM upregulation in response 
to nerve injury could possibly act to reduce the formation of a glial scar and aid 
regeneration (Krushel et al., 1995). Further investigations have found that the NCAM 
inhibition of astrocyte proliferation response is mediated by the glucocorticoid receptor 
59 
and proliferation can be partially rescued by addition of RU-486, a glucocorticoid 
receptor inhibitor (Crossin et al., 1997). Astrocytes from NCAM KO mice are not 
sensitive to NCAM-mediated inhibition of proliferation (Krushel et al., 1998). The 
significance of the NCAM-glucocorticoid receptor signalling pathway has yet to be 
determined but it appears to be distinct from the pathways involved in neurite outgrowth 
as inhibitors which block NCAM-stimulated neurite outgrowth have no effect on 
inhibition of astrocyte proliferation (Krushel et al., 1998). It has been suggested that the 
glucocorticoid receptor pathway could be NCAM120-specific as NCAM120 is the main 
NCAM isoform in astrocytes. NCAM120 is only a very minor component of neurons, 
possibly accounting for the separation of the neurite outgrowth and inhibition of 
proliferation signalling pathways. It has been speculated that an interaction between 
NCAM120 and the glucocorticoid receptor could be mediated by the association of 
NCAM120 and spectrin in lipid rafts. Spectrin has been shown to bind to the heat shock 
protein hsp70 which in turn can bind to the glucocorticoid receptor (Leshchyns'ka et al., 
2003). 
1.8 NCAM-VASE 
The Variable-Domain Spliced Exon (VASE) is a 10aa sequence that is alternatively 
spliced into IglV of all major NCAM isoforms (Small et al., 1988). The insertion of VASE 
into IglV changes its predicted structure from an Ig intermediate domain to an Ig 
variable domain (Figure 1.8.1). The most common example of an Ig variable domain is 
the antigen binding domain of an antibody. The splice location of the VASE exon 
resembles the hypervariable region of an antigen binding domain, which is the 
sequence directly responsible for antigen binding, suggesting that the VASE sequence 
could be involved in some sort of specific binding interaction (Small et al., 1988). 
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NCAM IglV NCAM-VASE IglV 
Figure 1.8.1 - The splicing of the VASE sequence (black) into IMCAM IglV is predicted to convert 
IglV from an Ig intermediate-type domain to a Ig variable-type domain. Domain structures 
homology modelled (http://www.bmm.icnet.Uk/servers/3diiqsaw/l 
Phylogeny 
The VASE exon is completely conserved between mammals and birds and is partially 
conserved in amphibians and fish, (Table 1.81). However, a genome search has not 
been able to identify a VASE or VASE-like sequence in NCAM homologues of 
Drosophila or C. elegans (http://www.ensembl.ora/index.html). In mammals and birds, 
each extracellular domain of NCAM is encoded by two exons, with VASE falling 
between exons 7 and 8 (Owens et al., 1987; Small et al., 1988). The lack of VASE in 
Drosophila can be accounted for by the absence of any exon boundaries in Drosophila 
NCAM IglV giving no site for a potential VASE sequence to splice into. There is a splice 
site in C. elegans NCAM IglV, however, the intron between exons 7 and 8 which would 
contain the VASE sequence is only 52bp long and so is easy to analyse and determine 
the absence of a 30bp VASE-like sequence (http://www.ensembl.orq/index.html) (Figure 
1.8.2). Unlike vertebrates with persistent NCAM expression in various regions 
throughout life, both Drosophila and C. elegans only express their NCAM homologues 
transiently during their larval or embryonic stages, correlating with neuronal outgrowth 
(Hall and Rutishauser, 1985). As the VASE exon splices into NCAM later in 
development (Small and Akeson, 1990), perhaps its function is redundant in Drosophila 
and C. elegans and this accounts for its absence. 
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Species VASE sequence Source Reference 
Homo sapiens 
(human) 
ASWTRPEKQE cDNA (Strausberg et al., 2002) 
Macaca mulatta 
(Rhesus Monkey) 
ASWTRPEKQE Genome 
prediction 
httD://www.ensembl.ore/index, html 
Pan troglodytes 
(Chimpanzee) 
ASWTRPEKQE Genome alone httD://www.ensembl.ora/index.html 
Rattus novegicus 
(Rat) 
ASWTRPEKQE cDNA (Small et a!., 1987) 
Mus musculus 
(Mouse) 
ASWTRPEKQE cDNA (Santoni et al., 1989) 
Canis familiaris 
(Dog) 
ASWTRPEKQE cDNA (Bonkobara et al., 2005) 
Gallus gallus 
(Chicken) 
ASWTRPEKQE Genome 
prediction 
httD://www.ensembl.ora/index.html 
Xenopus laevis 
(Frog)-gene 1 
ASWTRPLKHE Genome alone (Zorn and Krieg, 1992) 
Xenopus laevis 
(Frog) -gene 2 
ASWTRPLKQE cDNA (Zorn and Krieg, 1992) 
Xenopus tropicalis 
(Frog) 
ASWTRPLKQE cDNA http://www.ensembl.ora/index.html 
Gasterosteus 
aculeatus 
(Stickleback) 
ASWTRPEQHK Genome 
prediction 
httpV/www.ensembl.ora/index.html 
Tetraodon 
nigroviridis 
(Tetrodon) 
ASWTRPDTYE Genome 
prediction 
httD;//www.ensembl.ora/ir\dex.html 
Oryzias latipes 
(Japanese Medaka) 
ASWTRPDKYE Genome 
prediction 
httD://www.ensembl.ora/i ndex.html 
Danio rerio 
(Zebrafish) NCAM 
ASWTRPEKHK cDNA (Mizuno et al., 2001) 
Danio rerio 
(Zebrafish) PCAM 
ASWTRPEQHK cDNA (Mizuno et al., 2001) 
Danio rerio 
(Zebrafish) PCAM 
EQQKRIYQASWTRPEQHK cDNA (Mizuno et al., 2001) 
Drosophila 
melanogaster (Fruit 
fly) 
None detected Genome 
prediction 
httD://www.ensembl.ora/index.htmi 
Caenorhabditis 
elegans (Nematode) 
None detected Genome 
prediction 
httpV/www.ensembl.ora/index.html 
Table 1.8.1 - The 30bp VASE sequence is unique, occurring only once in the haploid human 
genome. It is completely conserved in mammals and birds but shows some variability in 
amphibians and fish. The first six aa of the VASE sequence are completely conserved between all 
vertebrates investigated. IMCAM homologues were present in Drosophila and C. elegans, however 
no VASE sequence could be detected. cDNA = actual transcript described, Genome predict = 
Predicted transcript from sequenced genome. Genome alone = Contains DNA sequence which 
could be translated as VASE. 
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Figure 1.8.2 - Sequence alignment of mammalian NCAM and C. Elegans and Drosophila NCAM homologues with exon boundaries overlayed 
(alternate dark and light shading indicates individual exons). Drosophila does not have an exon boundary in IglV which would be required for 
insertion of a VASE sequence. C. Elegans has an exon boundary close to the mammalian VASE splice site in IglV, however the intron in this 
region does not contain a VASE-like sequence in any reading frame. The varying sizes of exons is due to stretch caused by alignment and does 
not indicate their actual relative size. IglV and FNIII domains give an apparent large size due to lower sequence homology between species. C = 
location of ig domain Cys residues involved in the Ig fold intra-domain disulphide bridge which are completely conserved between species. 
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Known effects of VASE and hypothesis of action 
The splicing in of the VASE exon into NCAM mRNA increases in the brain during 
development, from about 3% of NCAM transcripts containing VASE at E15 to 43% in 
adult rat (Small et al., 1988). In the adult rat cerebellum VASE transcripts can account 
for up to 50% of the NCAM mRNA (Walsh et al., 1992). This is in complete contrast to 
PSA which is highest in early development and greatly reduces postnatally (Friedlander 
et al., 1985). Neurons taken from rats of increasing postnatal age show increasingly 
reduced neurite outgrowth response to NCAM stimulation despite containing a constant 
amount of NCAM (Doherty et al., 1990a). This downregulation of NCAM-stimulated 
neurite outgrowth with increasing age was found to be accounted for by an isoform 
switch to NCAM containing the VASE exon (Doherty et al., 1992a; Walsh et al., 1992). 
Unlike NCAM without VASE which stimulates neurite outgrowth (an effect enhanced by 
PSA (Doherty et al., 1990a)), NCAM containing VASE cannot promote neurite 
outgrowth when neurons were grown on top of a fibroblast monolayer expressing 
NCAM-VASE (Doherty et al., 1992a). NCAM-VASE can also inhibit NCAM-stimulated 
neurite outgrowth when transfected into the neuron itself and only requires 20-30% of 
the NCAM transcripts to contain VASE to downregulate outgrowth in response to an 
NCAM expressing monolayer (Liu et al., 1993; Saffell et al., 1994). The inability of 
NCAM-VASE to stimulate neurite outgrowth has been shown to not be due to simply 
being a non-functional isoform of NCAM, as a peptide corresponding to the VASE 
sequence is able to inhibit NCAM-stimulated neurite outgrowth, and the VASE inhibitory 
effects have been shown to be specific for inhibiting NCAM, as LI, N-Cadherin and K 
depolarisation-mediated neurite outgrowth are unaffected by the presence of VASE 
(Saffell et al., 1994). From this it has been suggested that NCAM-VASE does not 
generate a general inhibitory signal to neurite outgrowth but rather acts to target NCAM-
stimulated outgrowth in some way (Saffell et al., 1994). As mentioned before, the VASE 
sequence resembles part of the FGFR CHD which is hypothesised to be the binding site 
for NCAM FNII1-1 leading to NCAM-activated FGFR signalling and neurite outgrowth 
(Doherty and Walsh, 1996; Viollet and Doherty, 1997). It has been proposed, but not 
proven, that VASE can mimic the FGFR CHD and provide a competing binding site for 
NCAM FNIII-1 leading to a blocking of an NCAM-FGFR interaction and prevention of 
NCAM-stimulated signalling for neurite outgrowth (Saffell et al., 1994). The precise 
mechanism by which NCAM could fold to allow VASE in NCAM IglV could bind to the 
FRM sequence in FNIII-1 has yet to be proposed, however attempts to crystallise the 
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whole NCAM extracellular domain for structural studies have so far been unsuccessful 
due to high flexibility between NCAM domains (Kulahin et al., 2004) suggesting that an 
lglV-FNIII-1 interaction between two flexible NCAM molecules could be possible. 
Interestingly, although perhaps blocking an NCAM interaction to the FGFR, NCAM-
VASE has been shown to co-precipitate with FGFR1, suggesting that under some 
circumstances an interaction is possible (although this interaction might not be able to 
activate FGFR signalling) (Sanchez-Heras et al., 2006). 
Localisation of VASE 
As well as being developmentally regulated in the nervous system, splicing of the VASE 
exon is also spatially regulated. In adult rat, the NCAM transcripts containing VASE are 
highest in the thalamus, cerebellum, cortex, hippocampus and midbrain, with the 
olfactory bulb and dorsal root ganglia being almost devoid of NCAM mRNA containing 
VASE (Small and Akeson, 1990) (Table 1.82). NCAM-VASE transcripts are also 
curiously very high in the heart but absent in skeletal muscle (Andersson et al., 1993; 
Small and Akeson, 1990). The only antibody study of NCAM-VASE protein localisation 
in tissue found that VASE expression in the human hippocampus was expressed in the 
dentate gyrus granule layer, CA4 pyramidal neurons, and astrocytes in the CA4 region 
(also known as the hilus) and of the temporal horn of the lateral ventricle (Vawter et al., 
1998). 
Region 
Cerebellum ++ Lateral olfactory tract + 
Cortex ++ Spinal cord + 
Hippocampus ++ Dorsal root ganglia (+) 
Midbrain ++ Adrenal gland -
Thalamus +++ Heart +++ 
Olfactory Bulb (+) Skeletal muscle -
Olfactory Epithelium -
Table 1.8.2 - The relative abundance of NCAM transcripts containing the 
VASE exon in different regions of the nervous system and heart. + to +++ 
= increasing abundance; (+) = minimal abundance; - = absent. 
VASE vs PSA 
It is interesting to note the fact that VASE containing NCAM transcripts are excluded 
from the olfactory bulb, an area of plasticity, and the dorsal root ganglion (peripheral 
nervous system), an area with regenerative capacity, and are highest in the cerebrum 
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and cerebellum, both areas which are generally not plastic and cannot undergo 
regeneration. This contrasts with PSA-NCAM localisation to areas of plasticity, 
indicating that VASE and PSA are diametrically opposed to one another in both in 
temporal and spatial distribution, and also have opposite effects on neurite outgrowth. 
However, PSA and VASE are not mutually controlled, as the downregulation of PSA 
addition does not appear to stimulate the splicing of VASE into NCAM (Scares et al., 
2000). Conversely, VASE does not inhibit addition of PSA, as NCAM-VASE was shown 
to be only slightly less polysialylated in AtT20 cells (which contain PST) transfected for 
NCAM with or without VASE (Oka et al., 1995). The signal that induces a 
developmental isoform switch to NCAM-VASE has not been discovered, however 
hippocampal and cerebellar slice cultures from PND4 rats upregulate VASE transcripts 
similarly to the in vivo situation, suggesting the VASE splice signal is either local or cell-
intrinsic, rather than a long range signal such as a hormonal trigger or dependent on 
neuronal connectivity to elsewhere (Forster and Frotscher, 1995). 
VASE and correlation with neuropsychiatric and neurodegenerative disorders 
Increased amounts of NCAM containing the VASE exon have been correlated with 
neuropsychiatric disorders, with the hippocampi of people suffering from bipolar 
disorder but not schizophrenia or suicide containing more NCAM-VASE than control 
individuals (Vawter et al., 1998). In a separate investigation, the cerebrospinal fluid 
(CSF) of schizophrenia sufferers but not bipolar individuals was found to contain 
elevated levels of NCAM-VASE (Vawter et al., 2000). A study of Japanese individuals 
has also linked NCAM isoforms to bipolar disorder with two single nucleotide 
polymorphisms (SNPs), one located close to the VASE exon boundary and the other 
located close to the exon a/b/c/AAG/SEC, correlating nominally with bipolar disorder 
(Aral et al., 2004). NCAM-VASE could also be a diagnostic feature or play a role in age-
related memory impairment, as senescence-accelerated mice were found to have 
higher levels of NCAM containing VASE transcripts in their dorsal hippocampus 
(involved in spatial learning) than senescence-resistant mice, and consequently 
performed worse in the Morris Water Maze test for spatial learning (Qin et al., 2005). 
The presence of higher levels of VASE in the hippocampus could potentially create an 
unfavourable environment for the synaptic reorganisation that occurs here during 
memory formation. The authors suggest that the increase in NCAM-VASE in the dorsal 
hippocampus of senescence-accelerated mice could be due to the increased amount of 
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astrocytes present in the hippocampus of aged animals. An antibody reactive to only the 
VASE NCAM isoform has been shown to be reactive towards astrocytes in the 
hippocampus and also, cultured astrocytes from newborn mice differentiated by 
dibutyryl cyclic AMP (dBcAMP) treatment showed a large increase in NCAM-VASE 
mRNA transcription supporting this view (Gegelashvili et al., 1993; Vawter et al., 1998). 
In contrast to VASE transcripts being high in cAMP-differentiated astrocytes, 
proliferating cortical astrocytes express NCAM containing PSA, which is downregulated 
during differentiation, reinforcing the inverse correlation of PSA and VASE (Minana et 
al., 1998). 
VASE mRNA in the heart 
NCAM-VASE mRNA in the heart appears to be independently regulated from the brain. 
At El 5 there is negligible amounts of VASE transcripts in the brain, but VASE is present 
in the heart and remains high in adulthood (Gaardsvoll et al., 1993; Small and Akeson, 
1990). The presence of VASE containing NCAM in the heart and its absence from 
NCAM in skeletal muscle has not been discussed in the literature. However, 
NCAM125kDa containing VASE artificially overexpressed in mice specifically in skeletal 
muscle, has an identical effect to NCAM 125 without VASE in promoting enhanced 
myoblast fusion, suggesting perhaps that VASE does not play a role in skeletal muscle 
development and this could account for its absence (Fazeli et al., 1996). The role of 
VASE in the heart has not been determined, nevertheless NCAM has been shown to be 
important in proper heart development as NCAM KO mice have functional, but 
abnormally small, thin-walled hearts (Watanabe, 1998). 
Other hypotheses of VASE action 
Like PSA, VASE may have more than one function or method of reducing NCAM-
stimulated neurite outgrowth. A number of proposals have been discussed but none 
have been fully experimentally tested. The best characterised is the interaction of 
NCAM with LI. As LI has been shown to bind to NCAM in an interaction between 
oligomannosidic carbohydrates on LI and a lectin binding domain in NCAM IglV 
(Horstkorte et al., 1993), it has been hypothesised that VASE could alter this interaction 
(Lahrtz et al., 1997). Coated-down NCAM IglV containing VASE can stimulate neurite 
outgrowth of cerebellar granule neurons (CGNs) by 150% over a polylysine control, 
whereas NCAM IglV without VASE can stimulate CGN neurite outgrowth by 225%. 
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Blocking NCAM interactions with an NCAM antibody reduced IglV outgrowth down to 
the same level as VASE, whilst it has no effect on VASE. The small amount of VASE-
stimulated outgrowth could be abolished by the addition of an L1 antibody, suggesting 
that NCAM-VASE, although not being able to stimulate NCAM-mediated neurite 
outgrowth, can still play a part in L1-mediated outgrowth (Lahrtz et al., 1997). 
It has also been noticed that the first four aa of VASE, ASWT, is similar to MSWT 
found in neighbouring NCAM Iglll (Small et al., 1988). Perhaps VASE could mimic Iglll 
and create an alternative binding site, although MSWT has not been shown to be 
involved in any binding interactions as of yet. The VASE splice site is also only six aa 
downstream of the NCAM IglV glycosylation site. Perhaps VASE alters the structure of 
IglV in such a way that the Asn residue is not accessible for glycosylation (Walsh and 
Doherty, 1991). 
Another suggestion as to the mode of action of NCAM-VASE is that it could exert 
inhibitory effects on NCAM-stimulated neurite outgrowth by introducing stronger 
adhesion strength (as opposed to PSA which reduces NCAM adhesion (Hoffman and 
Edelman, 1983)). It has been commented upon that NCAM-VASE is slightly more 
adhesive than NCAM, but in the study no experimental data for this was produced 
(Doherty et al., 1992a). This suggestion has been contradicted in a later study which 
found that L cells transfected for NCAM or NCAM-VASE aggregated at exactly the 
same rate suggesting that they have the same adhesion strength (Chen et al., 1994). 
Crucially however, when NCAM and NCAM-VASE containing L cells were mixed, 
segregation in the aggregates between the different cell types was observed, 
suggesting that NCAM and NCAM-VASE have preferential binding specificity for 
themselves. This effect was most pronounced at longer time points suggesting perhaps 
that a two step process occurs - the first step being a more general, less specific 
binding, and the second step being a more precise sorting into isoform-specific 
aggregates (Chen et al., 1994). 
The function of VASE in vivo is currently unknown, however the insertion of only 
ten aa comprising the VASE exon into NCAM has been shown to induce a dramatic 
change of function from a molecule with growth-promoting effects to one with growth 
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inihibitory effects. Initial observations have noted the striking temporal, spatial and 
functional inverse correlation of VASE with PSA, supporting the idea that whilst PSA is 
promoter of development and plasticity, VASE function in vivo could be as a promoter of 
maturity and stability. To investigate the function of VASE, this project aims to 
comprehensively map VASE protein expression throughout the nervous system and 
muscle by antibody staining. This will be performed in adult rat, with an investigation 
into the developmental splicing in of VASE in postnatal rat also being undertaken. The 
aim is that mapping VASE expression will identify cells and cellular processes that are 
associated with VASE, which will allow hypotheses of VASE function to be created and 
give direction to further studies. Antibody mapping of in vivo VASE expression will also 
be supported by investigating VASE expression in cultured neurons, astrocytes and 
oligodendrocytes, and an investigation into the neurite outgrowth inhibitory effects of 
VASE. 
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Chapter 2 
Materials and Methods 
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2.0 Materials and Methods 
2.1 General methods 
Basic cell culture 
NIH 3T3 mouse fibroblast cells were routinely cultured on 10cm tissue culture plates 
(Appleton Woods) in Dulbecco's Modified Eagles Medium with glutamax (DMEM) 
(Invitrogen) containing 10% foetal bovine serum (FBS) (Invitrogen) and 1x 
penicillin/streptomycin (Invitrogen) (= DMEM + 10%FBS), in a 37°C humid incubator 
with 8% CO2. Cells were split when about 70-80% confluency was achieved by 
replacing growth media with a 0.25% trypsin-ImM EDTA solution (Trypsin) (Invitrogen) 
and incubating at 37°C for 10 minutes. Trypsinisation was inhibited by the addition of 
equal volume of DMEM + 10%FBS and then the cell suspension was transferred to a 
30ml universal tube (Appleton Woods) and spun down at 2000rpm in a benchtop 
centrifuge (Jencons) for 5 minutes. After centrifugation, the supernatant was aspirated 
with a glass pipette (VWR) and the cell pellet resuspended in fresh growth media, a 
portion of which was added back down to a fresh 10cm plate. If exact numbers of cells 
were to be plated, cells were thoroughly dissociated by syringing 3-4 times through a 19 
gauge needle (VWR), before counting in a haemocytometer (VWR) and diluting to the 
required concentration. 
For long-term storage of fibroblast cell lines, cells were frozen in cryotubes 
(VWR) in DMEM + 5% FBS + 10% DMSO (DMSO from Sigma) at -80% for a few days 
before being transferred to liquid nitrogen. 
All cell culture was carried out asceptically in lamina flow tissue culture hoods. 
Fibroblast cell lines 
Four cell lines were used during this investigation; 
NIH 3T3 mouse fibroblasts (American Cell Type Collection, Rockville) 
N24 cells (3T3 cells transfected with human NCAM 140); cells a gift of Dr Frank Walsh, 
Wyeth Research, Princeton, USA (Saffell et al., 1994). 
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140VG (3T3 cells transfected with human NCAM140-VASE; cDNA gift of Dr Pat 
Doherty, Kings College London (Walsh et al., 1992). 
Cos-7 cells (a gift of Prof Yuri Ushkaryov and Dr John Silva, Imperial College). 
Generation of 140VG cell line 
Bacterial stocks containing a cDNA corresponding to human NCAM140-VASE in a 
modified KEDES vector (Gunning et al., 1987) under the human p-actin promoter were 
obtained from Dr Pat Doherty (Walsh et al., 1992). Bacterial cultures were grown up 
overnight and the plasmid DNA was isolated from the bacterial culture by miniprep 
columns (Quiagen). DNA Sequencing confirmed that the NCAM-VASE cDNA is derived 
from the same sequence as the human NCAM 140 sequence (first published in (Dickson 
et al., 1987)) present in N24 cells, with the inclusion of the VASE exon; ASWTRPEKQE. 
200,000 3T3 cells were plated onto a 10cm plate and left to settle overnight. The next 
day 300pl of DMEM containing O.Spg of DNA was mixed with 300pl of DMEM 
containing 15pl of lipofectamine transfection reagent (Invitrogen) for 45 minutes. The 
plate of cells washed briefly twice in DMEM and the transfection mixture was made up 
to 3ml total volume with DMEM and added to the plate for 7 hours at 37°C. The 
transfection media was removed and replaced with DMEM + 10%FBS overnight before 
being supplemented with selective media containing 0.67mg/ml G418/geneticin 
(Invitrogen). Selective media was replaced regularly over the period of a week to 
remove dead cells, and the remaining transfected cells were grown up and a sample of 
these pooled clones was frozen down to be stored. Transfected cells were then plated 
at a density of 30 cells per plate for 3-4 weeks to allow the growth of colonies derived 
from single clones, before being individually trypsinised in chambers created by cloning 
rings stuck to the plate by silicone grease. Individual transfected clones were grown up 
and samples frozen before testing for expression level of NCAM-VASE was determined 
by ELISA. 10,000 cells were plated in quadruplicate in wells of a 96 welled plate and left 
overnight. The next day, the cells were fixed with 4% PFA and stained with aN16 (see 
antibody staining section). The cells were then stained with a peroxidase-conjugated 
secondary antibody and the expression level revealed by a K-Blue (Neogen) colour 
change reaction visualised at 650nm in a plate reader. A clone, named 140VG, was 
selected which had almost identical NCAM-VASE expression to NCAM expression in 
N24 cells (see Chapter 7) and was used throughout this study to compare the effects of 
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NCAM and NCAM-VASE, however, test neurite outgrowth assays were performed with 
a number of NCAM-VASE clones, all giving the same inhibition of NCAM-stimulated 
neurite outgrowth (not shown). 
2.2 Culture of primary cells 
Defined medium 
A number of assays required the use of defined medium. 
SATO medium (Bottenstein and Sato, 1979) was used in all neurite outgrowth assays. 
SATO medium consists of; 
DMEM (+ glutamax, + pen/strep) (Invitrogen) 
10% BSA (Sigma) 
25|jg/ml insulin (Sigma) 
125|jg/ml transferrin (Sigma) 
0.07|jg/ml progesterone (Sigma) 
20|jg/ml putrescine (Sigma) 
O.Sjjg/ml L-thyroxine (Sigma) 
0.05|jg/ml selenium (Sigma) triiodothyronine 
Purified P4 cortical oligodendrocytes were maintained in OLP medium (Hardy and 
Reynolds, 1993) consisting of; 
DMEM (+ glutamax, + pen/strep) (Invitrogen) 
ImM sodium pyruvate (Sigma) 
63ng/ml N-acetylcysteine (Sigma) 
1x N2 supplement (Invitrogen) 
lOnM hydrocortisone (Sigma) 
150nM triiodothryonine (Sigma) 
0.5mg/ml BSA (Sigma) 
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Finally, long term P4 cerebellar and E18 cortical neuronal cells were maintained in long 
term culture medium (modified from (Foran et al., 2003)), consisting of: 
3 parts DMEM (+glutamax, +pen/strep) (Invitrogen) 
1 part culture replacement medium: 
Tissue culture grade ddH20 
40mM HEPES/NaOH pH7.3 (VWR) 
78.4mM KCI (VWR) 
37.6mM D-glucose (Sigma) 
2.8mM CaCb (Sigma) 
1.6mM MgS04 (Sigma) 
1 .OmM NaH2P04 (Sigma) 
1x N2 supplement (Invitrogen) 
2% (v/v) horse serum (Invitrogen) dialysed in 2mM HEPES/NaOH pH7.3 + 
150nM NaCI (VWR) 
2mM sodium pyruvate (Sigma) 
Culture and isolation of primary neurons 
Mixed cerebellar cultures consisting primarily of cerebellar granule neuron precursors 
were used in all neurite outgrowth experiments. They were also used in some long term 
culture experiments as after a few days in culture, astrocytes and oligodendrocytes 
proliferate and so become more prevalent in this system. Postnatal day 4 (PND4) 
Sprague-Dawley rats were sacrificed by cervical dislocation and decapitated. Their 
heads were sterilised by spraying with a 70% industrial methylated spirit (70% IMS 
solution) before the skin around the skull was dissected away. The skull was detached 
at one side and peeled back to reveal the cortex, midbrain and cerebellum. The 
cerebellum was removed by tweezers to a 10cm plate containing Hank's balanced salt 
solution (HBSS) (Invitrogen) and microdissected under a dissection microscope to 
remove extra brain tissue, meninges, blood vessels and choroid plexus. The 'cleaned 
up' cerebellum was transferred to a 10cm plate containing trypsin and shredded into 
small pieces using tweezers before being incubated for 10 minutes at 37°C in an 
incubator. Trypsinisation was halted by addition of equal volume of growth medium, and 
then the cell suspension was further mechanically dissociated by triturating with a 10ml 
pipette (Appleton Woods) x15. The cell suspension was then centrifuged at 2800rpm for 
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lOminutes and the supernatant aspirated away and the pellet resuspended in growth 
medium. In the case of neurite outgrowth experiments, cells were cultured in SATO 
medium, for long-term culture experiments, cells were cultured in long-term culture 
medium but resuspended and plated in DMEM + 10% FBS overnight before being put 
into LT culture medium. The cell pellet was pipetted up and down x30 with a 10ml 
pipette to dissociate cells and then clumps were allowed to settle for 2 minutes. Cell 
suspension without clumps was then removed from the top and counted. The cell 
suspension was adjusted to the right density (neurite outgrowth was regularly performed 
at 10,000 cells/ml and long term culture at 1,000,000 cells/ml) before being plated either 
onto cellular monolayers, or onto plastic or glass precoated for 30 minutes in 16mg/ml 
poly-L-lysine (Sigma). 
El 8 cortical cultures were used in long term culture studies. E18 cortical cultures 
were obtained by the culling of a time-mated Sprague-Dawley pregnant female rat by 
cervical dislocation. The rat was sterilised by spraying with 70% IMS before being 
dissected open and individual embryos removed. The embryos were decapitated and 
their heads stored in sterile HBSS on ice whilst the dissection process was ongoing. 
The skull and skin were peeled back together from the top of the head and the two 
cortical hemispheres removed with a small spatula. The cortices were transferred to 
10cm plate of trypsin before being shredded by tweezers and trypsinised. From this 
point onwards the cortical cells were treated identically to the PND4 cerebellar cells, 
with the exception that after centrifugation, the cells were dissociated by syringing 4-5 
times through a 19 gauge syringe. For long term culture, the medium was changed 
every week. 
Culture and isolation of primary oligodendrocyte precursors 
Oligodendrocyte precursor cells (OPCs) were obtained from PND4 cortices by 
immunopanning. Untreated Petri dishes (VWR) were coated overnight with goat aIgM 
Fab2 (Cambridge Bioscience) 1:100 in 50mM Tris-HCI pH7.4 (Sigma) at 4°C before 
being washed and coated with 1:10 a04 (Gift of Professor Richard Reynolds) in 
DMEM/HEPES (Invitrogen) for two hours at 37°C. On the same day as coating the 
panning plates with a04, 8-12 PND4 pups were sacrificed as before, and their cortices 
removed into ice-cold DMEM. The non-cortical tissue was removed and the cortices 
separated into hemispheres before carefully being rolled on sterile filter paper (VWR) to 
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remove meninges, shredded, and then transferred to a 75cm^ tissue culture flask 
(VWR) containing 20ml trypsin. The cortices were allowed to trypsinise for 20 minutes at 
250rpm in a 37°C shaking incubator before being halted by the addition of trypsin 
inhibitor solution (Sigma) also containing MgS04 (VWR) and DNase 1 (Roche). The cell 
suspension was transferred to a 50ml falcon tube (VWR) and centrifuged at 1200rpm 
for 10 minutes. From this point onwards, all solutions were kept on ice. The supernatant 
was removed and the pellet resuspended in DMEM/HEPES + 5% FBS and dissociated 
to a single cell suspension by syringing through a 19 gauge needle 4-5 times. The cell 
suspension was carefully added to preprepared tubes containing 4% BSA (VWR) in 
DMEM/HEPES so that the suspension formed a layer on top of the BSA, and the tubes 
centrifuged at lOOOrpm for 10 minutes without centrifuge braking. The supernatant was 
aspirated off and the remaining pelleted cells resuspended in DMEM/HEPES + 5% FBS 
and plated into 75cm^ tissue culture flasks. The flasks were incubated in a 37°C 
incubator for 25 minutes to bind down adherent cells from the suspension. Cells that 
had not adhered during the incubation were removed from the flasks and spun down at 
1200rpm for 10 minutes. The supernatant was aspirated off and the pellet resuspended 
in DMEM/HEPES + 5% FBS supplemented with 5|jg/ml insulin. Medium supplemented 
with insulin was used for the rest of the panning process. The cell suspension was then 
plated onto the panning plates containing bound a04, specifically allowing OPCs to 
adhere for 30 minutes at room temperature. The panning plates were then gently 
washed x5 in media and then the OPCs were removed from the plates by mild 
trypsinising in a 0.125% trypsin/DMEM HEPES + 5% FBS solution for 10 minutes at 
37°C. The trypsin was inhibited as before and the OPCs dislodged from the panning 
plates by vigorous pipetting. The OPCs were centrifuged at 1200rpm for 10 minutes and 
resuspended in OLP medium, before being counted and plated onto poly-L-lysine 
coated plastic or glass, or cellular monolayers. 
Culture and isolation of primary astrocytes 
The cortices of four PND4 rat pups were prepared identically as for OPC isolation. After 
initial trypsinisation, the cortices were centrifuged at 2000rpm for 10 minutes before the 
supernatant was aspirated and the pellet resuspended in DMEM + 10% FBS. The cell 
suspension was dissociated by syringing through a 19 gauge needle and plated onto 
two 10cm plates. The next day the plates were washed with media to remove unbound 
cells and allowed to grow for about a week until confluent. The cells were then 
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trypsinised and transferred to tissue culture flasks and the next day shaken for 16 hours 
at 37°C. Immediately after shaking, the media containing detached cells was discarded 
and the remaining astrocytes were trypsinised and replated onto 10cm plates and 
allowed to grow up before use. 
2.3 immunostaining 
Immunocytochemistry 
Cells were either plated onto 8-welled chamber slides (VWR) or onto sterile 13mm glass 
coverslips when immunocytochemistry was required. 
Fixed staining 
Cells were fixed by addition of equal volume 4% paraformaldehyde in PBS (PFA) 
(VWR) to their growth medium for 15 minutes, which was then carefully removed and 
supplemented by neat 4% PFA for a further 15 minutes. This was again removed and 
the cells washed for 5 minutes in PBS (VWR) x2. If intracellular staining was required, 
cells were permeablilised with ice-cold methanol (for neurite outgrowth experiments) or 
0.2% triton (everything else) for 10 minutes before washing as before. Cells were then 
blocked in PBS + 10% PBS for 45 minutes before washing. The cells were then 
incubated with primary antibody diluted in PBS for 1 hour and washed. Secondary 
antibody was added for 45 minutes in PBS and then the cells washed. This process was 
repeated if a double labelling experiment was performed. 8-welled slides were mounted 
using rectangular coverslips (VWR) and glass coverslips were mounted onto glass 
slides (VWR) both using Mowiol mounting medium containing Ijjg/ml DAP I. Mowiol 
consists of a mixture of glycerol (Sigma), mowiol (Sigma), and also the antifade reagent 
DABCO (Sigma) in 0.3M TRIS pH8.5. 
Live staining 
If staining was to be performed live, cells were carefully washed in DMEM/HEPES 
before staining with primary antibody diluted in DMEM/HEPES + 2% FBS for 1 hour 
either at 37°C or on ice. Cells were then washed again before being fixed with 4% PFA 
and stained with secondary antibody in an identical manner to the fixed staining protocol 
at room temperature. 
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Tissue preparation, sectioning and immunohistochemistry 
Paraformaldehyde fixed frozen adult rat sections of the cortex, cerebellum and spinal 
cord were all a kind gift of Professor Richard Reynolds, Imperial College. 
Cerebella used for investigation of VASE expression developmentally were 
prepared from Sprague-Dawley littermates of the ages PND4,7,10,14, and 17. 
Cerebella were removed and fixed overnight in 4% PFA at 4°C. The next day the 
cerebella were transferred to a 10% sucrose/PBS solution again overnight at 4°C. The 
next day, the cerebella were blotted dry of PBS briefly, cut into thick parasaggital 
sections and frozen in moulds with OCT compound (VWR) in a 'slush bath' consisting of 
partially dissolved dry ice (BOC Ltd) and IMS. The tissue blocks were stored at -20°C 
until required. Sciatic nerve tissue was prepared in an identical manner. Heart and 
gastrocnemius skeletal muscle tissue was obtained from an adult female Sprague-
Dawley rat and fixed and cryoprotected like the cerebellar tissue. They were then 
dissected into smaller pieces, put into small moulds and covered with OCT. The heart 
and skeletal muscle tissue were then frozen quickly by plunging them into isopentane 
(VWR) precooled by dry ice before storing at -20°C until needed. The tissue blocks 
were then cryostat sectioned by either myself or Lorraine Lawrence (Leukocyte Biology 
Lab, Imperial College). Neuronal tissue was cut into 6jjm sections, heart and skeletal 
muscle into 12|jm sections and mounted onto poly-L-lysine-coated slides (VWR). Slides 
were then kept in boxes wrapped in clingfilm at -20°C until needed. If possible, serial 
sections were used in investigations so that a direct comparison between different 
stains could be performed. 
Before staining, sections were dipped into PBS for 5 minutes to dissolve away 
any remaining OCT compound. The sections were then treated with PBS + 0.1 % (w/v) 
sodium borohydride (Sigma) for 10 minutes to reduce background autofluorescence 
caused by free aldehyde groups. The sections were then washed with PBS before 
being treated with ice-cold methanol for 5 minutes x3 to delipidate the myelin. The 
sections were again washed and individual sections were drawn around with a 
hydrophobic immunopen (VWR) to create a water-resistant barrier for antibodies to be 
contained within. The sections were placed in a dark humid container for the duration of 
the staining so that the sections could not dry out. Primary antibody was added in a 1% 
BSA solution/PBS solution overnight before being washed in PBS for 5 minutes x3. 
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Secondary antibody was added diluted in PBS for 1 hour before being washed. If 
double immunolabelling was required the primary and secondary antibody steps were 
repeated with the costaining antibody. Sections were then mounted in mowiol. 
All staining was carried out with secondary antibody only controls in parallel. 
Antibodies used in ICC and IHC 
Primary antibodies: 
Antibody Source Species Reactive against ICC dilution IHC dilution 
aN16 Gift Dr John 
Hemperly 
(Aclciey et 
al., 1997) 
mouse Human NCAM Iglll 
domain 
1:10,000 Not used 
crude a VASE Gift DrJohn 
Hemperly 
(Vawter et 
al., 1998) 
rabbit VASE sequence 1:500 Not used 
affinity purified 
aVASE 
Purified by 
myself 
rabbit Crude a VASE affinity 
purified against NCAM-
VASE Fc 
1:20 1:20 
NCAM H-300 Santa Cruz rabbit Human and rat NCAM 
first 300aa of ECD 
1:20 1:20 
ASA DSHB mouse 
(IgM) 
Polysialic acid (PSA) 1:100 1:100 
GAP43 Chemicon rabbit Growth associated 
protein-43 (neurite 
outgrowth marker) 
1:1,000 Not used 
RT97 Chemicon mouse 200kD neurofilament 
heavy (neuronal 
marker, stains mainly 
axons) 
1:1,000 1:1,000 
GFAR Sigma mouse Glial fibrilary acid 
protein (astrocyte 
marker) 
1:1,000 1:1,000 
0 4 Gift 
Professor 
Richard 
Reynolds 
mouse 
(IgM) 
04 epitope (04+ve 
OPC marker) - only 
recognises in live 
staining 
1:20 Not used 
Z12 Gift 
Professor 
Richard 
Reynolds 
mouse Myelin oligodendrocyte 
glycoprotein (myelin 
marker) 
1:50 1:50 
Calbindin Sigma mouse Calbindin (Purkinje cell 
marker) 
Not used 1:1000 
aTau Biosource mouse Tau (axonal marker) 1:100 Not used 
Tubulin Gift Dr David 
Mann 
mouse All tubulin 1:50 Not used 
Phailoidin-
TRITC 
Sigma N/A TRITC-conjugated toxin 
against F-actin 
1:8,000 Not used 
Table 2.3.1 - Primary antibodies used in this study and their dilutions. 
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Secondary antibodies: 
Antibody Source Reactive 
against 
ICC dilution IHC dilution 
amouse IgG 
A488 
Invitrogen Mouse IgG 1:5,000 1:1,000 
amouse IgG 
A555 
invitrogen Mouse IgG 1:5,000 1:1,000 
amouse IgM 
A488 
Invitrogen Mouse IgM 1:5,000 1:1,000 
arabbit IgG 
A488 
Invitrogen Rabbit IgG 1:5,000 1:1,000 
arabbit IgG 
A555 
Invitrogen Rabbit IgG 1:5,000 1:1,000 
Table 2.3.2 - Secondary antibodies used in this report and their di utions. 
Microscopy 
A Zeiss Axiovert 200 inverted fluorescence microscope was used to visualise virtually 
all the images from this project. Images with this microscope were taken using x10, x20, 
x40 and x63 (oil immersion) objectives using a Zeiss digital camera. Exposure times 
and contrast adjustment were kept constant when comparing between different 
conditions. 
Some images were taken using a Zeiss LSM 510 laser confocal microscope. 
Images with this microscope were taken using x100 objective. Again, exposure times 
and contrast adjustment were constant for images used in comparisons. 
2.4 Primary cell assays 
Neurite outgrowth assays 
If monolayer experiments were performed, 8-welled chamber slides or sterile glass 
coverslips were coated with 16mg/ml poly-L-lysine for 30 minutes at room temperature 
before being washed in sterile dHaO and coated with 10pg/ml fibronectin (Sigma) in 
DMEM for 2 hours at 37°C. The fibronectin was removed and an appropriate amount of 
fibroblast cells were plated onto the 8-welled chamber slides or glass coverslips so that 
confluent monolayers were achieved by the next day. This equates to plating 80,000 
cells per well in a chamber slide, and 200,000 cells per 13mm coverslip (in a 24-welled 
plate (VWR)). The next day cerebellar granule neurons were isolated as previously 
described and 6,000 were plated per well in a chamber slide, with 12,000 plated onto a 
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glass coverslip in SATO medium. The cultures were incubated overnight before fixing 
and staining for GAP-43 which specifically stains neurites and cell bodies. 
"Patch" monolayers were constructed by plating 22,400 cells per coverslip 
consisting of 25% N24 or 140VG cells to 75% 3T3 cells. These low density cells were 
allowed to grow up for 4 days so that the single N24 and 140VG cells could form colony 
"patches" within a majority 3T3 monolayer. Cerebellar granule neurons were then 
isolated and plated as previously described. 
If monolayers were not required for neurite outgrowth, neurons were directly 
plated onto poly-L-lysine coated coverslips or chamber slides and routinely cultured for 
2 days as outgrowth takes longer to induce under these conditions. 
If soluble growth factors were added, neurons were plated at twice the cell 
density in half the media volume, and then the total volume made up by adding medium 
containing the growth factors at twice their intended concentration. NCAM and NCAM-
VASE containing conditioned medium was produced by incubating identical densities of 
the respective fibroblast cells in SATO media for 4 days and then collecting and filtering 
the media. 
Neurite outgrowth was determined by visualising the slide with a Zeiss Axoivert 200 
fluorescent microscope using a macro written inside the KS300 program by Paul 
Whetton of Imaging Associates. The macro allows the user to take an image of the 
microscope field of view and then "paint" on the computer screen a tracing of the 
neurites visible. The program then records and stores the length of the neurites. In 
measuring neurites a few rules were observed to keep the assessment consistent 
between data samples: 
1. Only neurites attached to cell bodies were measured. 
2. Only the longest neurite of each neuron (including all of its branches) was 
measured. 
3. Neurons without any neurites were recorded with a single pixel so that they could 
be still counted. 
4. If neurites were interacting with other neurons they were not counted. 
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For each datapoint, 200 neurites were measured and a mean length of longest neurite 
calculated. 
Oligodendrocyte area assay 
Purified PND4 cortical OPCs were isolated as previously described. 4,000 OPCs were 
plated in OLP media onto preprepared monolayers identical to those used in neurite 
outgrowth assays in chamber slides. The cocultures were incubated for 2 days before 
being stained live for 04, and then fixed. Oligodendrocyte area spreading was then 
assessed using the cell area macro within the KS300 program (also written by Paul 
Whetton) by "drawing" a polygon around the oligodendrocyte. 50-100 oligodendrocytes 
were measured for each datapoint and a mean area was calculated. 
2.5 SDS gels and western blotting 
Protein sample preparation, gel running and western blotting 
Soluble protein such as NCAM-Fc were prepared by diluting in PBS and adding equal 
volume of 2xSDS sample buffer (containing lOOmM TRIS-HCI pH6.8 (Biorad), 4% w/v 
SDS (National Diagnostics), and 20% v/v glycerol (Sigma)). If reducing conditions were 
required, 1:1,000 dithiothreitol (DTT) (Sigma) was added to the sample buffer. 
Bromophenol blue (Biorad) was added to samples which were then boiled for 5 minutes 
at 100°C. 
Cell lysates were prepared by lysing cells in 2xSDS sample buffer and using a 
cell scraper (Triple Red) to remove the cells from the tissue culture plate. Cell lysates 
were sonicated briefly on ice with a probe sonicator in five 1 second pulses to break up 
cellular DNA and reduce the viscosity of the samples. If required, total protein 
concentrations were determined by BCA protein assay (Pierce) and adjusted 
accordingly by dilution in sample buffer. Samples were reduced if necessary and boiled 
as described before. 
Brain membranes were prepared by removing the brain of an adult female 
Sprague-Dawley rat culled by cervical dislocation. The brain was then homogensised on 
ice in a tissue homogeniser in homogenisation buffer - a 10% sucrose/20mM TRIS-HCI 
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pH8 solution, also containing freshly added 1:100 phenylmethanesulphonylfluoride 
(PMSF) (Sigma) and half a tablet of complete protease inhibitor (Roche). The brain 
homogenate was centrifuged at SOOOrpm for 5 minutes at 4°C and the supernatant and 
pellet removed, all apart from the bottom layer of the pellet containing cell nuclei. The 
homogenate was resuspended in additional homogenisation buffer before being 
centrifuged at 15,000rpm for 30 minutes at 4°C. The supernatant corresponding to the 
brain cytosol was discarded and the pellet resuspended in homogenisation buffer and 
again centrifuged to wash. After the final resuspension, the brain membranes were 
treated with 2xRIPA buffer (Sigma) also containing 1:100 PMSF and complete protease 
inhibitor for 30 minutes at 4°C on a roller to solubilise the membranes. The brain 
membranes were then spun down at 15,000rpm for 30 minutes at 4°C before the 
supernatant was collected and added to 2xsample buffer. The brain membranes were 
then treated as the soluble proteins and cell lysates. 
Samples were run on 7.5% polyacrylamide SDS gels using Biorad Mini-
PROTEAN 3 Electrophoresis equipment (Biorad). Prestained protein markers of known 
molecular weights (Biorad) were loaded onto gels to facilitate protein identification. Gels 
were run in SDS running buffer (25mM TRIS-HCI pH8.3 + 192mM glycine (Biorad) + 
0.1% SDS) at 80V until the samples had stacked and were about to pass into the 
running gel, and then raised 120V for the duration of the run. 
After electrophoresis, if a coomassie stain was required, gels were washed three 
times for 5 minutes in water before being fixed in a 40% methanol, 10% acetic acid. 
50% water solution for 1 hour. Gels were then washed again and immersed in Bio-Safe 
coomassie stain (Biorad) overnight. The next day the stain was removed and the gel 
washed in copious amounts of water until the gel destained to an appropriate level. Gels 
were then scanned on a flatbed scanner (Hewlett Packard) and images taken. 
If western blotting was required, after electrophoresis the gel was placed into a 
Biorad Mini Trans-Blot cell cartridge, sandwiched between two sponges, two pieces of 
blotting paper (VWR) and one piece of nitrocellulose membrane (Biorad). The gels were 
transferred in ice-cooled transfer buffer (25mM TRIS-HCI pH8.3 + 192mM glycine 
(Biorad) + 20% methanol) at 100V for 1.5 hours. The nitrocellulose membrane 
containing transferred proteins was then blocked and stained according to the desired 
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protocol, before being visualised in a HRP-catalysed chemiluminesence reaction 
(Amersham Biosciences). The blots were developed either by exposure to X-Ray film 
(Amersham Biosciences) or visualised in a Fuji Image Analyser LS3000 machine. 
Western blotting antibody protocols 
Antibody litre Block Washes Secondary 
aN16 1:10,000 in PBS + 
5% milk (1 hour RT 
or overnight 4°C) 
PBS + 10% milk 
(1 hour RT or 
overnight 4°C) 
PBS SxlOmin •mouse - HRP 
(Biorad) 1:3,000 in 
PBS + 5% milk (1 
hour RT) 
NCAM H-300 1:1,000 in PBS + 
0.05% Tween 
(Sigma) + 1 % BSA 
(Sigma) (overnight 
RT) 
PBS + 0.05% 
Tween (Sigma) + 
10% milk (2 
hours RT) 
PBS + 0.05% 
Tween 3x5min 
arabbit - HRP 
(Biorad) 1:10,000 in 
PBS + 1% BSA (1 
hour RT) 
Crude a VASE 
antiserum 
1:1,000 in PBS + 
0.05% Tween + 1% 
BSA (overnight RT) 
PBS + 0.05% 
Tween (Sigma) + 
10% milk (2 
hours RT) 
PBS + 0.05% 
Tween 3x5min 
arabbit - HRP 
(Biorad) 1:10,000 in 
PBS + 1% BSA (1 
hour RT) 
Affinity purified 
aVASE 
1:200 in PBS + 
0.05% Tween + 1% 
BSA (overnight RT) 
PBS + 0.05% 
Tween (Sigma) + 
10% milk (2 
hours RT) 
PBS + 0.05% 
Tween 3x5min 
arabbit - HRP 
(Biorad) 1:10,000 in 
PBS + 1% BSA (1 
hour RT) 
ahuman Fc -
HRP (Sigma) 
1:10,000 in PBS + 
5% milk (1 hour RT 
or overnight 4°C) 
PBS + 10% milk 
(1 hour RT or 
overnight 4°C) 
PBS + 0.05% 
Tween 3x5min 
None needed 
Table 2.5.1 - Western blotting conditions for the various antibodies used in this report. 
2.6 Production of NCAM-Fc and NCAM-VASE-Fc by DEAE-dextran 
Transient Transfection of Cos-7 Cells 
A useful tool in the study of NCAM has been the production of a chimeric fusion protein 
- NCAM-Fc (Meiri et al., 1998), consisting of the extracellular domain (ECD) of NCAM 
attached to the Fc fragment of gamma immunoglobulin (IgG) (Figure 2.6.1). The Fc 
fragment consists of the IgG heavy chain CHS and CH2 domains and also the flexible 
hinge region to which the NCAM ECD is attached. There is a disulphide bond in the 
hinge region, linking two Fc fragments, effectively making NCAM-Fc a dimer. The 
functional consequence of this is that NCAM-Fc is thought to be able to bind to more 
than one NCAM molecule on the surface of a cell and cluster NCAM in a similar fashion 
to an NCAM clustering antibody, triggering signalling and neurite outgrov^^h (Beggs et 
al., 1997). Indeed, treatment of cerebellar granule neurons grown for 16 hours on 3T3 
fibroblast monolayers showed a dose-dependent increase in neurite outgrowth when 
treated with NCAM-Fc, maximal at a concentration of Spg/ml (Meiri et al., 1998). In this 
project I have made use of this published NCAM-Fc cDNA construct and also an 
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unpublished construct identical but containing the VASE exon (kind gift of Lee Needham 
and Prof Pat Doherty, King's College London). 
NCAM ECD 
Hinge > 
CH2 > 
Disulphide bridge 
U 
Fc fragment 
Figure 2.6.1 - NCAM-Fc consists of the extracellular domain (ECD) of NCAM attached to the Fc 
fragment of gamma globulin. The hinge region allows flexibility of the NCAM ECD, a 
disulphide bridge contained within makes NCAM-Fc a dimer. 
NCAM and NCAM-VASE-Fc were expressed in the Cos-7 eukaryotic cell line so that the 
protein would be correctly folded and glycosylated. Cos-7 cells were transiently 
transfected using the DEAE dextran method which had previously been selected for its 
high transfection efficiency and protein yield (Meiri et al., 1998). NCAM and NCAM-
VASE-Fc cDNA was prepared from bacterial stocks by streaking a sample of each onto 
LB-agar plates (+ 20|jg/ml ampicillin + 10|jg/ml tetracycline) (VWR) and growing up 
overnight at 37°C. 
The next day, colonies were selected and grown up overnight in 250ml LB 
cultures containing ampicillin and tetracycline at 37°C in a shaking incubator before 
undergoing the Qiagen maxiprep protocol (Qiagen) to purify the cDNAs. The purified 
cDNAs were restriction digested and run on agarose gels along with a DNA ladder 
(Bioline) and the digest bands compared to expected sizes. For each Fc, fifteen 15cm 
tissue culture plates (VWR) were prepared containing 2.5million Cos-7 on each, 
maintained in DMEM +10% FBS. The day after plating, the cells were washed with 
DMEM and the transfection mixture was added consisting of DMEM with 2|jg/ml cDNA, 
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51.6|jg/ml chloroquine (Sigma) and 0.4mg/ml DEAE dextran (Sigma) for 3.5 hours at 
37°C. DEAE dextran is a polymeric cation which can be endocytosed into cells and can 
bind the negatively charged DNA thus facilitating entry of the DNA into the cell. 
Chloroquine increases transfection efficiency, and although the precise mechanism is 
unclear, chloroquine affects the lysosome membrane and this perhaps may play a part 
in the releasing of the DNA into the cytoplasm (Ciftci and Levy, 2001). After incubation 
with the DNA, the Cos-7 cells were osmotically shocked to increase transfection 
efficiency by incubation with PBS + 10% dimethylsulphoxide (DMSO) (Sigma) at room 
temperature for no more than 90 seconds before being allowed to rest overnight in 
DMEM + 10% FBS at 37°C. 
The next day, the medium was removed from the cells and 20ml of DMEM + 1 % 
gamma globulin-free FBS (Invitrogen) was added to each plate and the cells allowed to 
secrete NCAM and NCAM-VASE-Fc into the media for 6-7 days. After this time, the 
medium was collected and filtered to remove dead cells before incubating with 200pl of 
Protein A-sepharose beads (Sigma) on a roller overnight at 4°C. Protein A is a protein 
derived from Staphylococcus aureus which binds to the Fc region of immunoglobulins 
(Xiao et al., 2007). Incubating the medium containing the NCAM-Fc or NCAM-VASE-Fc 
with Protein A beads causes the Fc fusion proteins to bind non-covalently to the beads 
and so be captured from the solution. After overnight incubation, the medium was 
passed through disposable polypropylene columns (Pierce), allowing the beads to be 
collected in the column. The columns were then washed twice with PBS and then the 
fusion proteins eluted by lowering the column pH with lOOmM glycine-HCI pH2.7 
(Sigma). SOOpI fractions were collected into a neutralising solution of 50pl 1M TRIS-HCI 
pH9 and then run on a 12.5% SDS gel and stained with coomassie for the presence of 
the eluted protein and a duplicated gel was transferred onto nitrocellulose and a 
western blot for NCAM performed (Figure 2.6.2). Protein-containing fractions were then 
pooled and concentrated in a spin-concentrator (VWR), also replacing the elution 
solution with PBS by successive rounds of concentration and dilution with PBS. The 
concentration of the Fc fusion proteins was then determined by spectrophotometry at 
280nm and then were diluted in PBS to the same concentration, which was confirmed 
by enzyme-linked immunoabsorbant assay (ELISA). Briefy, an ELISA 96-well plate 
(Triple Red) was coated in ahuman IgG-FC specific (Sigma) in DMEM/HEPES for 1 
hour at 37°C before being washed in DMEM and blocked in DMEM/HEPES + 2% BSA 
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for an hour at 37°C. The plate was then washed again before being coated with 
decreasing amounts of the Fc fusion proteins (that had been presonicated in an ice bath 
for 15 minutes to disrupt and NCAM hemophilic binding) in DMEM/HEPES overnight at 
4°C. The next day the unbound protein was washed off with PBS and the plate blocked 
with PBS + 10% milk. After blocking, the plate was washed again and treated with 
1:10,000 aN16 antibody in PBS for 1 hour, washed and then treated with 1:15,000 
•mouse - HRP (Amersham Biosciences) for 1 hour. After a final wash, lOOpI of kBlue 
TMB substrate (Neogen) was added to each well for 30 minutes and the colour change 
observed in an ELISA plate reader at 650nm. Each datapoint was assayed in triplicate 
so that a mean and standard error could be calculated. The ELISA confirmed that the 
samples of NCAM-Fc and NCAM-VASE-Fc were diluted to the same concentration and 
so could be used comparatively in functional studies (Figure 2.6.3). 
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Figure 2.6.2 - (a) An example coomassie stain of the eluted fractions of NCAM-Fc purified 
from the media of Cos-7 cells transiently transfected for 7 days that have been reduced with 
DTT. Fractions yield two bands - a minor band of >250kDa representing the NCAM-Fc diamer 
which has not undergone disulphide bond reduction and a major band of ~130kDa which 
represents a fully reduced NCAM-Fc monomer. Usually the bulk of NCAM-Fc or NCAM-VASE-
Fc eluted in the first two fractions, (b) Western blot for NCAM showing an identical gel to (a) 
except that the protein samples were not reduced with DTT as this sometimes interfered with 
antibody detection. NCAM-Fc gives a number of bands in the western blot when fractions 
were run, possibly due to the high salt content of the elution buffers or incomplete 
neutralisation of the acidic elution buffer, (c) When dialysed into PBS, only the monomer and 
diamer bands were detected. Media before = culture medium direct from Cos-7 cells 
containing Fc fusion protein. Media after = culture medium after Fc fusion protein has been 
removed by the Protein A. Wash = PBS wash of beads. 
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Figure 2.6.3 - (a) Fc-fusion proteins were tested by ELISA to determine whether they had been 
diluted to the same concentration. A serial dilution of the fusion proteins were coated down 
on a 96-well plate in triplicate and probed by the NCAM antibody alM16. The binding curves 
almost completely superimpose, saturating at the same concentration - 200ng/ml, indicating 
that the fusion proteins are of similar concentrations, (b) IMCAM-VASE-Fc and human IgG were 
coated at 200ng/ml and probed with ISlCAM-specfic aN16. Binding of the antibody to NCAM-
VASE-Fc was about 3.5 times greater showing it is specific for NCAM-Fc and NCAM-VASE-Fc. 
2.7 Affinity Purification of NCAM-VASE-Fc binding antibodies from the 
Hemperiy crude a VASE antisera 
0.5g of cyanogen bromide-coupled sepharose beads (Amersham Biosciences) were 
rehydrated in 5ml of HCI buffer (50ml dH20 + 25pl conc. HCI) for 5 minutes at room 
temperature on a roller. 250[jg of NCAM-VASE-Fc was made up to 1.5ml in Carbonate 
buffer (50ml dH20 + 1g sodium hydrogen carbonate ~pH8.3 (Sigma)). The hydrated 
beads were put into a disposable polypropylene column and washed with HCI buffer 
four times, then four times with dH20, finally three times with Carbonate buffer. The 
NCAM-VASE-Fc was added to the column and both ends sealed with plugs and 
parafilm (VWR) and left on a roller overnight at 4°C. The next day the NCAM-VASE-Fc 
solution was removed from the beads and the unreacted cyanogen bromide quenched 
with an excess of amine groups provided by 4ml of TRIS-Carbonate buffer (2ml 
Carbonate buffer + 2ml 1M Tris-HCI pH9) for 1 hour. The column was then washed 
three times with dH20, then once with Elution buffer (10mM sodium citrate (Sigma) + 
200mM NaCI pH2.6), and finally three times with HEPES buffer (20mM HEPES (Sigma) 
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+ 0.15mM NaCI pH7.5). The affinity column was loaded with 10ml of crude a VASE and 
an equal volume of HEPES buffer and the breakthrough collected and passed through 
the column another two times. The column was then washed with SOOpI of HEPES 
buffer which was collected with the breakthrough. The column was washed twice with 
1ml of Salt Wash buffer (20mM HEPES + 0.4M NaCI) before the bound VASE 
antibodies were eluted by passing three 1 ml volumes of Elution buffer down the column 
and collecting the 1ml fractions into 150^1 of Neutralisation buffer (1M HEPES pH8.2) 
which were retained and stored. The column was then regenerated with HEPES buffer 
and the breakthough passed through the column as previously described another six 
times to collect as many VASE-reactive antibodies as possible (Figure 3.3.2). The 
fractions from elutions 1 and 2 were determined to hold the highest antibody titre and 
were pooled and concentrated down from 6ml into 1.5ml in a spin concentrator, 1% 
sterile BSA was added as a cryoprotectant and the antibody was aliquotted and frozen. 
The remaining fractions were also frozen and kept. 
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Chapter 3 
A non-specific polyclonal VASE antibody 
becomes highly VASE-specific after affinity 
purification against NCAM-VASE-Fc 
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3.0 A non-specific polyclonal VASE antibody becomes highly 
VASE-specific after affinity purification against NCAIVI-VASE-Fc 
3.1 The Need 
NCAM-VASE mRNA transcripts have been mapped both spatially and temporally in 
cultured cells and tissue homogenates (Small and Akeson, 1990; Small et al., 1988; 
Walsh et al., 1992). Although a great deal of information can be gained about the 
expression level and tissue localisation of a protein through looking at its 
transcription, it gives little information as to the subcellular localisation of the protein, 
or even if it is translated. There are only two published papers addressing the 
localisation of NCAM-VASE protein, with limited results. Small and co-workers 
reported that a polyclonal antibody against a VASE peptide (VASE sequence 
followed by a Tyr and a Cys residue) stained a subpopulation of cultured NCAM-
positive El 4.5 rat brain cells with the morphology of neurons and over 8 days in 
culture, increasingly more cells became VASE-positive (Small et al., 1988). 
Hemperly and co-workers produced a similar polyclonal antibody using a peptide 
immunogen consisting of the VASE sequence, the four flanking amino acids either 
side, and an N-terminal Cys residue (CSEEKASWTRPEKQETLDG) (Vawter et al., 
1998). The Vawter et al paper focused on a series of protein bands around 140-
145kDa in size that were picked up by the VASE antibody on western blots of brain 
extracts. These bands were not recognised by an NCAM intracellular-specific 
antibody (140 and 180 isoforms) (Figure 3.1.1). The bands were proposed to be 
differently glycosylated variants of NCAM (but not with PSA), and although it is not 
explicitly discussed, it is implied that they are not reactive for the NCAM intracellular 
antibody due to their lack of a cytoplasmic domain. However, there also appears to 
be a very high molecular weight band that is VASE-reactive, but not reactive for 
NCAM (Figure 3.1.1) which is not commented upon in the paper (Vawter et al., 
1998). 
92 
NCAM 1 2 3 4 5 6 7 8 
Actin 
Denatured 
Figure 3.1.1 - The polyclonal VASE antibody produced in (Vawter et al., 1998) appears to be 
bind to several protein bands from various human brain membrane extracts which are not 
recognised by an antibody to NCAM. Figure 4a (Vawter et al., 1998). The two images are of the 
same stripped and re pro bed blot. Left blot = NCAM antibody; right blot = VASE antibody. 
Having probed VASE expression in western blots, Hemperly and co workers 
went on to look at VASE expression in human hippocampal brain sections by 
immunohistochemistry. This showed VASE staining in the dentate gyrus granule 
layer, CA4 pyramidal neurons, and astrocytes in the CA4 region and of the temporal 
horn of the lateral ventricle (Vawter et al., 1998). As with the western blots, the brain 
sections showed VASE staining in areas which were not immunoreactive for the 
NCAM cytoplasmic domain antibody (for example. Figure 6D (Vawter et al., 1998)). 
These again are not commented upon in the paper, although perhaps they reflect 
the VASE exon in NCAM120 which would not be recognised by the cytoplasmic 
NCAM antibody. This seems unlikely as the VASE-positive, NCAM-negative staining 
appears to be localised to dentate gyrus neurons and neurons have been reported 
to contain only very low levels of NCAM120 (Keilhauer et al., 1985). 
Polyclonal antibodies are generated by immunising animals (usually rabbits) 
against the epitope of interest and eliciting an immune response. The short VASE 
peptides used as immunogens by Small and Hemperly lack the structure and 
context of VASE in its native conformation, and are likely to generate polyclonal 
antibodies reactive to different conformations of the peptide which might not be 
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reflected in the NCAM-VASE protein, and even bind non-specifically to other 
proteins. In addition, the antiserum will contain antibodies present naturally in the 
animal which could potentially mask the specificity of the VASE antibody. Possibly 
this could account for Vawter et al finding that their polyclonal VASE antibody 
recognised protein bands on western blots and cells in the brain which are not 
NCAM immunoreactive (Vawter et al., 1998). This is counterintuitive as proteins 
which are VASE-reactive, must be NCAM-reactive by nature. 
3T3 cells (Parental) N24 cells (NCAM) 140VG cells (NCAM-VASE) 
Figure 3.1.2 - The Hemperly a VASE antisera (Vawter et al., 1998), whilst staining 3T3 
fibroblasts transfected for human NCAM140-VASE (140VG), also gives non-specific staining on 
parental 3T3 fibroblasts and 3T3 fibroblasts transfected for NCAM lacking the VASE exon. 
Fibroblast cells were plated in DMEM + 10% FBS overnight before being fixed with 4% PFA and 
stained. Hemperly aVASE antisera (red); DAPI (blue). Bar= 60pm 
Initial testing of the Hemperly aVASE antiserum (kind gift of John Hemperly) 
suggests that it does have a non-specific component, staining NCAM-VASE and 
NCAM without VASE transfected 3T3 fibroblasts, and the parental untransfected 
cells (Figure 3.1.2) - see section 3.30 and figure 3.3.1 for further details of this 
experiment. In this study, the Hemperly a VASE antiserum (from now on referred to 
as crude aVASE) will be taken and affinity purified against NCAM-VASE-Fc to 
isolate antibodies that recognise VASE in its native conformation. The affinity 
purified antibody will then be used to probe the VASE localisation In cells and tissue. 
The subcellular and overall localisation of NCAM-VASE the nervous system both 
during development and in adulthood will give an important insight into the potential 
functions and role of the VASE exon by correlating the presence of VASE at certain 
developmental timepoints, cell types and regions of the nervous system. The aim is 
that this information will focus this, and further investigations into specific areas and 
mechanisms where VASE could be important. The need to have an antibody specific 
for the VASE sequence Is self-evident If localisation studies are to be carried out. 
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Results 
3.2 Affinity purification of NCAIVI-VASE Fc binding antibodies from 
the Hemperiy a VASE peptide antiserum 
I 
II 
Human hFc Fc + NCA M-VAS E 
Ab portion extracellular domain 
1. cDNA transfected into COS-7 cells 
and protein harvested via Fc 
binding to Protein A sepharose beads 
J k ^ J k 
A 
2. NCAM-VASE Fc coupled to 
CNBr sepharose beads 
Y\&f 
)Vk 
3. Hemperiy VASE antisera passed 
through column. Specific VASE 
Abs bi nd to beads 
Figure 3.2.1 - Basic schematic of the process of affinity purifying the crude aVASE Ab. 
4. Non-specific Abs washed away. 
VASE Abs eluted and concentrated 
To isolate antibodies recognising the VASE epitope in a native conformation, the 
crude aVASE antiserum was affinity purified against NCAM-VASE-Fc (Figure 3.2.1). 
NCAM-VASE-Fc production and VASE antibody affinity purification were carried out 
as described in the Materials and Methods section. Briefly, Cos-7 cells were 
transiently transfected with a plasmid containing the NCAM-VASE-Fc cDNA 
sequence, by the DEAE dextran method. After 6-8 days, the medium containing the 
secreted Fc fusion protein was collected and NCAM-VASE-Fc isolated by binding to 
Protein A sepharose. The Protein A was trapped in a column and the NCAM-VASE-
Fc eluted from it, then collected, dialysed into PBS and concentrated. The NCAM-
VASE-Fc was then linked to cyanogen bromide-activated sepharose beads via 
amide group coupling and collected in a column. The crude a VASE antiserum was 
then passed through the column, binding the antibodies specific for VASE in a native 
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conformation. The column was washed and the specific antibodies eluted. The 
antisera flow-through was passed five more times through the column to ensure all 
antibodies were collected (Figure 3.2.2). 3T3 cells transfected for human NCAM140-
VASE (see section 3.30) were stained with the elutions to confirm the presence of 
VASE-reactive antibodies (Figure 3.2.2). The first three elutions were found to 
contain the highest titre of antibody, so were collected, concentrated and frozen 
down to store. 
Elution 1 Eiution 2 E ution 3 
Elution 5 Elution 4 Elution 6 
Figure 3.2.2 - 10ml of crude aVASE antisera was bound and eluted from a column of cyanogen 
bromide-coupled NCAM-VASE-Fc - sepharose beads six times. With each binding and elution, the 
antisera became progressively depleted of VASE-reactive antibodies. This was visualised by staining 
4%PFA fixed 3T3 cells transfected for NCAM-VASE (140VG cells) with the first fraction of each 
antibody elution, having corrected for the progressive dilution of the breakthrough as the purification 
progressed. Affinity purified a VASE (red); DAPI (blue). Bar = GOpm 
3.3 The specificity of affinity purified aVASE 
After purification, the affinity purified a VASE antibody was tested for specificity by 
cell staining. NIH 3T3 cells transfected for human NCAM140 were obtained (kind gift 
of Pat Doherty (Doherty et a!., 1990)) (called N24 cells) and a stable clone of human 
NCAM-VASE140 expressing NIH 3T3 cells was produced by lipofectamine 
transfection (cDNA a kind gift of Pat Doherty (Walsh et al., 1992)) (called 140VG -
see Materials and Methods section). It was determined that 140VG cells expressed 
about the same amount of NCAM-VASE as N24 cells express NCAM by ELISA (see 
Materials and Methods section). These cells were plated onto glass coverslips in 
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DMEM + 10% FBS overnight before being fixed with 4% PFA, blocked in PBS + 
10%FBS, stained, and then the staining pattern compared by fluorescence 
microscopy. Duplicate coverslips of cells were stained with crude a VASE antiserum, 
affinity purified a VASE and aN16 - which is reactive for the third Ig domain of 
human NCAM (Figure 3.3.1). Whilst giving a clear surface stain on NCAM-VASE 
expressing 140VG cells, the Hemperly aVASE antiserum also gave bright patches of 
staining on the parental untransfected 3T3 cells and NCAM (without VASE) 
expressing N24 cells (Figure 3.3.1, top panel). The affinity purified aVASE gave a 
very strong surface stain on 140VG cells, but did not stain 3T3 or N24 cells (Figure 
3.3.1, middle panel). aN16 which will recognise both VASE and non-VASE isoforms 
of NCAM stained N24 and 140VG cells equally well, but as expected gave no 
staining for 3T3 cells (Figure 3.3.1, bottom panel). By affinity purifying the crude 
aVASE antiserum, it has been possible to isolate and separate out a fraction of 
antibodies which specifically recognise NCAM-VASE expressed by recombinant 
cells from amongst a pool of non-specific antibodies. 
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Figure 3.3.1 - The crude aVASE antiserum, whilst staining 3T3 fibroblasts transfected for 
human IMCAM140-VASE (140VG cells), also gives non-specific staining for 3T3 fibroblasts 
transfected for human NICAM140 lacking the VASE exon (N24 cells) and untransfected 3T3 
fibroblasts. Affinity purified aVASE gives specific staining only for VASE-transfected cells. 
alM16, an antibody to all NCAM isoforms stains both NCAM-expressing cell lines. Antibody 
(red); DAPI (Blue). Bar = 60pm. 
After showing that affinity purified a VASE is specific only for NCAM-VASE 
expressing cells, whilst the crude a VASE antiserum non-speclfically binds also to 
NCAM expressing, and untransfected cells, the specificity of the antibodies in 
western blots was investigated. Initially, the antibodies were tested against cell 
lysates of N24 and 140VG cells. Cell lysates were prepared by washing cells in PBS 
twice before lysing in 2xSDS sample buffer and sonicating on ice briefly. Protein 
concentrations were determined by BCA protein assay and then 20pg of protein per 
well was reduced with DTT and loaded into a 7.5% SDS acrylamide gel. The gel was 
run with three duplicate cell lysate samples, transferred onto nitrocelluose and then 
cut into three. One third was stained with crude a VASE antiserum, another with 
affinity purified aVASE, and the final third was stained with NCAM H-300 - a 
polyclonal antibody recognising the first 300 amino acids of rat and human NCAM 
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extracellular domain (Figure 3.3.2a). The crude a VASE antiserum gave very high 
background all over the blot but only a single band could be very faintly 
distinguished at 140kDa in the VASE cell lysate, and no bands in the NCAM cell 
lysate (Figure 3.3.2a, middle blot). A corresponding band at 140kDa was also 
observed in the VASE cell lysate with the affinity purified aVASE, however the band 
stained strongly, with a very low amount of background staining (Figure 3.3.2a, right 
blot). The affinity purified aVASE picked up no other bands in the VASE cell lysate 
and no bands at all in the NCAM cell lysate. NCAM H-300 stained very strongly, 
giving a single band of 140kDa in both NCAM and NCAM-VASE cell lysates (Figure 
3.3.2a, left blot), identifying the 140kDa bands as NCAM and NCAM-VASE 
respectively. The affinity purified a VASE was also shown to be specific for NCAM-
VASE-Fc - the immunogen it was purified against. Serial dilutions of NCAM-Fc and 
NCAM-VASE-Fc starting at 2.75[jg of protein per well and halving each time, were 
loaded in duplicate under identical conditions as the cell lysate western blot. The blot 
was cut in half and stained with NCAM H-300 and aVASE (Figure 3.3.2b). NCAM H-
300 stained both NCAM-Fc and NCAM-VASE-Fc, whilst aVASE was specific for 
NCAM-VASE-Fc. 
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Figure 3.3.2 (a) Affinity purified a VASE specifically recognises a single band at 140kDa in 
NCAM-140-VASE transfected 3T3 cell lysate, whilst not giving any bands in an NCAM-140 
(without VASE) transfected 3T3 cell lysate. The Hemperly aVASE antisera also stains a 140kDa 
band in the NCAM-140-VASE cell lysate, but only very faintly, and gives a high background 
stain. A total NCAM antibody (NCAM H-300) recognises a 140kDa band in both NCAM and 
NCAM-VASE cell lysates. 20pg of DTT reduced cell lysate was loaded per well on a 7.5% SDS 
acrylamide gel. Crude aVASE antisera was stained at 1:1000; affinity purified aVASE was 
stained at 1:200; NCAM H-300 was stained at 1:1000. (b) NCAM H-300 recognises both NCAM-
Fc and NCAM-VASE-Fc. Affinity purified aVASE specifically binds to NCAM-VASE-Fc - the 
immunogen it was purified against, whilst not binding to NCAM-Fc which lacks the VASE 
sequence. Serial dilutions of NCAM-Fc and NCAM-VASE-Fc starting at 2.75pg and halving with 
each dilution, were DTT reduced and loaded into a 7.5% SDS acrylamide gel. The blot was 
then cut in half and stained under identical conditions to (a). N = NCAM-Fc; V = NCAM-VASE-
Fc. 
Having shown that affinity purified a VASE is specific only for the VASE isoform of 
NCAM in transfected cell lysates and recombinant Fc fusion proteins by western 
blot, the expression of NCAM-VASE in adult rat brain membranes was investigated. 
Brain membranes were isolated by homogenising the brain of an adult rat and 
separated from the cytosol by centrifugation. Brain membranes were solubilised in 
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RlPA buffer and the soluble fraction reduced with DTT before having 75pg of 
protein/per well run on a 7.5% SDS acrylamide gel. Samples were run in duplicate 
and half were stained for NCAM H-300 and the other for affinity purified aVASE. 
NCAM H-300 (recognising all NCAM isoforms) produced two major bands of about 
180 and 14GkDa and a very faint band of about 120kDa in the brain membrane 
sample, matching the three major NCAM isoforms at 120, 140 and 180kDa (Figure 
3.3.3a). The affinity purified a VASE also gave two bands at 180 and 140kDa, 
however no band was observed at 120kDa (Figure 3.3.3a). If the amount of protein 
added was doubled to 150(jg/well, the 120kDa band was much clearer to visualise 
with NCAM H-300, and a faint 120kDa band could also be observed with affinity 
purified aVASE (Figure 3.3.3b). Densitometry showed that the faint VASE 120kDa 
band made up proportionally less of the VASE containing NCAM isoforms compared 
to the total NCAM 120kDa band, whilst VASE appears to be enriched in the 140kDa 
isoform (Figure 3.3.3c). This data suggests that NCAM-VASE is expressed by the 
three major NCAM isoforms in adult rat brain. 
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Figure 3.3.3 - Adult rat brain membranes probed with NCAM H-300 for total NCAM expression, 
and affinity purified aVASE for NCAM-VASE expression. Membrane samples were reduced by 
DTT and loaded in duplicate onto a 7.5% SDS acrylamide gel. The gel was transferred to 
nitrocellulose and then cut in half, each half stained by the two antibodies, (a) 75pg/well of 
brain membrane protein was loaded. NCAM H-300 gives two major bands at 180 and 140kDa, 
and a less intense band at 120kDa. Affinity purified aVASE gave only the 180 and 140kDa 
bands, (b) If the amount of protein per well is doubled, all three NCAM isoforms can be clearly 
visualised by NCAM H-300. Additionally it was possible to visualise a faint 120kDa band with 
affinity purified aVASE at this higher protein concentration, (c) Densitometric analysis of the 
blots in (b) showing that NCAM140 is enriched in the VASE isoform and that VASE-reactive 
NCAM120 is considerably less abundant than non-VASE NCAM120 
As a final test of specificity, antibody binding by affinity purified aVASE was blocked 
by antigen preadsorption. If affinity purified aVASE is specific, preincubating it with 
saturating concentrations of its antigen will prevent binding to NCAM-VASE in 
samples. SOpg/ml of NCAM-VASE-Fc (the antigen the antibody was affinity purified 
against) was incubated with affinity purified aVASE made up to a working dilution 
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(1:100 on cultured cells, 1:20 on tissue sections) at 37°C for an hour. The antibody 
was then added to either fixed NCAM-VASE transfected 140VG cells or fixed PND7 
rat cerebellum sections and stained using standard staining protocols as described 
in the Materials and Methods section. In addition, duplicate staining was performed 
under the same conditions with antibody incubated with PBS, not NCAM-VASE-Fc. 
As before, the affinity purified aVASE gave a surface stain on 140VG cells, but no 
staining could be observed with the preadsorbed antibody (Figure 3.3.4). In the 
PND7 rat cerebellum, aVASE gives intense staining on cells in the Purkinje cell layer 
(Figure 3.3.4b, also see Chapter 6). With the preadsorbed antibody, only minimal 
background staining in the Purkinje cell layer was observed, however intense 
staining was observed at the edge of the section, consistent with non-specific "edge 
effect" secondary antibody binding. Antigen preabsorption of affinity purified a VASE 
was sufficient to block its binding to NCAM-VASE in cultured cells or tissue sections, 
indicating that it binds specifically to the VASE epitope and that non-specific binding 
is not contributing to the observed staining pattern. 
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Figure 3.3.4 - Incubating affinity purified a VASE with 90pg/ml NCAM-
VASE-Fc for 1 hour at 37°C blocks aVASE binding to fixed NCAM-
VASE transfected 140VG cells (a), and NCAM-VASE expressed a tissue 
section of fixed PND7 rat cerebellum (b). Note, the intense staining in 
(b) on the left of the images is non-specific staining routinely found at 
the edge of sections. For a detailed analysis of NCAM-VASE staining 
in the developing rat cerebellum, refer to Chapter 6. Affinity purified 
a VASE (red); DAPI (blue). Bar = 60pm 
3.4 Staining of VASE transfected cells by affinity purified a VASE is 
temperature dependent 
Having only stained 4% PFA fixed cells up to this point with affinity purified aVASE, 
staining of living cells was investigated. This was carried out as fixing cells can 
sometimes cause staining artefacts (Kohlwein, 2000), and also live cells have an 
intact cell membrane (Moulding et al., 2000), allowing only NCAM-VASE expression 
on the surface of the cell to be explored. PFA cross-links proteins within the cell, 
killing the cell, somewhat permeabilising it, but allowing cellular morphology to 
remain intact (Pearse, 1980). Live cellular staining allows the antibody to interact 
with a living cell. Live staining can be performed at a physiological temperature of 
37°C so that the effect of the antibody on cellular processes can be observed, or can 
be performed at a lower temperature such as 4°C which suspends cellular 
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processes (such as endocytosis which internalises the antibody) and so only allows 
the antibody access to the outside surface of the cell (Moulding et al., 2000). 
Duplicate coverslips of NCAM-VASE expressing 140VG cells were plated overnight 
before half were fixed with 4% PFA. The fixed and live cells were then incubated at 
37°C with aN16 or a VASE for an hour, or incubated at 4°C on ice with aVASE for an 
hour. Cells were then washed and the live cells fixed with 4% PFA before all cells 
were stained with secondary antibody. At 37°C, aN16 (which binds to human NCAM 
Iglll) binds to live and fixed NCAM-VASE expressing 140VG cells equally well, both 
giving a surface stain (Figure 3.4.1, top panel). aVASE gave surface staining at 37°C 
when fixed, however no staining was observed by a VASE on the live cells incubated 
at 37°C (Figure 3.4.1, middle panel). Reducing the staining temperature to 4°C gave 
live staining with aVASE, as well as when fixed (Figure 3.4.1, bottom panel). This 
difference in aVASE staining at 37°C and 4°C is very curious. It could suggest that 
the availability of the VASE epitope is affected by the incubation temperature in 
living cells, or perhaps that a VASE binding causes endocytosis or proteolysis of 
NCAM-VASE. Whatever the effect of aVASE may be, it appears to be epitope-
specific as aN16 stained live at 37°C. 
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aN16 
(NCAM) 
37°C 
Primary Ab LIVE 
aVASE 
37°C 
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4°C 
Figure 3.4.1 - aVASE stains fixed NCAM-VASE transfected 140VG cells at 37°C and 
4°C. aVASE cannot stain live cells at 37°C, whereas an NCAM Ab specific for NCAM 
Iglll does. However, at 4°C aVASE is able to stain live 140VG cells. Cells were plated 
overnight, and then half were fixed with 4% PFA, and half kept live, before staining with 
aN16 or aVASE for 1 hour. The cells were then washed and the live cells fixed in 4% 
PFA before secondary antibody staining. Antibody (red); DAPI (Blue). Bar = GOpm. 
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3.5 Discussion 
The crude aVASE antiserum gave non-specific staining on both 3T3 fibroblast cells 
by immunocytochemistry, and on lysates of the cells by western blot (Figures 3.3.1 
and 3.32a). I have affinity purified the non-specific crude aVASE antisera against 
NCAM-VASE-Fc, yielding an antibody which: 
• Can specifically recognise NCAM-VASE recombinantly expressed by 
transfected 3T3 cells whilst showing no reactivity for those transfected for 
NCAM, both by immunocytochemistry and on western blots. 
• Can specifically recognise NCAM-VASE in the three major NCAM isoforms in 
adult rat brain membranes by western blot. 
• Can be blocked from staining fixed cells and tissue sections by antigen 
preabsorption against NCAM-VASE-Fc. 
• Stains living 3T3 cells transfected for NCAM-VASE at 4°C but not 37°C, whilst 
staining fixed cells at both temperatures. 
When the affinity purified aVASE was used to probe VASE expression in 
adult rat brain membranes, the distribution of VASE isoforms appeared to be very 
similar to that of total NCAM isoforms, giving single bands at ISOkDa, 140kDa and 
120kDa - corresponding to the three major NCAM isoforms of this size in adult brain 
(Figure 3.3.3). This is in contrast to the western blot of human brain membrane 
samples probed with crude aVASE antisera from Vawter et a/which showed four 
bands around 140-145kDa in size, a band larger than ISOkDa in size, and no 
120kDa band (Figure 3.1.1) (Vawter et al., 1998). This difference could be due to the 
reasons discussed in the introduction to this chapter. The 120kDa VASE band given 
by the affinity purified antibody could only be visualised by loading a large amount of 
brain membrane protein onto the SDS gel. The total NCAM antibody also detected 
NCAM 120 at a lower abundance than the 180 and 140 bands, however there 
appears to be proportionally less NCAM120-VASE detected by a VASE (Figure 
3.3.3).This would be consistent with previous work finding proportionally less VASE 
mRNA transcripts in the 120kDa NCAM isoform in mouse brain (Gegelashvili et al., 
1993). 
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It was interesting to find that the staining of affinity purified aVASE to living 
3T3 cells transfected for human NCAM140-VASE (140VG cells) appears to be 
temperature-dependent, staining live at A^C but not at 37°C (Figure 3.4.1). There 
could be a number of different explanations for this; 1. The VASE sequence of 
NCAM may be unavailable for antibody binding, either by being buried, or because it 
is bound to something else. 2. a VASE binding could trigger NCAM endocytosis. 3. 
a VASE binding could trigger proteolysis and release of NCAM from the cell surface. 
Fixed cells did stain for VASE at 37°C. If the observed staining effect is caused by 
epitope availability, perhaps by fixing the cells a "snapshot in time" is created, with 
most VASE sequences bound to their natural ligand, but leaving a proportion of 
VASE sequences "free" and available to receive the antibody. In the live cells at 
37°C, the natural ligand for VASE could be outcompeting aVASE for binding and so 
preventing staining. At 4°C, a VASE was able to bind to live cells, possibly because 
at this low temperature cellular processes shut down. This could have resulted in the 
natural ligand of VASE remaining bound to some VASE sequences, allowing a VASE 
to bind to the population of "free" VASE sequences. It is worth noting that if this is 
the case and the VASE sequence is binding to something, it is binding "out of 
context" in a non-neuronal cell line. This would suggest that the natural ligand of 
VASE is either something fairly ubiquitous or is binding to another part of the NCAM 
molecule, such as FNIII-1, as Walsh and Doherty have proposed (Saffell et al., 
1994). Equally possible is that a VASE triggers endocytosis of NCAM-VASE from the 
cell surface. In the live cells at 4°C, endocytosis would be shut down allowing 
a VASE bound to NCAM-VASE to remain at the surface. At 37°C, endocytosis of 
aVASE bound NCAM-VASE would be allowed to occur unhindered. This could be 
easily tested by staining permeabilised cells and looking for intracellular staining. If 
a VASE binding induces NCAM-VASE proteolytic shedding, then this would occur at 
a faster rate at 37°C rather than 4°C, and so would mask aVASE staining at 37°C 
whilst allowing it to remain at 4°C. 
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Chapter 4 
Expression of NCAM-VASE in neurons, 
oligodendrocytes and astrocytes cultured in 
vitro 
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4.0 Expression of NCAM-VASE in neurons, oligodendrocytes and 
astrocytes cultured in vitro 
4.1 Introduction 
NCAM-VASE in cultured cells 
The expression of NCAM-VASE in cultured neurons has already been examined at 
the mRNA level and been determined to upregulate with time in culture. Forster and 
Frotscher found that PND4 rat hippocampal slice cultures upregulate VASE transcripts 
to 50% of all NCAM transcripts over 10 days in culture, however the equivalent 
upregulation took twice as long in vivo (Forster and Frotscher, 1995). In the 
cerebellum, PND3 rat cerebellar neurons cultured for 1,2 and 5 days (i.e equivalent to 
PND4,5 and 8) were found to increase expression of VASE mRNA over time, whilst 
cerebelia taken from the equivalent aged rats expressed almost twice as much VASE 
as the cultured cells (Walsh et al., 1992). This could be due to the fact that the 
cultured cells were 95% neurons, whilst the cerebellar homogenates from the different 
aged rats would contain a larger population of other cell types which could also 
express VASE. This highlights the need to study VASE expression by other cell types 
in the brain. 
There is only one study which has investigated astrocytic VASE mRNA 
expression in culture, which found that cortical astrocytes from newborn mice express 
only a small basal level of NCAM-VASE in all isoforms, but upon stimulation with 
dibutyryl cyclic AMP (dBcAMP) there is an upregulation of the NCAM 140 kDa 
transcript, particularly the 140-VASE isoform (Gegelashvili et al., 1993). dBcAMP is a 
non-hydrolysable membrane-permeable analogue of the second messenger cyclic 
AMP (cAMP) which induces astrocyte reactivity (termed "astrocyte differentiation" in 
the paper) - involving the upregulation of astrocyte-specific intermediate filament 
GFAP, hypertrophy, and an increase in cytoplasmic processes (Figure 4.1.1) (Miller et 
al., 1994). Astrocyte reactivity is usually in response to CNS insults such as injury 
(Menet et al., 2003). The terms astrocyte "differentiation" and "reactivity" are used 
interchangeably in the literature (Gegelashvili et al., 1993; Miller et al., 1994), but 
strictly speaking, astrocytes differentiate from precursors in the immature brain, 
providing a constructive support to surrounding developing neurons before becoming 
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relatively quiescent (Liu and Neufeld, 2007). When astrocytes become reactive, they 
reexpress proteins expressed by developing astrocytes such as epidermal growth 
factor receptor (EFGR) (Liu and Neufeld, 2007). This replay of differentiation 
unfortunately can be inappropriate in adult tissue, causing deleterious effects such as 
inhibition of axonal regeneration at lesion sites (Menet et al., 2003). It has been found 
that basic fibroblast growth factor (FGF-2) can also stimulate astrocyte reactivity, with 
local levels of FGF-2 increasing around areas of brain injury stimulating a reactive glial 
response (Bayatti and Engele, 2002; Eclancher et al., 1996). 
Unreactive Astrocytes Reactive Astrocytes 
Figure 4.1.1 - SEM images of cultured human foetal brain astrocytes either untreated (left) or 
treated with interleukin-lp (right) to induce a reactive phenotype. Bar = 20|jm, inset bar = 3pm. 
Taken from figure 1, John etal (John et al., 2004). 
NCAM-VASE expression in oligodendrocytes has only been very briefly 
mentioned in passing and was found to be expressed at very low levels in immature 
(Figure 4.1.2) cultured El8 rat oligodendrocytes (Itoh et al., 2000). VASE protein 
expression and distribution has never been investigated in either astrocytes or 
oligodendrocytes. 
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Figure 4.1.2 - Cellular morphology and markers of developing oligodendrocytes in culture as 
described by Hardy and Reynolds (Hardy and Reynolds, 1991). Additional information from 
(Levine et al., 2001). GD3 = ganglioside GD3; GAP43 = growth-associated protein 43; GalC = 
galactocerebroside; CNP = cyclic nucleotide phosphodiesterase; MBP = myelin basic protein; 
GS = glutamine synthetase; 04 = unidentified sulphated glycolipid antigen; MOG = myelin 
oligodendrocyte glycoprotein. 
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Figure 4.1.3 - The genesis of neurons, astrocytes and oligodendrocytes in the rat cortex occurs in a 
temporally distinct but overlapping sequence, with neurogenesis peaking at El4, astrocytogenesis peaking 
at PND2 and oligodendrogenesis peaking at PND14. E = embryonic day; P = postnatal day. Adapted from 
figure 1a (Sauvageot and Stiles, 2002). 
By birth, rat cerebral neurogenesis is almost complete, with most neurons being 
generated embryonically (Figure 4.1.3), however in the cerebellum about 77% of 
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neurogenesis occurs after birth (Porterfield and Hendrich, 1993). The postnatal 
generation of cerebellar neurons permits the easy isolation of a readily identifiable 
area of the brain which contains a large amount of neural precursors, without the 
inconvenience of isolating and working with small amounts of embryonic tissue. In 
addition, mixed cultures of cerebellar cells also contain astrocytes and 
oligodendrocytes (Shambaugh et al., 1994) which can be cultured along with neurons 
to provide an environment that better mimics the in vivo situation. Differentiated 
neurons do not survive indefinitely in culture, but survival can be promoted with the 
addition of depolarising concentrations of to the culture medium (Gallo et al., 1987). 
K"" depolarisation of neurons is thought to promote survival by mimicking in vivo 
electrical stimulation of the neurons which activates Ca^^-dependent signalling 
pathways leading to maturation and survival of the neuron (Gallo et al., 1987). 
NCAM-VASE transcript upregulation in cultured neurons has been well 
characterised and VASE protein distribution initially investigated (Forster and 
Frotscher, 1995; Small et al., 1988; Walsh et al., 1992). However less is known about 
VASE expression in astrocytes and oligodendrocytes, and the subcellular localisation 
of VASE protein has never been studied in any cell types. To best observe VASE 
expression in neurons, astrocytes and oligodendrocytes, culture conditions must be 
ideal for survival and mimic the in vivo situation closely. This could pose problems as 
mixed cultures of all three cell types could best reflect in vivo cell environment, 
however the optimum growth conditions for one cell type may not be optimal for the 
others. Therefore a number of cell culture systems will be required to better grasp 
NCAM-VASE expression by different cell types. 
4.2 Alms of This Chapter 
Costaining with cell-specific markers will make it possible to identify cell types 
expressing VASE. A myelin-specific marker will be used to compare VASE expression 
to oligodendrocyte differentiation, and chemical agents will be used to investigate 
VASE expression in response to astrocyte reactivity. This chapter will address VASE 
expression in cerebellar-derived cells as all three major neural cell types are 
represented in these cultures. In addition, cells taken from El 8 cortices will also be 
examined. Cells from the cortex must be taken at this early developmental timepoint 
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as cortical neurogenesis ceases soon after. However, in this culture system 
oligodendrocytes will be underrepresented as minimal oligodendrogenesis occurs at 
E18 in rat (Figure 4.2.1) (Sauvageot and Stiles, 2002). To compensate for this, the 
E18 cortical cultures will be supplemented with oligodendrocyte precursors cells 
(OPCs) taken from PND4 animals. This chapter aims to take the affinity purified 
aVASE antibody and investigate NCAM-VASE expression in culture over time by the 
major CNS cell types: neurons, astrocytes and oligodendrocytes. 
Results 
4.3 NCAM-VASE expression in mixed PND4 cerebellar cultures after 
short and long term culture 
NCAM-VASE expression in culture was first investigated using mixed cerebellar 
cultures in Long Term culture (LT) medium, taken from Foran et al (Foran et al., 
2003), slightly modified to boost neuronal survival by the addition of 2mM sodium 
pyruvate, on the advice of one of the authors (Dr P. Foran). This medium contains a 
depolarising concentration of K"" and is optimised for the long term survival and 
differentiation of cerebellar granule neurons to study neurotransmitter release from 
synapses (Foran et al., 2003). Mixed cultures were obtained from PND4 rat pup 
cerebella as described in the Materials and Methods section, and 1,000,000 cells were 
plated onto each poly-l-lysine-coated 13mm glass coverslip. To investigate NCAM-
VASE expression early in development, half the cells were fixed and stained after two 
days in culture (2DIV). To monitor expression of NCAM-VASE later in development, 
the remaining cells were fixed and stained after 17 days in culture (17DIV), which had 
previously been determined to be the approaching the longest time these cultures 
could survive and still look "healthy" (Figure 4.3.1). 
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Figure 4.3.1 - Mixed cerebellar cultures in LT medium cultured for 17 days. PND4 rat cerebella 
were dissociated with trypsin before 1,000,000 cells were plated onto poly-l-lysine coated 
coverslips in DMEM + 10% overnight. The next day, the media was carefully replaced with LT 
culture medium and replaced every 7 days. Bar = 100pm 
NCAM-VASE expression was identified using the affinity purified aVASE 
antibody. As of yet, no antibodies exist which only recognise non-VASE NCAM 
isoforms, and so a pan-NCAM antibody (aNCAM H-300) which will recognise both 
VASE and non-VASE NCAM was used as a control to stain total NCAM. This means 
that NCAM-VASE-specific staining must always be a subset of the total NCAM 
staining and should not be found to stain cells which the total NCAM antibody does 
not. Identification of neurons was achieved through a costain with an antibody to the 
microtubule-associated protein tau (Figure 4.3.2). In vivo tau is localised to the axon 
and plays a part in the reorganisation of the microtubule cytoskeleton that occurs with 
neurite outgrowth, however, it has been reported that in vitro, the axonal localisation of 
tau is not so stringent and can be found in other neuronal compartments (Brandt, 
1996; Kempfetal., 1996; Mukrasch et al., 2007). 
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VASE expression in neurons 
After two days in vitro (DIV), an intricate network of tau-positive neuronal processes 
was observed in the mixed cerebellar cultures (Figure 4.3.2a). Some, but not all of the 
tau-positive processes stained for total NCAM, with total NCAM staining being 
strongest in the neuronal cell body (Figure 4.3.2a, top panel). Some tau-negative cells 
also stained for total NCAM. At 2DIV, no cells, whether tau-positive or negative 
showed staining for aVASE (Figure 4.3.2a, bottom panel). By 17DIV, the network of 
tau-positive neuronal processes had fasiculated into a larger network of bundles 
processes (Figure 4.3.2b). Again, like 2D1V, some but not all of the tau-positive 
bundles stained for total NCAM at 17DIV (Figure 4.3.2b, top panel). Tau-negative cells 
growing underneath the neurons also gave staining for total NCAM. In contrast to 
2DIV, the mixed cerebellar cultures gave aVASE staining at 17DIV (Figure 4.3.2b, 
bottom panel). Bright VASE staining was clearly localised to tau-positive neuronal 
bundles, with a small amount of staining on the underlying cells. VASE isoform protein 
expression in tau-positive neurons was very low/absent at 2DIV and increased over 
time in culture and by 17DIV was comparable to total NCAM expression. The 
expression of NCAM-VASE at the 17DIV timepoint appears to be due to a switch in 
NCAM isoform production, not due to a general upregulation of NCAM expression, as 
total NCAM stained at a similar intensity at 2DIV and 17DIV (Figure 4.3.2). 
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(a) 2 DIV 
Tau Total NCAM Merge + DAP! 
Merge + DAPI 
(b) 17DIV 
Tau Total NCAM Merge + DAPI 
VASE Merge + DAPI 
Figure 4.3.2 - PND4 mixed cerebellar cells cultured for 2 days (a) or 17 days (b) in LT medium 
costained for Tau to visualise neurons and either total NCAM or VASE. At 2DIV, VASE splicing 
into NCAM is not observed in neurons, whilst at 17DIV VASE splicing is observed. NCAM is 
expressed at both 2DIV and 17DIV. PND4 cerebella were isolated, dissociated and 1,000,000 
cells were plated onto poly-l-lysine coated coverslips in DMEM + 10%FCS. The next day, the 
media was changed to LT media and changed every 7 days. Bar = 60pm 
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VASE expression in astrocytes 
Astrocytes in the mixed cerebellar cultures were visualised by an intracellular stain for 
the astrocyte-specific intermediate filament GFAP. At 2DIV, astrocytes were observed 
to have two or three long, thin GFAP-positive processes extending out from the cell 
body (Figure 4.3.3a). Whereas NCAM was highly expressed at 2DIV by neurons in 
this culture system (seen here as brightly stained small cell bodies), it was found to be 
present at comparatively lower levels in astrocytes at this time (Figure 4.3.3a, top 
panel). Total NCAM staining was localised around the nucleus of the astrocyte and 
into some, but not all astrocytic processes (Figure 4.3.3a, top panel). VASE staining in 
astrocytes at 2DIV was negligible (Figure 4.3.3a, lower panel). At 17DIV, astrocytes 
had lost their long, thin processes and had adopted a fibroblast-like morphology, 
proliferating and expanding to form a tight monolayer over the whole coverslip (Figure 
4.3.3b). Cells with a neuron-like morphology were observed to be growing over the top 
of the astrocytic monolayer. The 17DIV astrocytes stained for total NCAM over their 
whole surface, giving a much stronger staining than at 2DIV (Figure 4.3.3b, top panel). 
However, total NCAM-positive neuronal processes were observed to stain stronger 
than the astrocytes, suggesting that whilst astrocytes express NCAM, they do not 
express as much as neurons. NCAM-VASE astrocytic staining at 17DIV was present, 
but less intense than the total NCAM staining (Figure 4.3.3b, bottom panel). VASE 
stained a small amount around the nucleus of astrocytes, and compared to the 
staining intensity of the overlying neurons was comparatively weak. VASE was also 
observed to stain other cells interspersed in the astrocytic monolayer with a 
fibroblastic morphology. Astrocytes therefore appear to have a general upregulation of 
total NCAM during time in culture, and a slight upregulation of VASE expression. Also 
over time in culture, the astrocytes altered their morphology from a multi-process cell, 
to a fibroblast-like cell. The amount of NCAM expressed by astrocytes is 
comparatively less than in neurons. This is supported by a previous study finding that 
NCAM is expressed 20 times less in astrocytes compared to neurons (Nybroe et al., 
1985). 
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Figure 4.3.3- PND4 mixed cerebellar cells cultured for 2 days (a) or 17 days (b) in LT medium 
costained for GFAP to visualise astrocytes and either total NCAM or VASE. At 2DIV, astrocytes 
have long, thin processes, but by 17DIV display a fibroblast-like morphology and have 
proliferated and formed a tight monolayer over the whole surface of the coverslip. VASE 
appears to be absent from astrocytes at 2DIV. At 17DIV, there is a small amount of VASE 
staining around astrocytic nuclei. Total NCAM gives a small amount of staining on astrocytes 
at 2DIV, but by 17DIV gives a surface stain all over the astrocytes. However total NCAM 
staining in astrocytes is not as intense as the neurons growing on top suggesting astrocytes 
express less NCAM than neurons. PND4 cerebella were isolated, dissociated and 1,000,000 
cells were plated onto poly-l-lysine coated coverslips in DMEM + 10%FCS. The next day, the 
media was changed to LT media and changed every 7 days. Bar = 60pm 
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VASE expression in oligodendrocytes 
Oligodendrocytes were visualised by the surface antigen 04, which is an 
oligodendrocyte marker expressed throughout differentiation (Berry et al., 2002; 
Levine et al., 2001), but not by oligodendrocyte primordial stem cell progenitors or 
terminally differentiated myelinating oligodendrocytes (Figure 4.4.2) (Levine et al., 
2001). In this mixed cerebellar culture system the neurons are almost exclusively 
cerebellar granule neurons (Walsh et al., 1992). These neurons are unmyelinated in 
vivo, and so oligodendrocyte differentiation into a myelinating phenotype was not 
expected to occur and was not investigated. After 17DIV, 04-positive 
oligodendrocytes arranged their processes so that they contacted and grew along 
VASE-positive axons for a distance before terminating (Figure 4.3.4). Whilst the axons 
were clearly VASE-positive, oligodendrocyte processes did not appear to contribute 
any extra VASE immunoreactivity to the points of contact (Figure 4.3.4, top panel). 
Parts of oligodendrocytes not contacting axons were hard to distinguish, and no clear 
VASE staining could be definitively identified as solely oligodendroglial (Figure 4.3.4, 
bottom panel). As the culture conditions in this experiment were suboptimal for 
oligodendrocyte differentiation (i.e lacked appropriate neurons to myelinate), it is hard 
to draw conclusions as to the presence or absence of VASE in oligodendrocytes 
during in vitro development in this culture system. 
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VASE Merge + DAPI 
Figure 4.3.4.17DIV mixed PND4 cerebellar cultures in LT medium costained for an 
oligodendrocyte marker 04 and VASE. After 17 DIV, some oligodendrocytes have arranged 
their processes along the axons of neurons which are VASE-positive, although the 
oligodendrocyte processes do not appear to contribute to the VASE staining. Oligodendrocyte 
processes not in contact with axons do not appear to stain for VASE. PND4 cerebella were 
isolated, dissociated and 1,000,000 cells were plated onto poly-l-lysine coated coverslips in 
DMEM + 10%FCS. The next day, the media was changed to LT media and changed every 7 
days. Bar = 60pm 
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VASE expression in E18 cortical cultures supplemented with oligodendrocytes 
To observe whether VASE could be expressed at a later developmental timepoint in 
oligodendrocytes, conditions more favourable for myelination were provided. E18 
mixed cortical cultures were set up in an identical manner to the PND4 mixed 
cerebellar cultures, but with 80,000 additional purified PND4 OPCs added per well to 
supplement the lack of oligodendrocytes from cultures of this age, as performed by 
Sauvageot and Stiles (Sauvageot and Stiles, 2002). Cortical neurons are a mixed 
population of many different types of neurons, many of which will be naturally 
myelinated during development in vivo and so provide a better potential target for 
myelination than cerebellar granule neurons. The mixed cortical cultures survived 
better than the mixed cerebellar cultures and were routinely cultured for 21-28DIV 
whilst still remaining "healthy". 
Neurons in this culture system were identified by staining with a 200kD 
neurofilament heavy isoform antibody (RT97, Chemicon). Neurofilament is a neuron-
specific intermediate filament which in vivo is located mainly in the axon and cell body 
of the neuron (Matus et al., 1979). After 28D1V, neurofilament-positive neurons clearly 
stained for NCAM-VASE, giving staining both in neuronal cell bodies and in punctate 
patches along their processes (Figure 4.3.5a). E18 cortical astrocytes cultured for 
28DIV formed a monolayer like the 17DIV PND4 cerebellar astrocytes, however some 
cortical astrocytes retained a more multi-process morphology than the cerebellar 
astrocytes (Figure 4.3.5b + figure 4.3.3b). Whereas there was a small amount of 
VASE staining on the 17DIV cerebellar astrocytes, 28DIV cortical E18 astrocytes 
showed no VASE reactivity (Figure 4.3.5b + figure 4.3.3b). Even though this culture 
was supplemented with additional oligodendrocytes, no axon ensheathing, a 
prerequisite to myelination, was observed. 
The oligodendrocytes maintained an immature oligodendroglial morphology 
(Figure 4.3.5c+d and figure 4.1.2) (Hardy and Reynolds, 1991) but did express myelin 
oligodendrocyte glycoprotein (MOG), a myelin marker which has been reported only to 
be expressed by mature myelinating oligodendrocytes (Johns and Bernard, 1999; 
Levine et al., 2001) (Figure 3.4.5d). The MOG-positive oligodendrocytes stained for 
NCAM-VASE to varying degrees, however it was not possible to identify VASE 
staining on any 04-positive oligodendrocytes, suggesting that VASE splicing 
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correlates with the expression of myelin proteins and a downregulation of 04. Unlike 
the mixed cerebellar cultures, in which 04-positive oligodendrocyte processes grew 
along VASE-positive neurites, 04-positive oligodendrocytes in the cortical cultures put 
out only short processes which did not appear to contact and grow along neurites 
(Figure 4.3.5c). Both the cerebellar and cortical oligodendrocytes did not fully 
differentiate in culture, which would have been typified by extensive process formation 
and myelin ensheathing of axons (Sauvageot and Stiles, 2002). The failure of the 
oligodendrocytes to differentiate could be due to the chronic depolarisation of the 
neurons by the K"" present in the LT media. Depolarised neurons will not generate 
action potentials and so do not transmit electrical activity which has been shown to be 
required for myelination (Demerens et al., 1996). 
In this LT culture system, neurons showed the most marked upregulation of 
NCAM-VASE expression over time. Cerebellar astrocytes showed a general 
upregulation of NCAM without VASE, and a slight increase in VASE expression with 
time in culture. 04-positive oligodendrocytes did not express VASE, however those 
expressing the myelin marker MOG were VASE-positive to varying degrees. As the LT 
medium was designed for neuronal survival and differentiation, perhaps only the 
neurons are maturing optimally in this medium. This could account for only the 
neurons showing a convincing isoform switch to NCAM with VASE. A possible 
hypothesis for VASE upregulation could be that NCAM-VASE is upregulated by cells 
as they mature and differentiate. Alternatively, the data could indicate that only 
neurons (and perhaps oligodendrocytes) show a clear developmental upregulation of 
VASE. 
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(a) 
Neurofilament VASE Merge + DAPI 
GFAP VASE Merge + DAPI 
Merge + DAPI 
MOG Merge + DAPI 
Figure 4.3.5. E18 mixed cortical cells supplemented with purified PND4 cortical 
oligodendrocytes and cultured for 21 to 28 DIV in LT medium, (a) Neurons, visualised by 
neurofilament express VASE after long term culture similarly to the cerebellar system, (b) 
Unlike the cerebellar system, astrocytes do not completely adopt a fibroblast-like morphology 
and do not give any VASE staining. Oligodendrocytes were visualised by 04 and a myelination 
marker MOG. 04-positive oligodendrocytes were not observed to express VASE, however 
those expressing MOG stained for VASE to varying degrees. E18 cortices were isolated, 
dissociated and 1,000,000 cells were plated onto poly-l-lysine coated coverslips in DMEM + 
10%FCS. In addition, 80,000 purified PND4 cortical oligodendrocytes were added to enrich the 
cultures. The next day, the media was changed to LT media and changed every 7 days. Bar = 
60|jm 
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4.4 NCAM-VASE expression in oligodendrocyte cultures with defined 
oligodendrocyte-specific medium 
As LT medium was not optimal for oligodendrocyte differentiation, culturing them 
alone in an oligodendrocyte-defined medium was next attempted. This was performed 
in order to investigate further if cellular differentiation causes VASE upregulation in 
oligodendrocytes. OLP medium (Hardy and Reynolds, 1993) is optimised for growth 
and differentiation of OPCs without any external factors provided by other cells. 
Naturally, without the presence of neurons, the OPCs will have no substrate to 
myelinate but instead fully "differentiated" oligodendrocytes in culture produce 
flattened membrane protrusions containing myelin proteins (Figure 4.1.2) (Hardy and 
Reynolds, 1991). 
Oligodendrocyte precursor cells (OPCs) were isolated from PND4 rat cortices 
by immunopanning with 04 - an oligodendrocyte-specific antibody. OPCs were plated 
at 80,000 cells per well onto poly-l-lysine coated coverslips and cultured in OLP 
medium. Cells were fixed after 2 or 10DIV and costained for total NCAM or NCAM-
VASE and the myelin marker MOG which is found on mature myelinating 
oligodendrocytes (Levine et al., 2001). The physiological function of MOG is currently 
unclear, although an immune response to MOG is thought to be involved in the 
demyelinating pathogenesis of Multiple Sclerosis (Berger et al., 2003). At 2DI\/, the 
oligodendrocytes showed an immature phenotype (Figure 4.1.2) and did not express 
MOG (Figure 4.4.1a). At 10DIV, the oligodendrocytes showed a mature phenotype 
(Figure 4.1.2), with patches of MOG expression particularly on processes and 
flattened membrane (Figure 4.4.1b). The Total NCAM antibody gave very intense 
staining on the 2DIV oligodendrocytes, with the strongest staining localised to the cell 
body, and intermediate staining in the processes (Figure 4.4.1a). Total NCAM 
expression remained at a high level at 10DIV as well, being mainly localised to the cell 
body and primary processes. Speckled NCAM staining could be observed at a lower 
intensity in the flat myelin membrane regions (Figure 4.4.1b). Compared to total 
NCAM staining, NCAM-VASE staining of the2DIV immature oligodendrocytes was 
minimal. Faint staining could only be observed in the oligodendrocyte cell bodies and 
a tiny amount in the processes. At 10DIV, VASE staining was at least as intense as 
total NCAM staining in the mature myelinating oligodendrocytes and similarly was 
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located mainly to the cell body and primary processes with speckled staining in the flat 
membrane myelin. 
In this culture system, it is only the differentiated MOG-positive 
oligodendrocytes that expressed NCAM-VASE. Although LT mixed cultures did not 
facilitate the development of a fully differentiated oligodendrocyte phenotype, again it 
was only the MOG-positive (more differentiated) and not the 04-positive (immature) 
oligodendrocytes which expressed VASE. These findings are consistent with the 
isoform switch to NCAM containing the VASE exon being controlled by cellular 
differentiation. 
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(a) 2DIV 
MOG Total NCAM Merge + DAP! 
MOG VASE Merge + DAPI 
(b) 10 DIV 
MOG Total NCAM Merge + DAPI 
MOG VASE Merge + DAPI 
Figure 4.4.1 - PND4 purified cortical oligodendrocytes cultured for 2 days (a) or 10 days (b) in 
OLP medium costained for MOG and either total NCAM or VASE. At 2DIV the oligodendrocytes 
show an immature morphology and do not express the myelin marker MOG. At 10DIV, the 
oligodendrocytes show a differentiated myelinating morphology and are MOG-positve. 
Oligodendrocytes at 2 DIV strongly express NCAM but only a small amount of VASE. At 10 
DIV, oligodendrocytes upregulate VASE which stains with a similar intensity to total NCAM 
staining. PND4 cortical oligodendrocytes were isolated by immunopanning with the 
oligodendrocyte-specific 04 antibody and 80,000 were plated per well onto poly-l-lysine 
coated coverslips in OLP medium. Bar = 60pm 
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4.5 NCAM-VASE expression in reactive astrocytes 
Astrocytes triggered with dBcAMP to become reactive express elevated levels of 
NCAM-VASE mRNA (Gegelashvili et al., 1993). In LT cultures stained in section 4.30, 
astrocytes were observed to express moderate amounts of NCAM without VASE, but 
only minimally expressed NCAM containing VASE (Figure 4.3.3 and figure 4.3.5b). 
After some time in the LT cultures, the astrocytes typically formed a monolayer of 
fibroblast-shaped cells, providing a substrate for the growing neurons (Figure 4.3.3). 
This is a morphology indicative of unreactive astrocytes (Figure 4.1.1, left). Astrocytes 
in the LT cultures expressed little, if any NCAM-VASE (Figure 4.3.3 and Figure 
4.3.5b). Perhaps LT culture medium does not provide conditions favourable to induce 
astrocyte reactivity, leading to a lack of astrocytic VASE expression. 
This was tested using dBcAMP and FGF-2 to observe the effect of astrocyte 
reactivity on NCAM-VASE expression. Astrocytes (>90% GFAP-positive cells) were 
isolated from the cortices of PND4 rat pups as described in the Materials and Methods 
section and treated with 1 mM dBcAMP or 50ng/ml FGF-2 in DMEM + 10% FBS for 
two days. The astrocytes were then fixed and costained for total NCAM or NCAM-
VASE, and GFAP. Untreated astrocytes all appeared flat and fibroblast-like (Figure 
4.5.1a), although in vivo, astrocytes adopt a multiprocess morphology (gaining more 
processes when they become reactive). Treatment with FGF-2 or dBcAMP induced a 
reactive phenotype in the cultured astrocytes (Figure 4.5.1 b+c). dBcAMP produced 
the most dramatic change in astrocyte morphology with a large proportion of 
astrocytes adopting a 'star'-shaped reactive morphology (Figure 4.5.1c) indicative of 
reactive astrocytes (Figure 4.1.1, right). FGF-2 had an intermediate effect, with some 
cells having the 'star'-shaped morphology and some the fibroblast morphology. 
Similarly to the astrocytes from the mixed cerebellar and cortical cultures in LT 
medium (Figure 4.3.3 and Figure 4.3.5b), untreated astrocytes had no NCAM-VASE 
immunoreactivity (Figure 4.5.3, top panel), and had little, if any, immunoreactivity for 
NCAM in general (Figure 4.5.2, top panel). The astrocytes treated with both FGF-2 
and dBcAMP showed a large upregulation of total NCAM and NCAM-VASE staining in 
a similar pattern to each other (Figure 4.5.2 and figure 4.5.3). The NCAM and NCAM-
VASE staining was found to be localised to the perinuclear region of the astrocytes 
and also discrete patches on their processes. 
128 
Upregulation of the expression of NCAM-VASE in astrocytes appears to 
correlate with cellular differentiation into a reactive morphology, similarly to how VASE 
expression appears to be linked to oligodendrocyte differentiation into a myelinating 
phenotype and neuronal differentiation. However perhaps with astrocytes, it is not an 
isoform switch from NCAM without VASE to NCAM with VASE, as seems to be true 
for neurons and oligodendrocytes, as unreactive astrocytes appear to have only low 
levels of NCAM to begin with. 
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Untreated 
(c) 
50ng/ml FGF-2 1mM dBcAMP 
Figure 4.5.1 - PND4 cortical astrocytes untreated or treated for two days with FGF-2 or dBcAMP 
to induce a reactive phenotype. Dissociated PND4 rat cortical cells were plated in tissue culture 
flasks until confluent and then vigorously shaken for 18 hours to detach all cells except 
astrocytes. The remaining astrocytes were then plated at 50,000 cells per well for 2 days and 
then treated with 50ng/ml FGF-2 or 1mM dBcAMP for two days. Bar = 200pm. 
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GFAP Total NCAM Merge + PARI 
Untreated 
50ng/ml FGF 
1mM dBcAMP 
Figure 4.5.2 - Purified cortical astrocytes stained for NCAM and GFAP maintained in DMEM/10% 
FCS in the presence or absence of either 1mM dBcAMP or 50ng/ml FGF for two days. Dissociated 
PND4 rat cortical cells were plated in tissue culture flasks until confluent and then vigorously 
shaken for 18 hours to detach all cells except astrocytes. The remaining astrocytes were then 
plated at 50,000 cells per well for 2 days and then treated with with 50ng/ml FGF-2 or 1mM dBcAMP 
for two days before being fixed and stained. Bar = 60pm. 
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GFAP VASE Merge + DAPI 
Untreated 
50ng/ml FGF 
m. 
4 
1mM dBcAMP 
Figure 4.5.3 - Purified cortical astrocytes stained for IMCAM-VASE and GFAP maintained in 
DMEM/10% FCS in the presence or absence of either 1 mM dBcAMP or SOng/ml FGF for two days. 
See figure 4.5.2 for details. Bar = 60pm. 
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4.6 Discussion 
PND4 cerebellar neurons cultured in LT medium - a medium specifically designed for 
neuronal differentiation and long term culture, strongly expressed NCAM without 
VASE at 2DIV, but had minimal (if any) expression of the VASE isoform of NCAM 
(Figure 4.3.2a). At 17DIV, there was a dramatic upregulation of NCAM-VASE in 
neurons compared to 2DIV, indicating a developmental isoform switch from NCAM 
without VASE to NCAM with VASE (Figure 4.3.2b). This is similar to the findings of 
Small ef a/who investigated NCAM-VASE protein expression in cultured E14.5 
embryonic rat brain neurons and found that they upregulate NCAM-VASE over a 
period of 8 days in culture (Small et al., 1988). LT medium is optimised for neuronal 
differentiation, which could account for the failure of oligodendrocytes to fully 
differentiate in this medium (Figure 4.3.4 and figure 4.3.5c+d). Despite this, in the E18 
cortical culture, oligodendrocytes expressing the myelin marker MOG stained for 
NCAM-VASE, whilst those expressing 04, a marker expressed by less differentiated 
oligodendrocytes did not (Figure 4.3.5c+d). PND4 purified cortical oligodendrocytes 
cultured in OLP medium - designed to facilitate oligodendrocyte differentiation in the 
absence of neurons, expressed the myelin marker MOG after 10DIV but not at 2DIV, 
indicating that at 2DIV the oligodendrocytes are immature, and by 10DIV they have 
differentiated into a myelinating phenotype (Figure 4.4.1). Whilst expressing high 
levels of NCAM without VASE at 2DIV, the oligodendrocytes expressed little NCAM-
VASE. At 10D1V, NCAM-VASE expression had been greatly upregulated by the 
oligodendrocytes - mirroring their MOG expression profile. Astrocytes in the LT 
medium expressed little, if any NCAM-VASE, but showed an upregulation of NCAM 
without VASE expression with time in culture (Figure 4.3.3 and figure 4.3.5b). The 
astrocytes showed a broadly unreactive fibroblast-like morphology and continued to 
divide, forming a tight monolayer over the surface of the coverslip. Purified PND4 
cortical astrocytes expressed little NCAM with or without VASE when in an unreactive 
state (Figure 4.5.3 and figure 4.5.4). Inducing astrocyte differentiation to a reactive 
state with FGF-2 or dBcAMP caused an upregulation in total NCAM and NCAM-VASE 
expression, localised around the nucleus and in discrete patches along the astrocytic 
processes. 
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Previous studies on NCAM-VASE expression in cultured cells has mainly 
concentrated on neurons, finding that NCAM-VASE expression in early postnatal or 
embryonic neurons is low early in culture and increases over time (Small et al., 1988; 
Walsh et al., 1992). These studies were carried out soon after the VASE exon was 
identified and only address an initial characterisation of the developmental expression 
of VASE. The Walsh study focuses on the developmental increase in VASE 
transcripts, correlating this with the in vitro developmental loss of cerebellar granule 
neurons to respond to NCAM-stimulated neurite outgrowth and not, per se, studying 
the trigger for VASE expression (Walsh et al., 1992). Gegelashvili and coworkers 
discovered that cultured cortical astrocytes from newborn mice had a large 
upregulation of NCAM-VASE transcripts when induced to differentiate into a reactive 
phenotype with dBcAMP, providing a hint that at least in astrocytes VASE expression 
is linked to cellular differentiation triggered by an elevation in cAMP (Gegelashvili et 
al., 1993). The data described in this chapter appears to support the idea that NCAM-
VASE expression in neurons, oligodendrocytes and astrocytes is linked to cellular 
differentiation. Afunctional consequence of this is clear in neurons, with VASE 
expression correlating with the developmental loss of their ability to respond to NCAM-
stimulated neurite outgrowth (Walsh et al., 1992). A situation could be envisioned in 
which newly generated neurons must put out neurites to reach their target, but upon 
reaching their target need to stop growing, form synapses and fully differentiate. The 
initial outgrowth stage could involve the outgrowth promoting properties of NCAM, 
however when outgrowth is no longer required, a mechanism may be needed to 
"switch off' NCAM stimulation. This could be done simply by downregulating NCAM 
expression, but perhaps as NCAM has many other adhesive functions unrelated to 
neurite outgrowth stimulation, this might interfere with other necessary NCAM-
dependent processes (Doherty et al., 1992; Saffell et al., 1994). VASE could perhaps 
provide a mechanism by which NCAM-stimulated outgrowth is arrested but hemophilic 
and heterophilic interactions are maintained. 
NCAM-VASE upregulation by reactive astrocytes could also be significant due 
to reactive astrocytes being implicated as an inhibitory factor during nerve regrowth 
after CNS injury (Menet et al., 2003). NCAM-VASE on the astrocytes could interfere 
with NCAM-stimulated neurite outgrowth by the regenerating neurons at the lesion 
site, hindering the repair process. However, in contrast to this suggestion, it has been 
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found that newborn rat astrocytes cultured with dBcAMP for 3 days are actually at 
least as good a substrate for neurite outgrowth of cerebellar granule neurons as 
untreated astrocytes (Miller et al., 1994). This could be accounted for by the fact that 
reactive astrocytes secrete neurite outgrowth-promoting factors such as FGF-2 
(Bayatti and Engele, 2002) which might induce outgrowth independent of the effects of 
VASE. 
There are no significant reports on NCAM-VASE expression by 
oligodendrocytes (Itoh et al., 2000), however the data presented in this chapter shows 
an increase in VASE expression linked to oligodendrocyte differentiation into a 
myelinating phenotype (Figure 4.4.1). It has recently been reported that the PSA 
modification of NCAM is downregulated by oligodendrocytes as they differentiate into 
a mature myelinating phenotype (Fewou et al., 2007), Engineering mice to continue to 
express PSA-NCAM caused a significant decrease of mature oligodendrocytes in the 
brain and interfered with myelin maintenance (Fewou et al., 2007). This further 
highlights the observed apparent inverse expression profiles of PSA and VASE, and 
suggests that if PSA is inhibitory to myelination, perhaps VASE facilitates or is 
permissive to myelination. Figure 4.3.4 shows 04-positive, VASE-negative 
oligodendrocytes growing along VASE-positive neurites in the LT cerebellar cultures 
without any apparent hindrance to their growth. In contrast, MOG-positive 
oligodendrocytes did not appear to favour growing on VASE-positive neurites (Figure 
4.3.5d). Perhaps lacking VASE allows oligodendrocytes to put out processes and 
grow along neurites, and then splicing in VASE during differentiation hinders process 
formation and promotes myelination. This is not completely supported by the data, as 
the 04-positive, VASE-negative oligodendrocytes in the cortical cultures did not 
appear to grow along VASE-positive neurites in contrast to the cerebellar 
oligodendrocytes (Figure 4.3.5c). 
The data presented in this chapter identifies for the first time an upregulation in 
VASE protein expression in differentiating oligodendrocytes, and astrocytes 
differentiating into a reactive phenotype, and suggests that whatever the function of 
VASE may be, it is linked to mature differentiated cells. 
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Chapter 5 
The in vivo expression of NCAM-VASE in cells 
of the adult rat nervous system and muscle 
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5. The in vivo expression of NCAM-VASE in cells of the adult rat 
nervous system and muscle 
5.1 Introduction and aims 
As discussed in the Introduction, the localisation of NCAM-VASE protein in the 
nervous system has not been determined. VASE transcripts have been found to be 
particularly enriched in the CNS and heart, but virtually excluded from areas of 
synaptic plasticity such as the olfactory bulb, and areas with regenerative capacity, 
such as the PNS (Small and Akeson, 1990). VASE has also be shown to be almost 
absent in skeletal muscle (Andersson et al., 1993). The only cellular localisation 
study of VASE protein expression, which has been discussed in previous chapters 
and the Introduction, showed VASE expression in human brain hippocampal 
sections in the dentate gyrus granule layer, CA4 pyramidal neurons, and astrocytes 
of the CA4 region and of the temporal horn of the lateral ventricle (Vawter et al., 
1998). NCAM however has been well characterised throughout the nervous system 
and muscle. Generally NCAM is highly expressed during development, before 
becoming more restricted with maturity. NCAM has been found to be expressed by 
neurons, astrocytes, oligodendrocytes, Schwann cells, ependymal cells, cardiac 
myocytes and skeletal muscle myotubes (see Introduction for full commentary on 
NCAM expression). 
The results in Chapters 3 and 4 have established that an affinity purified 
a VASE antibody has been developed that is specific only for the VASE isoform of 
NCAM, and that it can recognise VASE in cultured cells. This antibody will now be 
used to map NCAM-VASE localisation in the adult rat brain. Building upon the data 
in the previous chapter which has shown that VASE can be expressed by neurons, 
oligodendrocytes and astrocytes in correlation with their differentiation, localising 
VASE expression in tissue will hopefully be able to further shed light on the 
physiological function of VASE. As with the cultured cells, an antibody reactive to all 
NCAM isoforms will be used as a comparison to the VASE staining, and various cell-
specific antibodies will be used to identify different cell types. Also as before, the 
VASE-specific staining must be a subset of the total NCAM staining and cannot 
occur anywhere which does not stain for NCAM. 
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The nervous system areas that will be focussed upon in this study have been 
selected based upon areas already characterised for NCAM expression and areas 
which are known to have high or low levels of VASE expression. The adult rat cortex 
will be investigated in a coronal section which includes the cortical hemispheres, the 
hippocampus, thalamus and hypothalamus (Figure 5.2.1a). The adult rat cerebellum 
shall be investigated in parasagittal section through the vermis (Figure 5.21b). The 
adult rat spinal cord shall be visualised in transverse, and the adult rat sciatic nerve 
transverse and longitudinally. In addition to these nervous system regions, smaller-
sub regions will be explored such as the olfactory bulb and the subventricular zone 
(SVZ) of the lateral ventricle (Figure 5.2.1c), and the dorsal root ganglion. To 
investigate VASE expression in cardiac and skeletal muscle, sections from the adult 
rat heart and gastrocnemius muscle will be examined. 
Olfactory Cortex Cerebellum 
Bulb 
Figure 5.1.1 - Adult rat brain from above showing the 
location of various sections used in this study, (a) 
Coronal section of cortex, (b) parasaggital section of 
cerebellum, (c) parasaggital section of cortex. Modified 
image from 
http://www.med.upenn.edu/kaneslab/imaaes/puchebrain.ipa 
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Results 
5.2 General overview of VASE expression compared to total NCAM 
expression in the cortex, cerebellum, and spinal cord 
Cortex 
The major area of NCAM-VASE expression by the brain and cerebellum appears to 
be major myelinated axon tracts (Figures 5.2.1, 5.2.2, 5.2.4). At this low-power 
magnification, VASE staining appears virtually indistinguishable from total NCAM 
staining in brain and cerebellum. In the cortex, staining is most prominent in the 
external capsule - a continuous fibre tract which arches over the hippocampal 
formation, and the fimbria fibre tract which is one of the major outputs of the 
hippocampus (Figure 5.2.2). In the thalamus and hypothalamus, NCAM-VASE is 
also localised to myelinated fibre tracts comprising the medial lemniscus, fasciculus 
retroflexus, internal and external medullary lamina thalamus, cerebral peduncle, 
optic tract, stria medullaris and the principle mammillary tract (Figure 5.2.2). The 
grey matter of the cerebral hemispheres appears to be largely NCAM-negative at 
this magnification. 
The hippocampus contains staining that is subtly different for total NCAM and 
NCAM-VASE (Figure 5.2.3a+b). Whereas NCAM-VASE stains the CA1 region, 
dentate gyrus and stratum lacunosum-moleculare similarly to total NCAM (although 
staining sometimes appears brighter for VASE than total NCAM, this is due to 
contrast adjustment), it is absent from the dentate gyrus hilus and markedly reduced 
in the mossy fibre tract (stratum lucidum) stretching from the hilus to the CAS region, 
when compared to total NCAM expression (Figure 5.2.3a+b see arrows). As 
mentioned in the Introduction, this pathway contains axons extending from the 
dentate gyrus to the CAS region. It has previously been published that this mossy 
fibre pathway highly expresses PSA-NCAM (Abrous et al., 2002; Seki and Arai, 
1993), and it would appear that a PSA-NCAM antibody stains this region in the area 
which does not stain for NCAM-VASE (Figure 5.2.Sb+c). PSA-NCAM stained 
strongly in a single cell thick layer just under the dentate gyrus granular layer 
consistent with previous reports of high PSA expression by newly generated 
neurons in the subgranular layer (Figure 5.2.Sc, arrows) (Bonfanti, 2006). It would 
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appear therefore that the hypothesis that PSA and VASE expression are reciprocal 
in expression pattern (Small and Akeson, 1990) holds true for the hippocampus. At 
higher power, CA1 pyramidal neurons were found to stain for total NCAM, but were 
slightly less immunoreactive for VASE (Figure 5.2.4). 
Cerebellum 
In the cerebellum, the strongest total NCAM and NCAM-VASE staining was found to 
be in the white matter layer which, like the external capsule of the cortex, contains 
myelinated axons (Figure 5.2.5). Stained processes were also observed to be 
branching out of the white matter into the granule layer. The cerebellar molecular 
layer also showed immunoreactivity to total NCAM and NCAM-VASE. Total NCAM 
staining appears to be present at equal (low) levels in the cerebellar granule layer 
and molecular layer, but NCAM-VASE staining is absent from the granule layer. 
Spinal Cord 
In contrast to the cortex and cerebellum, total NCAM and NCAM-VASE in spinal 
cord was not predominantly localised to the myelin; in fact, at low-power 
magnification the white matter appeared to be virtually devoid of staining (Figure 
5.2.6). Also, the staining pattern for total NCAM was more widespread than that of 
NCAM-VASE. The pattern of staining for both remained consistent throughout the 
length of the spinal cord (not shown). At this magnification, total NCAM is strikingly 
expressed on radial processes in the white matter which extend inwards from the 
spinal cord surface. The spinal cord grey matter had a higher amount of total NCAM 
staining than the white matter. NCAM-VASE was expressed at a much lower level 
than in either the cortex or cerebellum, and so some spinal cord images had to be 
obtained through a longer exposure time (Figure 5.2.6b). NCAM-VASE expression 
was observed throughout the grey matter but highest expression was found in the 
substantia gelatinosa region (lamina II), whilst being absent, or at very low levels in 
the white matter. Like total NCAM, VASE appears to be expressed by radial 
processes in the white matter, although fainter than total NCAM. 
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(a) Total NCAM 
(b) NCAM-VASE 
Figure 5.2.1 - Coronal sections of adult rat brain cortex stained for total NCAM (a) and NCAM-
VASE (b). Bar= 600^jm 
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(a) 
Figure 5.2.2 - (a) VASE staining of adult rat cortex from figure 5.3.1b (b) Adult rat cortex 
highlighting major myelinated fibre tracts (grey). Rat cortex map modified from "Brain IVIaps: 
Structure of the Rat Brain" (2"^ ed.) L.W. Swanson. alv = alveus, cc = corpus calosum, cing = 
cingulum bundle, cpd = cerebral peduncle, dhc = dorsal hippocampal commissure, ec = external 
capsule, em = external medullary lamina thalamus, fi = fimbria, fr = fasciculus retroflexus, fx = 
columns of the fornix, im = internal medullary lamina thalamus, ml = medial lemniscus, opt = optic 
tract, pm = principle mammillary tract, sm = stria medullaris, VS = third ventricle, VL = lateral ventricle. 
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(a) Total NCAM 
(b) NCAM-VASE 
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(c) PSA-NCAM 
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Cortical hemisphere 
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Capsule 
\ 
Dentate gyms Hilus (CA4) 
Fimbria 
Figure 5.2.3 - Enlarged and contrast adjusted images from figure 5.3.1 showing (a) total 
NCAM, (b) NCAM-VASE, and (c) PSA-NCAM staining in the hippocampus. Total NCAM and 
NCAM-VASE staining is very similar apart from the notable absence of VASE staining from the 
mossy fibre tract (arrow) connecting the hilus (arrowead) to the stratum lucidum region (thick an-ow). 
The lack of VASE staining in the hilus region is contrasted with PSA-NCAM expression in the 
hippocampus (c) which is strongest in the hilus, especially in the subgranular layer of the dentate 
gyrus (arrows). Bar = 600pm (d) Simplified map of the major features of the hippocampus, modified 
from "Brain Maps: Structure of the Rat Brain" (2"^ ed.) LW. Swanson. 
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Neurofilament Total NCAM Merge + DAPI 
am 
Neurofilament VASE Merae + DAPI 
Figure 5.2.4 - High power magnification of the CA1 layer of the hippocampus showing CA1 
pyramidal neurons stained for neurofilament and either total NCAM or VASE. CA1 pyramidal neuron 
axons stain positive for neurofilament whilst total NCAM stains their cell bodies. VASE gives much 
fainter cell body staining. Bar= 60jjm. 
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(a) Total NCAM 
14, Vfr 
(b) NCAM-VASE 
Figure 5.2.5 - Parasagittal sections of adult rat cerebellum stained for total NCAM (a) and 
NCAM-VASE (b). Bar= 600|jm 
146 
(a) Total NCAM 
(b) NCAM-VASE 
Figure 5.2.6 - Transverse sections of adult rat spinal cord stained for total NCAM (a) and 
NCAM-VASE (b). NCAM-VASE staining was fainter in tine spinal cord than the cortex or cerebellum 
and so images were taken with a longer exposure time - 150ms for (a) compared to 400ms for (b). 
Sections shown are mid-way down the spinal column but are representative of the staining pattern 
found throughout the spinal cord. Bar= 600|jm 
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5.3 NCAM-VASE is mainly localised to the white matter tracts of the 
cortex, exactly mirroring the total NCAM distribution in this region, 
but is excluded from cortical astrocytes 
At higher power, total NCAM and NCAM-VASE staining in cortical myelinated axon 
tracts was examined and found to be indistinguishable (Figures 5.3.1 and 5.3.2). In 
cross-section, myelinated axons (detected by neurofilament staining for the axons 
and MOG staining for the myelin) were seen to have a thick ring of total NCAM or 
VASE staining around them (Figure 5.3.1a and figure 5.3.2a). Longitudinally cut 
myelinated axons had total NCAM or VASE staining running along the axon (Figure 
5.3.1b and figure 5.3.2b). Examining cross-sections of myelinated axons more 
closely showed that the rings of NCAM-VASE staining contained neurofilament on 
the inside and MOG staining on the outside (Figure 5.3.3). Both the neurofilament 
and MOG staining partially overlapped with the NCAM-VASE staining, but it is not 
possible to determine whether this is real or just due to slight overexposure. Total 
NCAM staining gave an identical ring. MOG is mainly localised to the 
oligodendrocyte cell body and the outer layers of myelin, whilst is found in much 
lower abundance in the inner compact myelin (Quarles, 2005). This suggests that 
total NCAM and NCAM-VASE in myelinated axon tracts are being expressed 
somewhere between the outer myelin and the axonal membrane. The thickness of 
the ring of NCAM (and NCAM-VASE) staining suggests that some, perhaps all of the 
NCAM staining is in the compact myelin, although the presence of NCAM cannot be 
confirmed or ruled out from the axonal surface. The data from the previous chapter 
showed that VASE is upregulated in correlation with oligodendrocyte differentiation 
to a myelinating phenotype, supporting the finding of VASE expression in myelin. 
NCAM was expressed by GFAP-positive astrocytes throughout the cortex and 
thalamus (Figure 5.3.4). However, astrocytes were not observed to stain for NCAM-
VASE in the cortex or thalamus (Figure 5.3.4). 
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(a) 
MOG Total NCAM Merge + DAP! 
MOG VASE Merge + DAPI 
MOG Total NCAM Merge + DAPI 
MOG Merge + DAPI 
Figure 5.3.1 - Both total NCAM and NCAM-VASE are expressed in myelinated axon tracts in 
the adult rat cortex. Comparison with MOG. (a) Axons in transverse, (b) Longitudinal axons. Bar = 
60|jm 
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(a) 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament VASE Merge + DAPI 
Neurofilament Total NCAM Merge + DAPI 
Neurofi ament VASE Merge + DAPI 
Figure 5.3.2 - Both total NCAM and NCAM-VASE are expressed in myelinated axon tracts in 
the adult rat cortex. Comparison with neurofilament, (a) Axons in transverse, (b) Longitudinal axons. 
Bar = 60|jm 
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Figure 5.3.3 - Enlarged images from figures 4.5.1 and 4.5.2, showing 
adult rat cortical myelinated axons stained for NCAM-VASE. VASE (red) 
vs (a) neurofilament (green) or (b) MOG (green). NCAM-VASE is localised to 
a region in between, but overlapping with neurofilament and MOG. Bar = 
60pm 
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(a) Dentate gyrus 
GFAP 
(b) Thalamus 
GFAP 
Total NCAM 
Total NCAM 
Merge + PARI 
GFAP VASE Merge + DAPI 
Merge + DAPI 
VASE Merge + DAPI 
Figure 5.3.4 - Whilst NCAM is expressed in astrocytes in the adult rat cortex, they do not 
express the VASE exon. (a) Astrocytes in the dentate gyrus region of the hippocampus, (b) 
Astrocytes in the thalamus. Bar = 60pm 
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5.4 In the cerebellum, NCAM-VASE Is mainly localised to 
myelinated axon tracts, white matter, and molecular layer neuropil 
and is absent from astrocytes 
Molecular layer Granule cell layer White Matter 
Figure 5.4.1 - IMCAM-VASE expression in the adult rat cerebellum is strongest on myelinated 
axons but is also found in the molecular layer. Bar = 200pm 
As is the situation in the cortex, the strongest region of total NCAM and NCAM-
VASE staining in the cerebellum is the myelinated axon tracts (Figure 5.3.3 and 
figure 5.4.1). The cerebellar neuropil of the molecular layer also gave a moderate 
amount of VASE staining (Figure 5.4.1). The axon tracts of the cerebellum contain 
the myelinated axons of Purkinje cells leaving the cerebellum, and those of mossy 
fibres and climbing fibres entering the cerebellum. It was not possible to distinguish if 
VASE was preferentially localised to afferent or efferent axons, however some axons 
with VASE staining did appear to reach the Purkinje cell layer, implying that Purkinje 
axons may have VASE staining associated with them (Figure 5.4.1). Again, as in the 
cortex, total NCAM and VASE staining associated with the myelinated axons 
appears to be localised around neurofilament staining, but within MOG staining 
(Figure 5.4.2). The cerebellar molecular layer was observed to express total NCAM 
and NCAM-VASE in the neuropil, which is mainly composed of the axons of granule 
cells called parallel fibres (Figure 5.4.3). Purkinje cell bodies and dendrites in the 
molecular layer expressed total NCAM, however NCAM-VASE staining was absent 
(Figure 5.4.3a+b). Bergmann glial processes which rise up from the Purkinje cell 
layer through the molecular layer to the surface of the cerebellum also expressed 
total NCAM but did not stain for NCAM-VASE. The cerebellar granule cell layer gave 
faint staining for total NCAM and NCAM-VASE (Figure 5.4.2). 
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(a) 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament VASE Merge + DAPI 
MOG Total NCAM Merge + DAPI 
MOG Merge + DAPI 
Figure 5.4.2 - NCAM-VASE expression mirrors total NCAM expression in myelinated axon 
pathways through the granule cell layer of the adult rat cerebellum, (a) Neurofilament (b) MOG. 
Bar = 60|jm 
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(a) 
PSA-NCAM Total NCAM Merge + DAPI 
PSA-NCAM NCAM-VASE Merge + DAPI 
(t)) 
Total NCAM NCAM-VASE 
Figure 5.4.3 - (a) NCAM-VASE is expressed in the neuropil of the adult cerebellum molecular 
layer but is absent from Purkinje cell dendritic trees projecting up into the molecular layer. 
Purkinje cells are reactive for total NCAM. Bar= 60 |jm. (b) Confocal images of cerebellar Purkinje 
cells stained for PSA-NCAM (green) and total NOAM (red, left) and NCAM-VASE (red, right). 
Arrowheads = Purkinje cell bodies. Bar = 20 |jm. 
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GFAP Total NCAM Merge + DAPI 
VP^P'-:T> 
VASE GFAP Merge + DAPI 
Figure 5.4.4 - In the adult rat cerebellum, Bergmann glia express NCAM without the VASE 
exon. Bar = 60pm 
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5.5 NCAM-VASE does not closely match total NCAM expression in 
the spinal cord and PNS 
Unlike the cortex and cerebellum, in which VASE staining closely matched total 
NCAM staining, VASE staining in the spinal cord and peripheral nervous system 
(PNS) appears more restricted than total NCAM (Figure 5.2.5). The spinal cord also 
appeared to stain considerably less intensely for NCAM-VASE overall compared to 
either the cortex or cerebellum, suggesting lower expression of NCAM-VASE. 
Staining in the Spinal Cord White Matter 
Contrasting with other brain regions, astrocytes, oriented radially from the surface of 
the spinal cord white matter were VASE positive (Figure 5.5.1a). These cells also 
stained very strongly for total NCAM, brighter than any other cell type in the spinal 
cord. Another contrast observed was that NCAM-VASE, and total NCAM in general, 
were expressed only at low levels in white matter myelin (Figure 5.5.2). Compared to 
the high NCAM expression of the radial oriented astrocytes of the white matter, 
NCAM myelin staining was very faint, being localised to compact myelin (Figure 
5.5.2, upper panel). Myelin staining for NCAM-VASE was identical to that of total 
NCAM, but could only be observed at high exposure times, indicating very low 
abundance (Figure 5.5.2, lower panel). 
Staining in the Spinal Cord Grey Matter 
At lower magnification, total NCAM appeared to stain uniformly in the spinal cord 
grey matter (Figure 5.2.6a + 5.5.3a), however at higher power, the substantia 
gelatinosa was observed to have elevated expression of total NCAM (Figure 5.5.3b). 
The substantia gelatinosa had notably the highest NCAM-VASE staining of the 
spinal cord. The pattern of staining appeared to be associated around what are 
probably neuronal cell bodies (Figure 5.5.3b). In the ventral horn of the grey matter, 
large neuronal cell bodies, with a location and morphology consistent with motor 
neurons (Joosten, 1994), stained strongly for total NCAM but not NCAM-VASE in 
their cytoplasm (Figure 5.5.4). The neuropil of the lamina X region of the spinal cord 
also expressed NCAM-VASE, with the ependymal cells surrounding the central 
canal giving high VASE expression (See later - Figure 5.6.1c). 
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Dorsal Root Entry Zone (DREZ) 
The dorsal root entry zone (DREZ) is the point at which sensory neurons enter the 
spinal cord, separating the CNS from the PNS (McPhail et al., 2005). It is particularly 
enriched with astrocytes, which after injury to dorsal root axons can become reactive 
and provide an inhibitory barrier to regenerating axons trying to reenter the spinal 
cord (McPhail et al., 2005). Similarly to radially oriented astrocytes, astrocytes of the 
DREZ were found to stain very strongly for total NCAM (Figure 5.5.5). Whilst 
staining less intensely than total NCAM, NCAM-VASE staining was clearly visible in 
the DREZ astrocytes. 
Peripheral Nervous System 
Sensory axons from the periphery enter the spinal cord in the dorsal region, whilst 
motor axons from the spinal cord leave through the ventral region (Fraher, 2000; 
McPhail et al., 2005). Close to the spinal cord, the dorsal nerve possesses the bulb-
like dorsal root ganglion (DRG) containing the cell bodies of sensory neurons 
(Cardenas et al., 2003). After the DRG, the dorsal and ventral nerves merge into one 
bundle which extends out into the periphery before dividing out into mixed nerve 
bundles to innervate various targets (Cardenas et al., 2003). In the dorsal nerve, 
total NCAM staining was strong, but not as strong as in the spinal cord. Total NCAM 
was found to colocalise with neurofilament in the axoplasm of the axon but was 
absent in a ring around the axon, consistent with an absence from compact myelin. 
For total NCAM, highest staining in the dorsal nerve was around the nuclei of cells 
found in between the myelinated axons, and in a punctate pattern surrounding the 
compact myelin (Figure 5.5.6a, top panel, arrows). In the ventral nerve, total NCAM 
staining was identical to that in the dorsal nerve, with staining in the axoplasm, 
around the nuclei of the cells in the myelin, and the punctate ring, whilst was absent 
from the compact myelin (Figure 5.5.6b, top panel). In contrast to total NCAM, 
NCAM-VASE staining was absent from the dorsal nerve (Figure 5.5.6a, bottom 
panel). However, staining for NCAM-VASE could be observed in the ventral nerve, 
around the nuclei of the cells residing in the myelin and the punctate ring 
surrounding the compact myelin (Figure 5.5.6b, bottom panel), but not in the 
axoplasm or the compact myelin. In the DRG, total NCAM was strongly expressed in 
a perinuclear arrangement in the large cell bodies of sensory neurons (Figure 5.5.7, 
top panel, arrows), whilst NCAM-VASE was completely absent (Figure 5.5.7, bottom 
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panel). The perinuclear total NCAM distribution could be highlighting intracellular 
NCAM that is in the process of being translated and modified in the ER or Golgi, 
which are distributed around the nucleus. In the sciatic nerve, total NCAM was 
strongly expressed throughout the compact myelin, and weakly expressed in the 
axoplasm (Figure 5.5.8). This is in contrast to previous published reports showing 
NCAM is absent from compact myelin (Dolapchieva et al., 2001; Jessen et al., 1987; 
Mirsky et al., 1986; Roche et al., 1997), and the findings of this study that show an 
absence of NCAM from compact myelin in both the dorsal and ventral root nerves 
(Figure 5.5.6). NCAM-VASE had a much more restricted pattern in the sciatic nerve, 
forming punctate patches just outside the compact myelin in transverse sections 
(Figure 5.5.8a, lower panel), although not all myelinated axons appeared to have the 
VASE-positive patches. In longitudinal sections VASE staining of the sciatic nerve 
formed thin processes running along the outside of the myelin and also was 
associated around the nuclei of cells (Figure 5.5.8b, lower panel, arrows). 
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(a) 
GFAP Total NCAM Merge + DAPI 
GFAP Merge + DAPI 
Figure 5.5.1 - (a) Radially oriented astrocytes in the spinal cord strongly express total NCAM 
and also express NCAM-VASE. Bar = 60pm 
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MOG Total NCAM Merge + DAPI 
MOG VASE (high exposure) 
f S -w 
Merge + DAPI 
V. 
Figure 5.5.2 - Total NCAM expression is low in the adult rat spinal cord myelin, mainly being 
found at the inner myelin/axon interface and within the axoplasm (upper panel). NCAM-VASE 
appears to have a similar expression pattern in the myelin but can only be visualised at high 
exposure times indicating very low expression (lower panel). Bar = 60pm 
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(a) 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament Merge + DAPI 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament Merge + DAPI 
Figure 5.5.3 - (a) The substantia gelatinosa of the spinal cord dorsal horn expresses the most 
NCAM-VASE of the spinal cord grey matter. Bar= 200|jm. (b) The intense staining of the 
substantia gelatinosa appears to be associated with neuron cell bodies. Bar = 60|jm. 
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Figure 5.5.4 - NCAM is expressed in the cell bodies of large motor neurons (arrows) in the 
ventral horn of the adult rat spinal cord but NCAM-VASE is not. Bar = 60pm 
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(a) 
Neurofilament Total NCAM 
Neurofilament 
« s i i p 
(b) 
GFAP Total NCAM 
Merge + DAPI 
Merge + DAPI 
Merge + DAPI 
GFAP Total NCAM (low exposure) Merge + DAPI 
GFAP VASE Merge + DAPI 
Figure 5.5.5 - (a) NCAM is highly expressed by astrocytes at the dorsal root entry zone (DREZ) 
(arrows), whilst VASE is moderately expressed. Bar = 200|jm. (b) Higher power images of 
astrocytes at the DREZ. Due to high expression, total NCAM is also shown at a lower exposure. Bar 
= 60pm. 
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(a) Dorsal 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament VASE Merge + DAPI 
(b) Ventral 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament VASE Merge + DAPI 
Figure 5.5.6 - Total NCAM stains similarly in the dorsal and ventral spinal nerves, however 
VASE staining was only visible in the ventral nerve, (a) Dorsal nerves containing the afferent 
axons of sensory neurons show total NCAM staining within their axoplasm, around the nuclei of cells 
within the myelin (arrows), and in a punctate pattern around the compact myelin. Staining is absent 
from compact myelin. NCAM-VASE staining is absent throughout the dorsal nerve, (b) Ventral nerves 
containing the efferent axons of motor neurons show NCAM-VASE staining consistent with the total 
NCAM staining around the nuclei of cells in the myelin and punctate rings, but not in the axoplasm or 
in compact myelin. Total NCAM staining in the ventral nerve is similar to that of the dorsal nerve. Bar 
= 60|jm 
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Neurofilament Total NCAM Merge + DAPI 
* 
Neurofilament Merge + DAPI 
Figure 5.5.7 - Total NCAM is expressed in a perinuclear distribution in sensory neuron cell 
bodies in the dorsal root ganglion (DRG) (arrows), whilst NCAM-VASE is absent from the DRG. 
The nuclei of the sensory neurons only stained very faintly for DAPI and so are not visible in 
these images. Bar= lOOpm. 
166 
(a) 
Neurofilament Total NCAM Merge + DAPI 
Neurofilament VASE Merge + DAPI 
Neuron ament Tota NCAM Merge + DAPI 
Neurofilament Merge + DAPI 
Figure 5.5.8 - (a) Transverse sections of adult rat sciatic nerve. NCAM-VASE is localised to 
discrete patches which appear to be associated with the outside of the myelin. In contrast, total 
NOAM was localised throughout the whole myelin and sometimes was visible in the axoplasm. (b) 
Longitudinal sections of adult rat sciatic nerve. NCAM-VASE is localised to thin processes which run 
along the outside of the myelin and round the nuclei of cells (arrows), whilst total NCAM is present 
throughout the whole myelin. Bar = GOpm. 
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(a) 
Total NCAM 
# 
Figure 5.5.9 - Enlarged images from figure 5.5.8 showing (a) Total NCAM staining in the sciatic 
nerve and (b) VASE staining in the sciatic nerve. Left panels show in transverse, right panels 
longitudinal, (a) Total NCAM, red; Neurofilament, green, (b) VASE, red; Neurofilament, green. 
Bar = 30pm. 
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5.6 NCAM-VASE is highly expressed by ependymai cells and is 
absent from sites of adult neurogenesis 
Ependymai cells 
A major site of both total NCAM and NCAM-VASE staining was ependymai cells 
which line the brain and spinal cord ventricles. Ependymai cells of the 4*"^  ventricle 
between the cerebellum and brain stem, of the 3''^  ventricle in the cortex, and of the 
spinal cord central canal all stained strongly for NCAM-VASE (Figure 5.6.1). 
Interestingly the only ependymai cells observed not to express NCAM-VASE were 
those lining the lateral ventricle (see later - Figure 5.6.2b). 
Adult Neurogenesis and Synaptic Plasticity 
Three sites of adult neurogenesis and synaptic plasticity were investigated for 
NCAM-VASE expression. In adult mammals, the subgranular layer of the dentate 
gyrus is constantly making new neurons which migrate and insert themselves into 
the dentate gyrus granular layer (Sohur et al., 2006). These new neurons highly 
express PSA-NCAM (Bonfanti, 2006), and so are reactive for a PSA antibody (figure 
5.6.2a, top panel). Strangely, total NCAM staining was observed on some, but not all 
of the PSA-positive cells. This could be due to differing antibody affinities - the PSA 
antibody giving very strong staining at dilute concentrations and the NCAM antibody 
giving comparatively weaker staining. This effect has been noted with various NCAM 
antibodies (Bonfanti et al., 1992; Joosten, 1994). NCAM-VASE however was absent 
from the dentate gyrus subgranular layer (Figure 5.6.2a, bottom panel). Neurons are 
also generated at the subventricular zone (SVZ) of the lateral ventricle, from which 
they migrate along the rostral migratory pathway to the granule cell layer of the 
olfactory bulb (Abrous et al., 2005). Neurofilament-positive neurons in the SVZ 
highly express total NCAM in their cell bodies but have no NCAM-VASE expression 
at all (Figure 5.6.2b). It is very interesting to note that the ependymai cells lining the 
lateral ventricle did not stain for VASE (or even total NCAM) (Figure 5.6.2). These 
were the only ependymai cells investigated which did not stain for VASE (Figure 
5.6.1). NCAM-VASE is also absent from the olfactory bulb, whereas the cell bodies 
of mitral neurons and granule neurons stain for total NCAM (Figure 5.6.2c). 
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a Fourth ventricle 
GFAP VASE Merge + DAP! 
b Dorsal third ventricle 
Neurofilament 
• # • -T, 
VASE Merge + DAPI 
c Spinal cord central canal 
GFAP VASE Merge + DAPI 
Figure 5.6.1 - Ependymal cells of the 4 (a), dorsal 3 (b), and spinal cord central canal (c) in 
adult rat stain strongly for NCAM-VASE. Bar = 60 pm. 
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(a) Dentate gyrus subgranular layer 
PSA-NCAM Total NCAM 
(b) Lateral ventricle subventricular zone 
Neurofilament Total NCAM 
Merge + DAPl 
PSA-NCAM Merge + DAPl 
Merge + DAPl 
Neurofilament Merge + DAPl 
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(c)Olfactory bulb 
Neurofilament Total NCAM Merge + DAP! 
Neurofilament Merge + DAPI 
Figure 5.6.2 - NCAM-VASE is absent from areas of neurogenesis and synaptic plasticity in the 
adult rat cortex, (a) NCAM-VASE is absent from PSA-NCAIVI expressing neurons in the dentate 
gyrus subgranular layer, whilst total NCAM is highly expressed throughout the region, (b) 
Neurofilament-positive neurons of the subventricular zone of the lateral ventricle highly express 
NCAM but not NCAM-VASE. NCAM-VASE is also absent from the lateral ventricle ependymal cells, 
which are not even reactive for total NCAM. (c) Total NCAM is strongly expressed by mitral neuron 
cell bodies, and expressed slightly weaker by granule cell bodies in the olfactory bulb. NCAM-VASE 
is completely excluded from the mitral (large cells) and granule cell (small cells) layers of the olfactory 
bulb. Bar = 60pm 
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5.7 NCAM-VASE is highly expressed in ventricular cardiac muscle, 
but is excluded from skeletal muscle 
The investigation into VASE localisation was extended past the nervous system to 
the heart and skeletal muscle as Small and Akeson have reported that NCAM-VASE 
transcripts are high in the heart (Small and Akeson, 1990), whilst Andersson et al 
have reported that NCAM-VASE transcripts are very low in skeletal muscle 
(Andersson et al., 1993). In the heart, NCAM has been found to be most abundantly 
expressed on the sarcolemma of myocardial cells in the ventricular wall (Wharton et 
al., 1989) and so tissue from this area was examined. The total NCAM antibody 
stained intensely throughout the sarcolemma of the myocardial cells (Figure 5.7.1a, 
left). Similarly VASE staining had an identical pattern (Figure 5.7.1a, right). In 
contrast to cardiac muscle, skeletal muscle (taken from the gastrocnemius leg 
muscle) had fainter staining for total NCAM, and the staining was less continuous, 
not covering the whole of the myotubes (Figure 5.7.1b, left). The total NCAM 
staining also was observed to show striations running perpendicular to the length of 
the myotubes. Strikingly, VASE staining was completely absent from skeletal muscle 
(Figure 5.7.1b, right). In adult skeletal muscle, NCAM has been reported to be 
expressed in a restricted pattern localised around neuromuscular junctions (NMJs) 
(Covault and Sanes, 1985). This was investigated by costaining for 
acetlycholinesterase (AChE) which is particularly enriched at the NMJ of skeletal 
muscle cells (Figure 5.7.2a) (Donoso et al., 1987). NCAM and AChE almost 
completely colocalised (Figure 5.7.2a), whilst an antibody to GFAP which is not 
expressed in muscle gave no immunoreactivity (Figure 5.7.2b). 
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a Cardiac muscle 
Total NCAM VASE 
b Skeletal muscle 
Total NCAM 
fc' 
VASE 
Figure 5.7.1 - (a) Myocardial cells give intense staining for total NCAM and VASE in their 
sarcolemma. (b) In contrast, adult rat gastrocnemius skeletal muscle gives staining for total 
NCAM, but not NCAM-VASE. Bar = 60pm. 
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(a) 
Acetyl ch 01 i neste rase Total NCAM Merge + D / ^ l 
I 
Acetyl ch 0 li n este rase 
rc=; 
Merge + DAPI 
GFAP + DAPI Green Secondary Only + DAPI Red Secondary Only + DAPI 
Figure 5.7.2 - (a) Adult rat gastrocnemius muscle costalned with acetylcholinesterase and 
total NCAM or NCAM-VASE. (b) Control sections of adult rat gastrocnemius muscle stained for 
GFAP - a non-muscle protein, and green and red secondary antibody only controls. Images were 
taken at the same exposure as the images in (a). Bar = SOpm. 
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5.8 Qualitative summary of the distribution of total NCAM and 
NCAM-VASE staining in the nervous system and muscle 
Region Total NCAM NCAM-VASE 
Cortex 
Myelinated axon tracts ++++ 
Grey IVIatter (+) 
Neurons of lateral ventricle SVZ ++++ 
Mitral neurons of olfactory bulb ++ 
Granule neurons of olfactory bulb ++ 
Ependymal cells of 3'^ '' ventricle ++++ 
Ependymal cells of Lateral ventricle -
Astrocytes +++ 
++++ 
++++ 
Hippocampus 
CA1 pyramidal neurons ++ 
Stratum lucidum (mossy fibre tract) +++ 
Stratum lacunosum moleculare ++ 
Hilus (CA4) +++ 
Dentate gyrus molecular layer ++ 
Dentate gyrus subgranular layer +++ 
+ 
+ 
++ 
++ 
Cerebellum 
Molecular layer neuropil +++ 
Purkinje cells +++ 
Granule cells + 
Myelinated axon tracts ++++ 
Bergmann Glia ++ 
Ependymal cells of 4*^  ventricle ++++ 
+++ 
(+) 
++++ 
++++ 
Spinal Cord 
Grey matter ++ ++ 
Radially oriented astrocytes ++++ ++ 
Grey Matter astrocytes ++++ ++ 
DREZ astrocytes ++++ ++ 
Myelin + (+) 
Lamina II (Substantia gelatinosa) ++++ ++++ 
Lamina X +++ +++ 
Motor neurons ++++ -
Ependymal cells of central canal ++++ ++++ 
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PNS 
Dorsal nerve - axoplasm ++ -
Dorsal nerve - compact myelin - -
Dorsal nerve - around nuclei in the myelin ++++ -
Ventral nerve - axoplasm ++ -
Ventral nerve - compact myelin - -
Ventral nerve - around nuclei in the myelin ++++ ++++ 
Sensory neurons of the DRG ++++ -
Sciatic nerve - Axoplasm ++ -
Sciatic nerve - Compact myelin ++++ -
Sciatic nerve - around nuclei in the myelin ++++ ++++ 
Muscle 
Heart ++++ ++++ 
Skeletal muscle +++ -
Table 5.8.1 - Key: + to ++++ = increasing amount of staining; (+) = very faint 
staining: - = no staining 
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5.9 Discussion 
This chapter shows for the first time the distribution of NCAM-VASE protein 
expression in adult rat nervous system and muscle. Broadly speaking, in the brain 
and cerebellum the staining pattern for NCAM-VASE was largely localised to myelin, 
and was identical to that of total NCAM. NCAM-VASE staining was found to be 
absent from sites of synaptic plasticity and neurogenesis, and also was not localised 
to brain and cerebellar astrocytes. In the spinal cord, VASE staining was faint, and 
was mainly localised to radially oriented white matter astrocytes and the spinal cord 
grey matter, especially the substantia gelatinosa. Interestingly ependymal cells lining 
ventricles, except the lateral ventricle were highly VASE-positive. In the ventral 
spinal nerve and sciatic nerve, VASE staining was highly restricted to localised 
points arranged around the outside of compact myelin, which appear also to be 
associated with the nuclei of cells. Curiously, this VASE staining pattern was not 
observed in the dorsal spinal nerve, whilst total NCAM stained both dorsal and 
ventral. In muscle tissue, VASE strongly stained ventricular cardiac muscle, whilst 
was absent from total NCAM-positive skeletal muscle. The relevance of these 
staining patterns and their possible implications will now be further discussed. 
NCAM-VASE and myelin 
In the brain and cerebellum, myelin was by far the major site of VASE expression. In 
fact, it appeared to be the major site of total NCAM expression as well (Figures 5.2.2 
+ 5.2.5). In the CNS, NCAM-VASE and total NCAM were localised in a ring 
surrounding neurofilament -positive axons, and within a partially overlapping larger 
ring of MOG staining - consistent with localisation to compact myelin (and also 
possibly the axonal membrane) (Figure 5.3.3). It has been reported that mature 
myelinating oligodendrocytes express only NCAM120 (Bhat and Silberberg, 1988), 
however Figure 3.3.3 from chapter 3 would suggest that the 120kDa isoform of 
NCAM-VASE is relatively minor in comparison to 140 and 180. If VASE is low in 
NCAM 120, and myelin only contains the 120 isoform, then the finding that VASE 
staining is so high in myelin is hard to reconcile. The isolated brain membranes used 
in chapter 3 were solubilised in RlPA buffer at 4°C (see Materials and Methods). 
RlPA buffer contains the detergents 1% Triton x-100 and 1% sodium deoxycholate. 
A search of the literature yielded a report stating that NCAM-120 is resistant to 
solubilisation in triton x-100 at 4°C (Kramer et al., 1997), which could account for its 
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low abundance in the brain membrane samples tested in chapter 3. In contrast to 
the brain and cerebellum, both NCAM and NCAM-VASE were a relatively small 
component of myelin in the spinal cord (Figure 5.5.2). It has been reported that 
oligodendrocytes from the spinal cord and brain are derived from spatially distinct 
populations of precursors during development (Kessaris et al., 2006). Perhaps this 
could account for the different expression levels of NCAM between the brain and 
spinal cord myelin. As discussed in the Introduction, there have been variable 
reports as to the expression of NCAM in PNS compact myelin, however most agree 
that it is absent. Compact myelin of the PNS was completely lacking in VASE, and 
total NCAM was present in the compact myelin only of the sciatic nerve (even when 
the total NCAM Ab was titred down (not shown), suggesting that it wasn't a non-
specfic binding artefact), but not the dorsal or ventral spinal nerves (Figure 5.5.6 and 
5.5.8). Perhaps this difference in the observed compact myelin staining between the 
dorsal/ventral nerves and the sciatic nerve highlights the variability of NCAM 
expression in the PNS compact myelin given by different reports (Dolapchieva et al., 
2001; Martini and Schachner, 1986). 
The pattern of VASE staining in the PNS is interesting and will require further 
characterisation. In the ventral nerve and sciatic nerve in transverse sections, VASE 
was observed to stain in discrete puncta situated at the outer edge of the compact 
myelin and in the cell bodies of cells in the myelin (Figure 5.5.6b and figure 5.5.8a). 
In longitudinal sections the staining ran along the outer edge of the myelin and was 
associated with cell bodies (Figure 5.5.8b). This staining is reminiscent of a 
published report showing bands of cytoplasm which run transverse and 
longitudinally along the outside of Schwann cell myelin called Cajal bands (Court et 
al., 2004) (Figure 5.9.1). These bands have been shown to be important in mRNA 
translocation along the Schwann cell (Sherman and Brophy, 2005) and could be 
important in Schwann cell elongation during nerve growth (Court et al., 2004). The 
significance of VASE potentially being localised to Cajal bands is unclear. A potential 
problem with this hypothesis is that bands of VASE staining were only seen running 
longitudinally and not in transverse, whilst Cajal bands run in both directions. 
Transverse bands would be hard to observe in the sections used in this chapter due 
to the thickness and orientation that they were cut at. Court et al used whole teased 
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quadriceps nerves in their investigation which would be better for observing the 
bands running in both directions (Court et a!., 2004). 
Figure 5.9.1 - (a) EM image of a myelinated axon from the mouse 
quadriceps nerve showing compact myelin (thick black line) and areas of 
cytoplasm outside the compact myelin called Cajal bands (asterisks). Taken 
from figure 1d Court ef a/(Court et al., 2004). (b) Enlarged image from Figure 
5.7.8a showing VASE (red) and neurofilament (green) staining of adult rat 
sciatic nerve. The punctate VASE staining (asterisks) is similar to the 
morphology of Cajal bands. 
Another alternative explanation for the pattern of VASE staining in the PNS 
could be that VASE is being expressed by non-myelinating Schwann cells residing 
between the myelinated axons. Non-myelinating Schwann cells have been identified 
as expressing NCAM in previous studies (Dolapchieva et al., 2001; Roche et al., 
1997). The problem with this hypothesis is that non-myelinating Schwann cells, 
whilst not producing compact myelin, do encircle bundled low-calibre axons, and a 
pattern of staining consistent with this was not observed. Staining for total NCAM 
showed the same pattern as that of VASE in the ventral root nerve, but also in the 
dorsal root nerve, where VASE staining was absent (Figure 5.5.6). This could 
suggest a difference between the Schwann cells of the dorsal and ventral nerves. It 
has been previously reported that dorsal and ventral Schwann cells express different 
levels of various proteins. Connexin29 has been found to be expressed in elevated 
levels by ventral Schwann cells relative to dorsal, whilst brain-specific fatty acid 
binding protein (BFABP) is preferentially expressed by dorsal Schwann cells (Li et 
al., 2007). The dorsal nerves contain sensory neurons whilst ventral nerves contain 
motor neurons. It has also been found that dorsal and ventral Schwann cells have 
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specific phenotypes, secreting growth factors specific to the axon-type they 
myelinate, and can "remember" their origin after deinnervation (Hoke et al., 2006). 
Taking these findings together, it does seem plausible that VASE expression in the 
ventral and dorsal nerves could be different, although the precise function for this is 
unclear. Not all of the myelinated axons in the sciatic nerve had VASE staining 
associated in patches surrounding the compact myelin (Figure 5.5.8). Perhaps it is 
only the myelinated motor axons which have associated VASE staining, whilst the 
myelinated sensory axons do not. 
NCAM-VASE and plasticity 
A general trend throughout the adult brain was the absence of NCAM-VASE staining 
from sites of neurogenesis and synaptic plasticity. In the hippocampus, NCAM-
VASE gave similar staining to total NCAM, but was absent from the dentate gyrus 
hilus and low in the mossy fibre pathway (Figure 5.3.3). The mossy fibre pathway 
stained for total NCAM, and was also reactive for PSA-NCAM (Figure 5.2.3c). 
Neurons are generated in the dentate gyrus subgranular zone and stain for PSA-
NCAM (Bonfanti, 2006) but not VASE (Figure 5.6.2a). These new neurons have a 
higher plasticity than the mature neurons and are proposed to integrate into the 
mossy fibre pathway, which could be important in the encoding of new memories 
(Piatti et al., 2006). The other site of adult neurogenesis is the subventricular zone 
(SVZ) of the lateral ventricle. Neurons are generated from the SVZ and migrate 
through the rostral migratory stream (RMS) to the olfactory bulb where they integrate 
(Ming and Song, 2005). PSA has also been implicated in this process, with its 
removal by endo-N treatment leading to a failure in precursor migration through the 
RMS (Ono et al., 1994). Again, NCAM-VASE was found to be excluded from both 
the SVZ and the olfactory bulb (Figure 5.6.2b+c). This is the first time that VASE 
protein has been confirmed to be absent from areas of neurogenesis and synaptic 
plasticity, and confirms an apparent in vivo inverse correlation with PSA addition to 
NCAM. The exclusion of VASE from these areas would seem logical, based on the 
fact that VASE inhibits NCAM-mediated neurite outgrowth (Doherty et al., 1992; 
Saffell et al., 1994) - neurite outgrowth being a process necessary for new neurons 
to establish their connections. If this were the case, it would support the hypothesis 
that VASE is inhibitory to plasticity, but conversely that it also may be required by 
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areas of the brain that seek to remain non-plastic, such as fully developed and 
formed structures like myelinated axon tracts, and cells such as ependymal cells. 
NCAM-VASE and ependymal cells 
NCAM has been reported to be present in ependymal cells of the central canal (Filiz 
et al., 2002). In this chapter, NCAM-VASE was found to be highly expressed by 
ependymal cells lining the spinal cord central canal, the fourth ventricle between the 
cerebellum and brainstem and the dorsal third ventricle (Figure 5.6.1). However, 
ependymal cells of the lateral ventricle were devoid of NCAM staining altogether 
(Figure 5.6.2b). Ependymal cells are situated lining the ventricles and are thought to 
play a critical role in brain homeostasis, acting as a permeable barrier between the 
brain and the CSF (Bruni, 1998; Spassky et al., 2005). It has been found that soluble 
NCAM-VASE is elevated in the CSF of schizophrenia sufferers (Vawter et al., 2000). 
It would seem possible that high VASE expression by ependymal cells could 
contribute to soluble NCAM-VASE in the CSF, especially as NCAM can be shed 
from the cell surface (Hubschmann et al., 2005). NCAM-VASE (and all NCAM) was 
absent from the ependymal cells of the lateral ventricle (Figure 5.6.2b). The 
ependymal cells at this location are situated immediately above the SVZ neural stem 
cell layer generating neurons to migrate to the olfactory bulb (Doetsch et al., 1997). 
As discussed in chapter 1, the newly generated neurons migrate in a PSA-NCAM-
dependent manner (Ono et al., 1994). Perhaps having ependymal cells expressing 
high amounts of NCAM-VASE immediately adjacent to the site of neurogenesis 
could interfere with any NCAM-dependent processes required for neurogenesis and 
migration. In a similar situation, reduced adult neurogenesis has been reported in 
schizophrenia (Reif et al., 2007). Perhaps the elevated levels of NCAM-VASE in the 
CSF of schizophrenia sufferers reflects an upregulation of VASE expression that can 
exert an inhibitory effect on the NCAM-controlled aspects of neurogenesis and 
migration. The absence of VASE from ependymal cells at the lateral ventricle raises 
two questions. Firstly, why it is absent from lateral ventricle ependymal cells, and 
secondly, why is it present on ependymal cells at all other locations investigated? A 
hint of an answer may come from a report which found a small amount of PSA-
NCAM expressing neural progenitor-like cells and partially differentiated neurons 
residing on the ependymal surface of the ventricular system (Alonso, 1999). Upon 
intraventricular injection of epidermal growth factor (EGF) or FGF-2, an 
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accumulation of these cells was observed on the ventricular wall of the lateral 
ventricle just above the SVZ. These neural progenitors have been proposed to 
migrate out of the SVZ through the ependymal layer into the lateral ventricle and 
then disperse along the ependymal ventricular wall into the third and fourth 
ventricles, and the spinal cord central canal, although their function is currently 
unknown (Alonso, 1999). 
Ependymal cells are known to be joined by adherens, gap and some tight 
junctions, although do not provide a diffusional barrier for factors travelling to and 
from the brain and CSF(Lippoldt et al., 2000; Rash et al., 2001). Being a cell 
adhesion molecule, perhaps NCAM contributes to the adhesion and anchoring of 
ependymal cells to their neighbours. In this case, the absence of NCAM from the 
ependymal cells of the lateral ventricle could possibly reduce their cell-cell adhesion 
and better facilitate the passage of the migrating neural progenitors out into the 
ventricle. The neural precursors would be migrating along ependymal cells of the 
third and fourth ventricles and central canal which express VASE. Perhaps this is a 
similar situation to the apparent unhindered interactions between VASE expressing 
neurites and VASE-negative oligodendrocytes observed in culture in Chapter 4 
(Figure 4.3.4). The migrating neural precursors were reported to possess small 
neurites, which were enhanced in length by addition of FGF-2 (Alonso, 1999). 
Perhaps it is not desirable for the precursors to put out neurites until they reach their 
intended destination, and having an underlying layer of VASE expressing ependymal 
cells acts to inhibit the growth of their neurites in a similar situation to the published 
monolayer experiments (Doherty et al., 1992). Presumably when the precursors 
reach where they are migrating to, they must migrate back out of the ventricle. A 
potential problem with this hypothesis is that if VASE is helping to anchor ependymal 
cells together then it would hinder the passage of the precursors out of the ventricle. 
NCAM-VASE and astrocytes 
Whilst astrocytes expressing NCAM without VASE were found throughout the brain, 
cerebellum and spinal cord, it was only in the spinal cord that astrocytes expressed 
NCAM-VASE (Figure 5.3.4, figure 5.4.4 and figure 5.5.1). Astrocytes in the spinal 
cord stained strongly for total NCAM and less strong for VASE, suggesting that they 
probably express a mixture of VASE and non-VASE isoforms of NCAM. Quite why 
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astrocytes in the spinal cord express VASE but not those in the cerebellum or cortex 
remains unclear. In the two studies highlighting NCAM expression in the spinal cord, 
astrocytes are not mentioned as expressing NCAM (Filiz et al., 2002; Joosten, 
1994). An interesting site of VASE expression is the astrocytes of the dorsal root 
entry zone (DREZ) (Figure 5.5.5). Whilst staining very strongly for total NCAM, there 
was moderate staining for VASE. The DREZ is an astrocytic structure situated at the 
point where the dorsal nerve enters the spinal cord and is a separation between the 
CNS and PNS (Adcock et al., 2004). If the dorsal nerve is crushed, the regenerating 
axons will begin to regrow but are halted by inhibitory cues such as chondroitin 
sulphate proteoglycans (CSPGs) presented by the DREZ (Adcock et al., 2004; 
Ramer et al., 2000). Given that NCAM-VASE can abrogate NCAM-dependent 
neurite outgrowth (Doherty et al., 1992), perhaps the presence of VASE in the DREZ 
contributes to its inhibitory environment. It would be interesting to test this 
hypothesis in light of the data from the previous chapter showing that VASE is 
upregulated in response to astrocyte reactivity which would presumably occur in the 
DREZ after nerve injury. 
NCAM-VASE in muscle 
Whilst total NCAM stained both cardiac and skeletal muscle, VASE stained only 
cardiac muscle. VASE and total NCAM stained all over the sarcolemma of the 
cardiomyocytes, although intense NCAM staining reported to be in intercalated discs 
was not observed (Figure 5.7.1) (Wharton et al., 1989). In skeletal muscle, NCAM 
was colocalised to areas of the myotubes which stained for AChE (Figure 5.7.2). 
One of the major difference between skeletal muscle and cardiac muscle is that 
skeletal muscle contains myotubes, which are multinucleate cells formed through the 
fusion of individual myoblasts (Gorbe et al., 2007), whilst cardiac muscle remains 
mostly mononucleate (Manasek, 1968). Another major difference is that 
cardiomyocytes are electrically coupled to each other whilst skeletal myotubes are 
not, allowing the organised and regulated contraction of the heart to occur (Valencik 
et al., 2006). This coupling is achieved by cell-cell communication via pore-forming 
structures called gap junctions which are made up of the connexin protein family 
(Valencik et al., 2006). Skeletal myotubes also contain gap junctions, but only during 
development, where they are important in myoblast fusion and are downregulated 
soon after (Gorbe et al., 2007). NCAM has been found to play a role in the 
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embryonic development of cardiac gap junctions, with an NCAM antibody reducing 
the gap junction coupling of cardiomyocytes as assayed by transmission of a dye 
between ceils (Watanabe, 1998). PSA was also found to be a negative regulator of 
gap junction formation and endoN removal of PSA increased dye transmission 
(Watanabe, 1998). The role of NCAM in cardiac gap junction formation cannot be 
essential as NCAM-KO mice are viable, but they do possess smaller thin-walled 
hearts than their wild type counterparts (Watanabe, 1998). As VASE in the brain 
appears to negatively correlate with PSA both in expression and functions, perhaps 
if PSA is inhibitory to gap junction formation, then VASE may promote gap junction 
formation. One possible mechanism of VASE promotion of gap junction formation 
could be that VASE is more adhesive than NCAM and better anchors the 
cardiomyocytes together, bringing cell membranes into tighter contact. Cell-cell 
adhesion by N-Cadherin has been found to be critical for gap junction connectivity 
(Saffitz, 2006). Perhaps VASE adhesion also contributes to this? It has been 
mentioned in passing that NCAM-VASE is slightly more adhesive than non-VASE 
NCAM (Doherty et al., 1992), although a later study found that cells transfected for 
NCAM or NCAM-VASE aggregated at the same rate (suggesting equal binding 
affinity) (Chen et al., 1994). The later study did however find that NCAM or NCAM-
VASE transfected cells possessed a preference for binding to cells of the same type, 
suggesting that VASE introduces some sort of alteration to the adhesive properties 
of NCAM (Chen et al., 1994). 
It has been reported that adult cardiomyocytes express FGFR1 (Liu et al., 
1995) and that their gap junction coupling is thought to be sensitive to FGF-2 via 
PKC phosphorylation of connexin43 stimulated by the FGFR-1 signalling pathway 
(Detillieux et al., 2003). Gap junction uncoupling in response to FGF-2 is thought to 
be a form of cardioprotection during ischemia to prevent the spreading of damaging 
contractions throughout the heart (Detillieux et al., 2003). FGFR-1 activation of PKC 
is also involved in NCAM-stimulated neurite outgrowth signalling (Povlsen et al., 
2003). Perhaps NCAM in the heart could signal through FGFR-1 and activate this 
pathway causing undesirable gap junction uncoupling. As VASE does not promote 
neurite outgrowth, perhaps it would not activate PKC, and gap junction connectivity 
would be maintained, whilst having the added effect of NCAM-VASE contributing 
favourably to cell-cell adhesion. This could provide an alternative hypothesis of 
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VASE function in the heart, which would be to permit the gap junction-promoting 
properties of NCAM, whilst abrogating its signalling properties which could be gap 
junction inhibitory. It is important to note however, that VASE has never been shown 
not to activate NCAM signalling pathways, only that it does not promote neurite 
outgrowth. 
Gap junctions are also important in astrocytes. Astrocytes are normally 
arranged into an interconnected network via gap junctions which allow for electrical 
and metabolic coupling (Theriault et al., 1997). In a rat model of stroke, the gap 
junction blocker octanol reduced the volume of tissue damage by 60%, presumably 
by preventing the transmission of toxic factors from the site of damage via the 
astrocytic syncytium (Rawanduzy et al., 1997). Upon injury, astrocytes become 
reactive, and as a consequence show a transient uncoupling of gap junctions, before 
they are redistributed and reconnected in arrangement which is thought to isolate 
the lesion site (Ochalski et al., 1995). Chapter 4 shows that VASE is upregulated in 
reactive astrocytes (Figure 4.5.3). Perhaps therefore VASE plays a role in reactive 
astrocyte gap junction remodelling after injury. 
It has recently been discovered that gap junctions are essential for 
myelination, with connexin47 and connexin32 double KO mice lacking properly 
formed CMS myelin and dying by postnatal week 5-6 (Menichella et al., 2003). If 
VASE is more adhesive than NCAM, then perhaps it aids gap junction formation in 
myelin. Inversely to VASE expression in mature myelin, downregulation of PSA 
(which is anti-adhesive) from oligodendrocytes is essential for efficient myelin 
formation (Fewou et al., 2007). FGFR1 is also expressed by oligodendrocytes 
(localised to the myelin) and FGFR1 signalling in response to FGF-2 causes them to 
downregulate myelin proteins and reenter the cell cycle. Perhaps if NCAM without 
VASE was expressed in myelin, it would activate this signalling pathway and cause 
undesirable oligodendrocyte dedifferentiation. NCAM-VASE in the myelin could 
provide the adhesive properties of NCAM without its signalling properties. However, 
this would depend on NCAM mimicking the effects of FGF-2, which has been shown 
not to always be the case, as whilst FGF-2 can promote cellular proliferation 
(Garcia-Maya et al., 2006), NCAM has been found to inhibit proliferation (Krushel et 
al., 1995). 
186 
It is interesting to note that VASE staining was primarily observed on glial and 
ependymal cells, with only a small proportion of staining appearing to be neuronal 
(Figure 4.3.2 - cultured cerebellar neurons, 5.2.4 - CA1 neurons and 5.53b -
substantia gelatinosa) whilst most neurons displayed varying degrees of NCAM 
immunoreactivity (Figure 5.4.3b, figure 5.5.4, figure 5.5.7 and figure 5.6.2c). This is 
surprising seeing as NCAM action and function in the CNS is mostly studied in 
neurons. It is conceivable that VASE expression in CNS myelinated neurons is 
masked by the intense VASE myelin staining. Investigations at the EM level would 
be needed to observe whether VASE is also localised to the axonal membrane. 
Even if VASE is restricted mainly to glial and ependymal cells, this potentially does 
not prevent it acting on neurons via trans NCAM interactions as simulated by neurite 
outgrowth monolayer experiments (Doherty et al., 1992). 
The aim of mapping VASE expression was to shed light onto the possible 
functions of VASE by correlating with areas of expression. As NCAM-VASE is 
temporally regulated as well as spatially regulated (Small and Akeson, 1990), the 
next chapter will probe VASE expression developmentally to further delineate VASE 
distribution. 
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Chapter 6 
The developmental expression of NCAM-VASE 
in the postnatal rat cerebellum 
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6.0 The developmental expression of NCAM-VASE in the postnatal 
rat cerebellum 
6.1 Introduction 
Studies have shown that NCAM-VASE mRNA is upregulated during rat development 
from about 3% of NCAM transcripts containing the VASE exon in the embryo, to about 
43-50% of NCAM transcripts containing VASE by adulthood (Small et al., 1988; Walsh 
et al., 1992). This window of change in VASE levels could give a crucial insight into 
understanding the role and function of NCAM-VASE within the nervous system by 
allowing the observation of specific timings of VASE expression by different cell types 
and correlating these to developmental progression. The affinity-purified VASE 
antibody allows a study of this nature to be performed for the first time. 
At birth, a rat brain has developed to the equivalent of that of a human foetus at 
5-6 months gestation, and by PND10 is the equivalent of a human brain at birth 
(Porterfield and Hendrich, 1993). As mentioned in Chapter 4, by birth, rat cerebral 
neurogenesis is almost complete, with most neurons being generated embryonically, 
however in the cerebellum about 77% of neurogenesis occurs after birth (Porterfield 
and Hendrich, 1993). Therefore, a study of the postnatal development of the 
cerebellum will allow observation of VASE expression in a brain region which is still 
going through a dramatic developmental change that is well characterised. Analysis of 
VASE expression in the adult rat cerebellum showed that VASE was mainly restricted 
to the myelinated axon tracts in the granule cell layer and the myelin of the white 
matter, with the second site of VASE expression being the neuropil of the molecular 
layer. The emergence of VASE expression in these regions during cerebellar 
development will be studied in this chapter. 
Rat Postnatal Cerebellar Development 
The postnatal development of the rat cerebellum requires the interdependent ordered 
generation, migration and differentiation of a number of different cells (Delaney et al., 
1996; Mathis et al., 2003). The basic plan for cerebellar development can be 
summarised by the following processes - proliferation of granule cell precursors in the 
external germinal layer (EGL), migration of granule cells to the internal granule cell 
layer (IGL), differentiation, elaboration and synaptogenesis of Purkinje cells, and 
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myelination. Although these processes occur in an ordered and regulated manner, 
they occur at slightly different times in different regions of the cerebellum (in a general 
rostral to caudal direction) (Altman, 1972b). 
Proliferation of granule cell precursors 
In the cerebellum at birth, rats contain a germinal layer of neural precursors about 4 
cells thick, called the proliferative zone of the external germinal layer (EGL -
sometimes called the external granule cell layer) on the outer surface of the 
cerebellum (Altman, 1972b). The bulk of granule cell genesis occurs during the 
second postnatal week, from about PND7-15 (Altman, 1972a). By about PND5, the 
EGL expands to about 6-8 cells thick by the generation of another layer within the 
EGL called the premigatory zone, containing postmitotic neurons with a spindle-
shaped morphology which are derived from the germinal cells of the proliferative zone 
(Altman, 1972b). The premigatory zone expands in size, peaking about PND8-9 
before declining as the cells migrate away, and disappearing by about PND20. The 
proliferative zone remains a constant size until about PND9-10 before declining and 
disappearing by about PND20 (Altman, 1972b). 
Migration of granule cells 
Granule 
cell 
Direction 
of 
migration 
M 
Purkinje 
cell 
Figure 6.1.1 - Developing cerebellar granule cells migrate from the external germinal layer, 
through the Purkinje cell layer, to their final destination in the internal granule layer. During 
migration, granule cells extend bi-directional axons which form parallel fibres. Successive 
waves of granule cell migration leads to the gradual vertical stacking of parallel fibres. Based on 
figure 3 (Altman, 1972b). 
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Differentiating granule cells must migrate from their place of birth in the EGL to their 
fully differentiated position in the internal granule cell layer (IGL). Accompanying this 
migration is a change in morphology in which the spindle-shaped granule neuron 
extends a bi-directional axon out in the long axis plane of the cerebellar folia, forming 
a parallel fibre (Figure 6.1.1). Successive waves of granule cell migration stack 
parallel fibres on top of each other, building up the cerebellar molecular layer (Altman, 
1972b). 
The migration of granule cells from the EGL to the IGL is thought to be aided by 
Bergmann glia - radial glia which reside in the Purkinje cell layer but extend 
processes up through the molecular layer and EGL to the cerebellar surface (Komuro 
and Rakic, 1998). Granule cells have been observed to form close contact with 
Bergmann glia which are thought to produce growth factors and cues favourable for 
migration (Komuro and Rakic, 1998). Others have played down the role of Bergmann 
glia in granule cell migration, observing granule cells migrating closely together, 
following along the fibres of the proceeding cell (Liesi et al., 2003). In all probability, 
both types of migration occur, as selectively killing cerebellar astrocytes during 
development has been found to reduce the number of granule cells in the IGL but not 
prevent migration altogether (Delaney et al., 1996). Stellate and basket cells are other 
neurons which are present in the molecular layer. The development of these neurons 
will not be discussed. 
Differentiation, elaboration and synaptogenesis of Purkinje cells 
PO P3 P6 P9 P9 P12 
Pie P18 P30 P39 PSD 
60 (im 
Figure 6.1.2 - Postnatal maturation of a cerebellar Purkinje cell dendritic tree. Taken from 
figure 1a, (McKay and Turner, 2005). 
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At birth in rat, Purkinje cells form an irregular arrangement between the developing 
molecular layer and white matter, which rearranges by PND3-4 into a monolayer 
(Altman, 1972c). From about PNDO-9, Purkinje cell processes remain relatively simple 
and close to the cell body. By about PND9, a primary process extends to the 
molecular layer and rapidly elaborates into a huge dendritic tree by PND18 and from 
then on, only undergoes minor reorganisation (Figure 6.1.2) (McKay and Turner, 
2005). The timing of Purkinje cell differentiation is not exact, as Purkinje cells from 
different regions of the cerebellum develop at different times (Altman, 1972c). Growth 
of the Purkinje cell dendritic tree is thought to be aided by Bergmann glia, with the 
dendrites aligning themselves along glial processes (Lordkipanidze and Dunaevsky, 
2005). By about PND15, glial processes begin to ensheath most of the primary 
dendrites, and by PND21 this also includes secondary dendrites, apart from where the 
dendrites contact and synapse onto the parallel fibres (Figure 6.1.3) (Altman, 1972a). 
Parallell fibre - Purkinje cell synaptogenesis occurs temporally from the bottom of the 
molecular layer upwards (Figure 6.1.3) (Altman, 1972a) and is gradually complete by 
about the fourth postnatal week (McKay and Turner, 2005). 
Cerebellar Myellnation 
Cerebellar white matter contains the myelinated axons of Purkinje cells leaving the 
cerebellum, and climbing and mossy fibres entering (Mathis et al., 2003). Myelination 
in the cerebellum proceeds in a rostrocaudal direction, with the myelin markers myelin 
basic protein (MBP) first being detected between PND7-14 (Hamano et al., 1996), 
proteolipid protein (PLP) between PNDO-7 (Hamano et al., 1998) and myelin 
oligodendrocyte glycoprotein (MOG) between PND14-21 (Coffey and McDermott, 
1997). Oligodendrocytes play an essential role in postnatal cerebellar development. 
Selectively killing oligodendrocytes at birth leads to abnormal layering of the Purkinje 
cells which fail to produce a proper dendritic tree, reduced granule cell number, and 
disorganised growth of Bergmann glia (Mathis et al., 2003). 
NCAM expression In the developing cerebellum 
Publications on NCAM expression throughout postnatal cerebellar development are 
contradictory. However, the developing Purkinje layer, molecular layer, and IGL have 
been consistently reported to highly express NCAM (Beasley and Stallcup, 1987; 
Daniloff et al., 1986; Goldowitz et al., 1990; Hirn et al., 1983), Cerebellar white matter 
NCAM expression has been reported (Daniloff et al., 1986; Goldowitz et al., 1990), 
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and also NCAM expression by Bergmann glia (Beasley and Stallcup, 1987; Persohn 
and Schachner, 1987). Conflicting reports indicate both the presence (Goldowitz et al., 
1990; Persohn and Schachner, 1987) and absence (Daniloff et a!., 1986; Hirn et al., 
1983) of NCAM from the developing EGL. One report claims the EGL is NCAM-
negative at PND2 but positive by PND7 (Beasley and Stallcup, 1987), so perhaps the 
EGL begins to express NCAM sometime around PND2-7. By PND13, NCAM 
cerebellar staining looks essentially like adult (Hirn et al., 1983). 
Aims of this chapter 
To investigate the temporal distribution of VASE expression in the cerebellum, the cell 
types expressing VASE at different postnatal timepoints will be studied. This will 
enable VASE expression to be correlated with the developmental processes occurring 
in the cerebellum, with the intention that this will shed light on the function of VASE. 
As with the previous two chapters, VASE expression will be studied by costaining for 
astrocytes, oligodendrocytes and neurons. The cerebellum will be studied at the 
following ages: PND4,7,10,14 and 17. 
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Figure 6.1.3 - Postnatal development of the Purkinje cell in rat, showing its relationship to other 
cell types in the cerebellum. Taken from figure 13 (Altman, 1972a). 
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6.2 General distribution of total NCAM and VASE staining in the 
postnatal developing rat cerebellum 
At PND4, total NCAM staining was strong throughout the cerebellum, with the EGL 
visualised as a continuous band of staining running at the outermost layer (Figure 
6.2.1). During the developmental progression, total NCAM staining became 
progressively fainter and more restricted, and by PND14 was localised to the white 
matter (strongest staining), molecular layer, and granule cell layer (least intense 
staining), consistent with the adult expression pattern (Figure 5.2.5). At all ages 
studied, the EGL was NCAM positive. At the low magnification of Figure 6.2.1, NCAM-
VASE appears to be absent from the PND4 cerebellum (the staining around the edge 
is a non-specific artefact visible on secondary antibody alone control sections (not 
shown)). By PND7, there is a striking thin layer of VASE staining situated at around 
the position of the Purkinje cell layer. This has largely faded by PND10, with VASE 
staining appearing to nearly be absent. At PND14, VASE stains strongest in the 
developing molecular layer, with faint staining appearing in some white matter tracts. 
By PND17, although slightly fainter, VASE staining looks essentially identical to total 
NCAM staining and resembles the adult staining pattern with staining strongest in the 
white matter and molecular layer (Figure 5.2.5). To summarise, total NCAM staining 
appears to undergo two changes during cerebellar development. Firstly it decreases in 
intensity with postnatal age, and secondly it becomes restricted to certain regions. 
NCAM-VASE expression appears to be more complex - it is absent early in 
development, before being transiently upregulated in the Purkinje cell layer at PND7, 
and then finally increases in the molecular layer and myelin to become identical to the 
total NCAM staining pattern by PND14-17. 
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Figure 6.2.1 - Rat cerebella of PND4,7,10,14 and 17 stained for total NCAM and NCAM-VASE. 
Whilst staining very intensely and fairly ubiquitously at PND4, total NCAM reduces in staining intensity 
during development and becomes restricted. By PND17, total NCAM staining is most intense in the 
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cerebellar white matter and molecular layer, similarly to the adult staining pattern (see Figure 5.2.5). 
NCAM-VASE staining was absent at PND4, but shows a thin layer of staining at PND7 at around the 
position of the Purkinje cell layer. At PND10 this had disappeared and by PND17 VASE staining was 
identical to total NCAM staining. Images taken all at same exposure to allow comparison of protein 
expression between ages. Bar = 600pm 
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6.3 During postnatal rat cerebellar development NCAM-VASE is 
transiently expressed by Bergmann glia-like cells in the Purkinje cell 
layer 
The most striking staining pattern observed in the developing cerebellum was the 
transient upregulation of VASE staining in the area of the Purkinje cell layer at PND7 
(Figure 6.2.1). This was examined in more detail at a higher power magnification with 
two cell specific markers. Firstly, as the staining appeared to be in the Purkinje cell 
layer, costains with calbindin were performed. Calbindin is a calcium binding protein 
found in neurons, and in the cerebellum is particularly enriched in Purkinje cells 
(Barski et al., 2003). During postnatal development, the Purkinje cells arrange 
themselves from a disordered layer, to a one-cell thick layer, and then extend their 
dendrites into the molecular layer (Altman, 1972c; McKay and Turner, 2005). At 
PND4, the Purkinje cells showed a loose, jumbled arrangement, layered 2-3 cells thick 
in places (Figure 6.3.2). At PND7, the Purkinje cells were more ordered - a single cell 
layer emerged but no dendritic growth was observed (Figure 6.3.2). Between PND10-
17, the Purkinje cell dendritic tree began to rapidly grow and elaborate, and by PND17 
completely covered the whole molecular layer (Figure 6.3.2). This was quantified by 
measuring the mean height of the dendrites for 100 Purkinje cells selected at random, 
which confirmed the visual observations (Figure 6.3.1). 
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Figure 6.3.1 - (a) The mean height of calbindin-stained Purkinje cell dendritic tree, including cell 
body was measured for 100 randomly selected Purkinje cells and found to remain low at PND4-
7, before rapidly increasing from PND7-17. (b) Qualitative expression level of NCAM-VASE 
staining in the Purkinje cell layer 
At low power, VASE staining was only observed in the Purkinje cell layer at 
PND7 (Figure 6.2.1). At higher power magnification VASE staining was additionally 
observed at PND4 (Figure 6.3.2). At PND4, VASE staining was closely associated 
with the calbindin staining, appearing to weave round the Purkinje cells in places. 
However not all of the surfaces of the Purkinje cells appeared to have associated 
VASE staining, suggesting that VASE could have a patchy distribution in Purkinje 
cells, or be expressed by a different cell type in the Purkinje cell layer (Figure 6.3.2, 
first panel). In addition, VASE could be seen to stain thin processes extending from 
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the Purkinje cell layer up a short distance into the molecular layer (Figure 6.3.2, first 
and second panels). At PND7, like the low-power images, VASE staining was 
strongest in the Purkinje cell layer (Figure 6.3.2, second panel). The VASE staining 
mostly encircled, and was closely associated with the Purkinje cell bodies, but as at 
PND4, extended up in filamentous processes which at this age reached all the way 
through the molecular layer to the outer surface of the cerebellum (Figure 6.3.2, 
second panel). At PND10, VASE staining of the Purkinje cell layer had almost faded 
away to the general levels of the developing molecular layer. There was some staining 
around the Purkinje cell bodies and in the filamentous processes in the molecular 
layer (Figure 6.3.2, third panel). At both PND14 and PND17, VASE staining in the 
Purkinje cell layer had reduced to the extent that it was no more intense than the 
VASE staining in the molecular layer (Figure 6.3.2, fourth and fifth panels). 
Interestingly, the relative staining intensity of VASE in the Purkinje cell layer peaked 
and diminished at the same time as dendritic growth by the Purkinje cells was 
observed to commence (Figure 6.3.1a+b). 
In contrast to VASE, total NCAM staining was not restricted to the Purkinje cell 
layer at PND7 but intensely stained throughout the EGL, molecular layer, Purkinje cell 
layer and IGL (Figure 6.3.3, top panel). At PND17, total NCAM staining appeared to 
be broadly similar to VASE staining at this age, but perhaps stained stronger (Figure 
6.3.3, bottom panel). 
Another cell type that resides in the Purkinje cell layer is Bergmann glia 
(Komuro and Rakic, 1998). These radial glia express GFAP, so can be stained by a 
GFAP antibody. During the developmental ages studied, Bergmann glia were 
observed to have filamentous processes extending from the Purkinje cell layer up 
through the molecular layer to the surface of the cerebellum (Figure 6.3.4). At PND7, 
the age with the most intense VASE staining in the Purkinje cell layer, the GFAP-
positive Bergman glial processes completely colocalised with VASE staining. However 
the VASE staining pattern was slightly larger and extended into GFAP-negative areas 
in the Purkinje cell layer area where the Bergman glia cell bodies reside (Figure 6.3.4, 
second panel). This was visible also at PND4 (Figure 6.3.4, first panel). At PND10, 
there was only faint VASE staining associated with a few of the GFAP-positive 
Bergmann glial processes (Figure 6.34, third panel). At PND14 and PND17, no VASE 
staining was observed associated with the Bergmann glia (Figure 6.3.4, fourth and 
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fifth panel), mirroring the adult VASE staining pattern (Figure 5.4.4). Closer 
examination of the VASE staining at PND7 would appear to show that most of the 
VASE staining in the Purkinje cell layer is associated with GFAP-positive Bergman glia 
(Figure 6.3.6), however there is some overlapping of VASE staining with calbindin in 
Purkinje cells, suggesting that perhaps both cell types could be expressing VASE 
(Figure 6.3.5). An investigation at the EM level would be required to resolve this issue. 
202 
Calbindin VASE Merge + DAPI 
PND4 
PND7 
PND10 
PND14 
PIMD17 
Figure 6.3.2 - During postnatal rat cerebellar development, NCAM-VASE staining in the 
Purkinje cell layer is transiently seen at PND4, maximal at PND7 and absent by PND14. The 
VASE staining appears to be closely associated with calbindin staining which is expressed in 
Purkinje cells throughout development. Bar = GOpm. 
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Figure 6.3.3 - Total NCAM highly stains the developing cerebellum and does not share the 
restricted transient staining VASE pattern in the Purkinje cell layer. Total NCAM appears 
associated with the surface of calbindin-positive Purkinje cells in addition to all the other cells 
that stain positive. Bar = 60pm. 
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Figure 6.3.4 - During postnatal rat cerebellar development, NCAM-VASE staining in the 
Purkinje cell layer is transiently seen at PND4, maximal at PND7 and absent by PND14. The 
VASE staining appears to colocalise with GFAP stained Bergmann glial fibres and is closely 
associated with Bergman glial cell bodies. Bar = 60pm. 
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Figure 6.3.5 - Enlarged imaged of PND7 rat cerelbellum 
stained for VASE (red) and calbindin, DAPI stained nuclei 
(blue). Taken from figure 6.3.2. Caibindin-positive Purkinje 
cells only partially colocalise with VASE staining but have 
most of the VASE staining closely associated around the 
Purkinje cell body (arrow). Bar = SOprn. 
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Figure 6.3.6 - Enlarged imaged of PND7 rat cerelbellum 
stained for VASE (red) and GFAP (green), DAPI stained 
nuclei (blue). Taken from figure 6.3.4. GFAP-positive 
Bergman glia are VASE-reactive (arrow), although the VASE 
staining appears to be broader and extends into GFAP-
negative regions. Bar = 60|jm. 
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6.4 During postnatal rat cerebellar development NCAM-VASE is 
upregulated in concert with the myelin marker MOG 
Chapter 4 showed that in culture, oligodendrocytes upregulate NCAM-VASE 
expression in correlation with the expression of MOG and differentiation into a mature 
myelinating phenotype (Figure 4.4.1). Chapter 5 showed that in adult rat cerebellum 
and brain, myelin is the major site of VASE expression (Figure 5.2.5). For these 
reasons, the emergence of NCAM-VASE expression in the cerebellar white matter 
was investigated. At low power magnification, VASE white matter staining was 
observed at PND14 and PND17 (Figure 6.2.1). The developmental cerebellar sections 
were stained for VASE and MOG and examined at high power (Figure 6.4.1). The first 
staining for MOG in the developing white matter was observed at PND7 (Figure 6.4.1, 
first panel). No MOG or VASE white matter staining was observed at the PND4 
timepoint (not shown). During the developmental progression, MOG staining in the 
white matter increased in intensity, peaking at PND14 and remaining high at PND17. 
This is in contrast to a report showing that the cerebellum is devoid of MOG staining 
until PND14 (Coffey and McDermott, 1997). VASE staining appeared and increased in 
intensity similarly to the MOG staining, suggesting an upregulation of VASE in 
oligodendrocytes with myelination (Figure 6.4.1). However the VASE staining was not 
restricted to areas staining for MOG. At all developmental timepoints observed there 
was faint VASE staining in the granule cell layer (Figure 6.4.1), but bright VASE 
staining in MOG-positive oligodendrocytes. 
208 
MOG VASE Merge 
PND7 
PND10 
PND14 
PND17 
Figure 6.4.1 - NCAM-VASE staining in cerebellar white matter increases in correlation with 
staining for MOG - a marker of myelination. All images were taken at the same exposure to 
allow comparison of expression level. Bar= GOpm. 
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6.5 Discussion 
During postnatal rat cerebellar development, NCAM-VASE expression appears to be 
under the control of two distinct processes. The first is a transient expression of VASE 
in the Purkinje cell layer which peaks at PND7 and drops away to nothing by PND14 
(Figure 6.3.3). The second process could be described as the development of the 
cerebellum into the adult VASE staining pattern, with a developmental increase in 
VASE staining in the white matter and molecular layer neuropil (Figure 6.2.1). Staining 
for total NCAM is widespread and intense at the earliest developmental timepoint, and 
progressively decreases in intensity as it becomes more restricted later in 
development (Figure 6.2.1). Total NCAM staining showed no transient upregulation 
during development. The fact that total NCAM staining is present early, and remains 
throughout development, whilst VASE staining is upregulated with increasing 
postnatal age (second process), would suggest that development causes an isoform 
shift to NCAM containing the VASE exon in the cerebellum. The transient expression 
of VASE in the Purkinje cell layer (first process) would appear to be not directly related 
to the overall increase in VASE expression by the developing cerebellum. At the 
fluorescence microscopy level it is impossible to definitively identify which cells in the 
Purkinje cell layer are staining for VASE, however it would appear that VASE is more 
closely associated with GFAP staining than calbindin staining(Figure 6.3.5), 
suggesting that VASE is at least expressed by the Bergman glia (but could also be 
expressed by Purkinje cells as well). It would not be expected that complete VASE 
colocalisation would be achieved with either GFAP and calbindin, as both of them are 
intracellular proteins whilst VASE is a surface expressed protein (although some 
VASE would be visible in intracellular compartments involved in protein synthesis). 
Perhaps staining with cell-specific surface markers, such as the glutamate transporter 
GLAST for Bergman glia would help to reconcile this problem. GLAST staining of 
PND9 rat cerebellar slice-cultured Bergmann glial fibres surrounding a Purkinje cell 
does look similar to that of the PND7 VASE staining in the Purkinje cell layer (Figure 
6.5.1) (Tanaka et al., 2003). Perhaps VASE could play a specific role in the 
development of Bergmann glia or a process mediated by them. 
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(a) 6DIV PND9 cerebellar slice culture (b) PND7 cerebellar section 
Figure 6.5.1 - (a) Confocal image of IP3R stained cerebellar Purkinje cells (red) surrounded by 
GLAST-positive Bergmann glial fibres (green) from a PND9 rat cerebellar slice culture 6DIV. 
Image taken from Figure 7, Tanakake ef a/(Tanaka et al., 2003). (b) VASE staining (red) 
surrounding calbindin-positive Purkinje cells (green) from PND7 rat cerebellum sections is 
similar to the GLAST Bergmann glial staining, suggesting VASE could be primarily expressed 
on the surface of Bergmann glia in the Purkinje cell layer. 
VASE staining in the Purkinje cell layer was highest at PND7, before greatly 
reducing in intensity by PND10 and was absent by PND14 (Figure 6.3.3). A couple of 
critical events occur in this PND7-14 window. Firstly, the bulk of cerebellar granule 
cells are born in the second postnatal week, with the premigratory zone peaking in 
size at PND8-9 and depleting by PND20 as the granule cells by then have moved 
away (Altman, 1972b). As mentioned in the introduction to this chapter, granule cell 
migration is at least in part dependent upon contact with Bergmann glia to guide them 
to the IGL (Komuro and Rakic, 1998). The newborn granule cells in the EGL are 
strongly NCAM (without VASE) positive (Figure 6.2.1). Perhaps expression of NCAM-
VASE by the Bergmann glia is inhibitory to NCAM-mediated cell migration in a similar 
situation to its inhibition of NCAM-mediated neurite outgrowth of cerebellar granule 
cells (Doherty et al., 1992). The downregulation of VASE from Bergmann glia could be 
a signal for the bulk migration of granule cells to commence. There are many factors 
however which are involved in cerebellar granule cell migration, including neuregulin, 
astrotactin, tenascin, brain derived neurotrophic factor and platelet activating factor, to 
name but a few. If VASE plays a role in the control of granule cell migration, it is one 
protein among many, and in addition, NCAM has never been reported to be involved 
in granule cell migration in vivo. 
Another process which occurs within the PND7-14 window is the 
commencement of rapid outgrowth of the Purkinje cell dendritic tree, which according 
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to McKay and Turner occurs at about PND9 (Figure 4.1.2) (McKay and Turner, 2005). 
As discussed in the introduction to this chapter, Purkinje cell dendrites have been 
shown to use Bergmann glial processes as a substrate to grow along when reaching 
out into the molecular layer (Lordkipanidze and Dunaevsky, 2005). This PND9 timing 
of Purkinje cell dendrite expansion fits well the expression profile of VASE in the 
Purkinje cell layer, peaking around PND7 and falling by PND10 (Figure 6.3.1). As 
VASE has been shown to inhibit NCAM-mediated neurite outgrowth (Doherty et ai., 
1992), it would seem reasonable to suggest that VASE expression by Bergmann glia 
at PND4-7could be having a negative influence on the ability of Purkinje cells (which 
appear to be NCAM-positive - see Figure 6.3.2) to extend their dendrites along the 
glial processes. At PND7-14, the decreasing VASE expression in Bergmann glia 
would then allow NCAM-mediated Purkinje cell dendritic extension to begin. In support 
of this hypothesis, the measurements of the mean height of Purkinje cell dendritic 
trees (Figure 6.3.1) showed that at PND4-7, when VASE expression in Bergmann glia 
is highest, the Purkinje cells had only very short dendrites. By PND10, when VASE is 
significantly downregulated in Bergmann glia, the mean height of Purkinje cell 
dendritic trees had more than doubled. The rapid increase in dendritic tree height then 
continues as VASE became completely absent from the Bergmann glia. This 
hypothesis could equally be applied if VASE is being expressed in the Purkinje cells 
too, as VASE expression within the cell (c/s- NCAM interactions) has been shown to 
inhibit NCAM stimulated neurite outgrowth as well (Saffell et al., 1994). Potentially this 
could be a site where the neurite outgrowth inhibitory properties of VASE could be 
experimentally observed in vivo for the first time. 
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Chapter 7 
Functional effects of NCAM-VASE on neurite 
extension and oligodendrocyte process growth 
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7.0 Functional effects of NCAM-VASE on neurite extension and 
oligodendrocyte process outgrowth 
7.1 Introduction 
The function of NCAM-VASE is not known, but the main effect currently ascribed to 
VASE is that it is inhibitory to NCAM-stimulated neurite outgrowth (Doherty et al., 1992; 
Saffell et a!., 1994). This effect has been shown in a number of ways. Firstly, by 
expressing VASE in 3T3 fibroblasts and observing that cerebellar granule neurons 
cultured on top do not undergo the enhanced outgrowth stimulated from those cultured 
on fibroblasts expressing NCAM without VASE (Doherty et al., 1992). Secondly, NCAM-
VASE transfected into PCI2 cells has been shown to inhibit NCAM-stimulated neurite 
outgrowth provided by an NCAM-expressing fibroblast monolayer (Saffell et al., 1994). 
These experiments suggest that VASE can exert its effect both in cis (within the cell) 
and trans (between cells) interactions. The NCAM-VASE transfected PCI2 cells were 
able to respond normally to N-Cadherin monolayers, indicating that VASE inhibition is 
specific for NCAM (Saffell et al., 1994). Lastly, a peptide comprised of the VASE 
sequence has also been shown to dose-dependently inhibit NCAM-stimulated neurite 
outgrowth by an NCAM-expressing monolayer (Saffell et al., 1994). The only other 
effect of VASE that has been described is that when VASE or NCAM are transfected 
into recombinant cell lines, they aggregate at the same rate, suggesting similar 
adhesive binding affinities. However, when the cells are mixed together they 
preferentially segregate into clusters of NCAM or VASE-expressing cells, suggesting 
whilst having similar binding affinities, NCAM and VASE have different specificities 
(Chen et al., 1994). 
Aims of this Chapter 
This chapter aims to further investigate the known effect of NCAM-VASE on cellular 
morphology. Firstly, it will test the effect of NCAM with or without VASE on 
oligodendrocyte morphology. This will be achieved by replicating the transfected 
monolayer neurite outgrowth experiments of Doherty etal (Doherty et al., 1992), instead 
replacing the cerebellar granule neurons with purified oligodendrocyte precursors and 
measuring process area rather than neurite outgrowth. A coated-down NCAM substrate 
is already known to induce a 2-3 times increase in oligodendrocyte process area over a 
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control substrate (Gard et al., 1996). Secondly, the effect of neurites encountering cells 
expressing either NCAM or NCAM-VASE within a monolayer of untransfected cells will 
be investigated to determine if VASE initiates a stop signal to the neurite, or if there is 
any preferential growth over NCAM or NCAM-VASE expressing cells. Lastly, the 
outgrowth promoting effects of soluble NCAM and NCAM-VASE will be investigated. 
Results 
7.2 The N24 and 140VG cell lines express similar levels of NCAM and 
NCAM-VASE 
As described in the Materials and Methods section, N24 cells are NIH3T3 cells 
transfected for human NCAM 140 which have been previously shown to induce a 
doubling in PND4 cerebellar granule cell neurite outgrowth (Doherty et al., 1990). The 
140VG cell line was created by transfecting NIH3T3 cells for human NCAM140-VASE 
similarly to Doherty etal (Doherty et al., 1992). It was established that 140VG cells 
expressed levels of NCAM-VASE comparable to the amount of NCAM expressed by 
N24 cells. This was characterised by ELISA (see Materials and Methods section) 
(Figure 7.2.1). N24 and 140VG cells also gave similar fluorescent staining intensity 
when stained for NCAM (see Figure 3.3.1, bottom panel). 
215 
1,20 1 
1.00 -I 
c 
0.80 
a 
€ 
a 
g 0.60 
I 
« 0.40 
m 
0 . 2 0 -
0.00 
• 3T3 
• N24 
H140VG 
4' 
% X, 1^' . 
Figure 7.2.1 - Expression level ELISA showing that 140VG cells express levels of NCAM-VASE 
comparable to the amount of NCAM expressed by N24 cells. Cells were plated in triplicate onto 
duplicate 96 well plates at 50,000 cells per well and cultured overnight. The next day, one plate was 
treated with MTS reagent at 37°C for 3 hours before being read at 492nm, whilst the other was fixed with 
4% paraformaldehyde before being stained for NCAM and a HRP-secondary. Antibody binding was 
visualised using the KBIue reagent and read at 650nm. Antibody binding absorbance values were then 
adjusted using the MTS absorbance to account for any variation in cell number (which only varied 
maximally by 10%). 
7.3 As well as promoting cerebellar granule cell neurite outgrowth, 
NCAM monolayers Induce enhanced oligodendrocyte process 
spreading whilst VASE monolayers do not 
Monolayer experiments were constructed by plating a high number of 3T3, N24 or 
140VG cells onto polylysine and fibronectin coated chamber slides so that the next day, 
the cells had expanded to fill the whole of the bottom of the chamber in a tight cellular 
monolayer. Cerebellar granule neurons were then isolated as described in the Materials 
and Methods chapter and plated at low density in SATO medium onto the monolayers 
and left overnight. The next day, slides were fixed with 4% PFA before being stained for 
GAP43 and analysed using the KS300 program to determine the mean length of the 
longest neurite for 200 individual neurons per monolayer. Neurons were measured 
according to the criteria stated in the Materials and Methods chapter. Monolayers for 
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oligodendrocyte experiments were constructed in an identical manner to those for the 
neurons. P4 purified cortical oligodendrocytes were isolated by immunopanning as 
described in the Materials and Methods chapter and seeded at low density onto the 
monolayers in OLP medium. The oligodendrocytes were then cultured for 2 days before 
being stained for 04 and fixed. The area covered by the oligodendrocyte processes was 
then measured using the KS3000 program for 50-100 oligodendrocytes per monolayer. 
In agreement with previously published data (Doherty et al., 1992), human 
NCAM 140 transfected 3T3 monolayers induce approximately a doubling of mean 
neurite length of cerebellar granule neurons over basal untransfected 3T3 monolayers, 
whilst human NCAM140-VASE transfected 3T3 monolayers give no significant increase 
over the mean basal length (Figure 7.3.1). Oligodendrocytes cultured on the NCAM 
expressing monolayers displayed a large increase in process area compared to those 
cultured on untransfected 3T3 monolayers (Figure 7.3.2). The increase in process area 
of oligodendrocytes on NCAM monolayers varied between experiments but was always 
at least double the area of those cultured on 3T3 monolayers, in agreement with the 
observations of Gard and coworkers on a purified NCAM substrate (Gard et al., 1996). 
Oligodendrocytes cultured on NCAM-VASE expressing monolayers showed no 
significant increase in process area over the basal area on 3T3 monolayers. The result 
of this experiment suggests that the failure of NCAM-VASE to stimulate the same 
response as NCAM (i.e promote neurite outgrowth/oligodendrocyte process growth) is 
not neuron specific and can be extended to other cell types that elongate 
processes/spread in response to NCAM. 
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Figure 7.3.1 - (a) As previously reported (Doherty et al., 1992), PND4 cerebellar granule neurons 
cultured overnight on 3T3 monolayers expressing NCAM have neurites on average double the 
length (c) of those on untransfected monolayers (b), and monolayers expressing NCAM-VASE do 
not stimulate NCAM-mediated outgrowth (d). Neurons stained for GAP43. Pooled data from five 
independent experiments, each with 200 neurites measured. Paired student's T test, ** p = <0.01 
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Figure 7.3.2 - (a) As with PND4 cerebellar granule neruons, purified PN4 cortical oligodendrocytes 
cultured for two days on 3T3 monolayers expressing NCAM show at least a doubling of process 
area (c) compared to oligodendrocytes cultured on untransfected monolayers (b), whilst those 
cultured on NCAM-VASE expressing monolayers show only basal process growth (d). Due to a 
large relative area variation between experiments, the pooled results of three independent 
experiments are expressed as a percentage of the basal process outgrowth on 3T3 monolayers. 
The areas recorded for one of the experiments is shown in (e). Between 50-100 oligodendrocytes 
were measured per experiment. Paired student's T test, * p = <0.05 
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7.4 Cerebellar granule neurons exhibit no change in behaviour upon 
encountering NCAM or NCAM-VASE expressing cells 
As NCAM-VASE expressing 3T3 monolayers do not induce NCAM-stimulated neurite 
outgrowth of cerebellar granule neurons, it was hypothesised that perhaps VASE could 
be an inhibitory stop signal for neurite extension. This possibility was explored by 
creating monolayers comprising patches of NCAM or VASE expressing cells 
surrounded by untransfected 3T3 cells. These were constructed by plating a low cell 
density mixture of 75% 3T3 cells and 25% N24 or 140VG cells which were allowed to 
grow up for 4 days. The idea was that over the 4 days, single N24 or 140VG cells divide 
to form NCAM or VASE expressing patches surrounded by control 3T3 cells. After 4 
days, a low density of cerebellar granule neurons were added to the monolayers and 
cultured overnight in an identical manner to the experiment in section 7.20. The next 
day, the cells were fixed and stained for GAP43 to visualise the neurons, and NCAM to 
visualise the NCAM and VASE expressing patches. 
The cerebellar granule neurons displayed a range of neurite lengths and 
morphologies: Some neurites appeared to have stopped when encountering an NCAM 
or VASE expressing patch, some appeared to have carried on growing straight over, 
some appeared to have turned towards a patch, some appeared to have some turned 
away, some appeared to have remained growing on a patch, and some did not grow on 
a patch at all (Figure 7.4.1). This was the case for both NCAM and NCAM-VASE 
expressing patches. There seemed to be no preference in behaviour between either 
monolayers (Figure 7.4.1). Next, the mean neurite length of neurons growing solely on 
3T3 cells in the cultures was compared with that of neurons contacting and growing 
over the patches (Figure 7.4.2). Neurons encountering an NCAM expressing N24 patch 
gave the doubling of outgrowth similar to that induced by a monolayer expressing 
exclusively NCAM (Figure 7.4.2, figure 7.3.1). Surprisingly, neurons cultured on the N24 
patch monolayer but growing on the 3T3 cells, and not in contact with any NCAM 
expressing cells, also gave an identical doubling of outgrowth. As these neurons were 
not in any physical contact with the N24 cells, it would seem that NCAM expressing N24 
cells are secreting an outgrowth signal which can be transmitted to the neurons at a 
distance. Cerebellar granule neurons cultured on the NCAM-VASE expressing 140VG 
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patch monolayers gave only basal 3T3 outgrowth, whether the neurons were 
encountering 140VG cells or not (Figure 7.4.2). 
IM24 (NCAM) Patches 140VG (VASE) Patches 
Figure 7.4.1 - Paten monolayers were constructed in which a low density of cells were plated 
consisting of 75% untransfected 3T3 cells and 25% N24 or 140VG cells. These were allowed to 
grow up for 4 days so that single cells could divide in to patches and cerebellar granule neurons 
added and cultured overnight. The cells were then fixed and stained for GAP43 (red) and NCAM 
(green). The cerebellar granule neurons displayed a range of neurite lengths and behaviours 
which did not seem to be dependent on whether they were growing over the 3T3 cells or 
NCAM/NCAM-VASE patches. 
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Figure 7.4.2 - The mean length of the longest neurite of cerebellar granule neurons was measured 
for neurons both encountering and not encountering an patch of NCAM expressing N24, or 
NCAM-VASE expressing 140VG cells within a population of untransfected 3T3 cells. This was 
compared to the basal outgrowth produced by cerebellar granule neurons cultured on a 3T3 
monolayer. Neurons encountering NCAM expressing patches showed a doubling of neurite 
length. Surprisingly, neurons cultured on the same NCAM expressing patch monolayer but not 
encountering a patch also showed a doubling effect, (pooled data from 3 independent 
experiments, each with 200 neurites measured). Paired student's Ttest, * *p = <0.01 
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7.5 N24 and 140VG cells release biologically active soluble NCAM or 
NCAM-VASE into their growth medium 
Having observed that simply the presence of NCAM expressing N24 cells in culture can 
cause a doubling in neurite length of cerebellar granule neurons, even though there is 
no physical contact between the two cell types, it was hypothesised that perhaps NCAM 
is being released from the cells into the media and can exert its effects in soluble form. 
This was investigated by culturing semi-confluent plates of 3T3, N24 and 140VG cells 
for 4 days in SATO medium, and then treating cerebellar granule neurons with the 
harvested conditioned media. Samples of the conditioned media were run on a western 
blot probed by aN16 for human NCAM (Figure 7.5.1a). N24 and 140VG conditioned 
media showed NCAM-positive bands at approximately 115kDa whilst 3T3 cells did not. 
aN16 binds to the third Ig domain of NCAM (Ackley et al., 1997), indicating that the 
soluble fragment in the conditioned media contains at least some of NCAM extracellular 
domain. The size of the soluble fragment agrees well with the approximate size of the 
entire extracellular domain of NCAM which has been observed to be shed from NCAM 
transfected L fibroblasts in a metalloprotease-dependent manner (Hinkle et al., 2006). 
The conditioned media were taken and added to cerebellar granule neurons 
plated onto poly-l-lysine coated coverslips at a dilution of 1:2 made up in fresh SATO 
media. The neurons were cultured for 2 days before being fixed and stained for GAP43, 
as few neurites were observed after 1 day in culture with any of the conditioned media. 
The mean neurite length was then calculated (Figure 7.5.1b). Unlike the monolayer 
experiments where NCAM monolayers induced a doubling in neurite length (Figure 
7.3.1), NCAM conditioned medium induced a statistically significant, but only 38% 
increase over the basal outgrowth induced by 3T3 conditioned medium (Figure 7.5.1b). 
This was due to the large basal increase in outgrowth induced by 3T3 conditioned 
medium (see later - Figure 7.5.2b), presumably caused by the accumulation of 
endogenous growth factors secreted by the 3T3 cells into the medium (Rajah et al., 
2001) having a near maximal effect on outgrowth. The NCAM-VASE conditioned 
medium, although containing approximately the same amount of soluble NCAM as the 
NCAM conditioned medium (although including the VASE exon), did not give any 
increase in neurite outgrowth over the basal 3T3 level (Figure 7.5.1b). 
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Figure 7.5.1 - (a) Semi-confluent plates of 3T3, N24 and 140VG cells in SATO medium were 
cultured for 4 days before harvesting the media. The conditioned media was run on a western blot 
and probed with aN16 for human NCAM. A band of about 115kDa was observed in the N24 and 140\/G 
conditioned medium, but none in the 3T3 conditioned medium, (b) Cerebellar granule neurons cultured 
on poly-l-lysine were treated with a 1:2 dilution of the conditioned media made up in fresh SATO. 
The neurons were cultured for 2 days before being fixed and stained for GAP43. Neurite outgrowth 
analysis was performed and it was observed that NCAM conditioned medium induced about a 38% 
increase in mean neurite length whereas NCAM-VASE conditioned medium gave only basal outgrowth. 
Pooled results of 3 independent experiments each measuring 200 neurites, expressed as a % of the 
outgrowth given by 3T3 conditionecj media for each experiment. Paired student's T test, * p = <0.05 
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The 3T3, N24 and 140VG conditioned media was then used to probe neurite 
outgrowth on the cellular monolayers. 3T3, N24 and 140VG monolayers were prepared 
as described before and cerebellar granule neurons plated at low density onto them. 
The neurons and monolayers were then cultured overnight in a 1:2 dilution of each of 
the conditioned media, before being fixed and stained for GAP43 and then neurite 
outgrowth analysed. 
Similarly to neurons cultured on poly-l-lysine and treated with NCAM conditioned 
medium (Figure 7.4.1b), those cultured on 3T3 monolayers and treated with NCAM 
conditioned medium showed an increase in mean neurite length of about 35% whilst 
those on VASE conditioned medium showed only a basal amount of outgrowth (Figure 
7.5.2). Neurons cultured on NCAM expressing N24 monolayers showed an increase in 
neurite outgrowth when supplemented with 3T3 conditioned medium due to the 
outgrowth promoting effect of the monolayer. Adding NCAM conditioned medium to 
neurons cultured on N24 monolayers did not give any extra increase in neurite length 
above the outgrowth stimulated by the underlying N24 monolayer, suggesting that the 
monolayer is already inducing maximal NCAM-stimulated outgrowth (Figure 7.5.2). 
Treating neurons on N24 monolayers with NCAM-VASE conditioned media was 
sufficient to interfere with the outgrowth promoting effects of the N24 monolayer, 
reducing neurite outgrowth back down to the basal 3T3 monolayer/3T3 conditioned 
media level. This situation may be similar to the inhibition of NCAM stimulated neurite 
outgrowth of PCI2 cells cultured on an NCAM cellular monolayer by a peptide 
corresponding to the VASE sequence (Saffell et al., 1994). Neurons cultured on 140VG 
monolayers and treated with either 3T3 or NCAM-VASE conditioned media showed only 
basal neurite outgrowth. However, treatment of neurons cultured on 140VG monolayers 
in the presence of NCAM conditioned media was sufficient to overcome the inhibitory 
effect of the VASE monolayer and neurite outgrowth of about 30% was induced over the 
basal level (Figure 7.5.2). The results of this experiment would appear to show that 
there is competition between NCAM and NCAM-VASE for the stimulation/inhibition of 
neurite outgrowth. Whichever isoform that was present in the conditioned media was 
able to overcome the effect of the other presented in the monolayer. 
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Figure 7.5.2 - (a) Semi-confluent plates of 3T3, N24 and 140VG cells were cultured in SATO 
medium for 4 days before the media was harvested and added at a dilution of 1:2 in fresh SATO to 
cellular monolayers with cerebellar granule neurons plated on top. These were cultured overnight 
before fixing, staining for GAP43 and neurite outgrowth was analysed. On 3T3 monolayers, NCAM 
conditioned media gave about a 35% increase in neurite outgrowth over 3T3 conditioned media. NCAM-
VASE conditioned media only gave basal outgrowth. N24 monolayers stimulated an increase in 
outgrowth with 3T3 conditioned medium but did not give any extra increase in the presence of NCAM 
conditioned media. NCAM-VASE conditioned media on N24 monolayers inhibited outgrowth back down 
to basal levels. Neurite outgrowth on 140VG monolayers with 3T3 and NCAM-VASE conditioned media 
was at basal levels, whilst NCAM conditioned media could overcome the 140VG monolayer to stimulate 
an increase in outgrowth of about 30%. Pooled results of 3 independent experiments each measuring 200 
neurites, expressed as a % of the outgrowth given by 3T3 conditioned media on a 3T3 monolayer for 
each experiment. Unpaired student's T test, * p = <0.05; ** p = <0.01 (b) Example of one of the individual 
experiments highlighting the enhanced basal outgrowth of the conditioned medium on the different 
monolayers. 
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7.6 Discussion 
The data presented in this chapter shows for the first time that NCAM-VASE presented 
within a cellular monolayer cannot induce NCAM-stimulated oligodendrocyte process 
outgrowth (Figure 7.3.2). Recently it has been proposed that postmigratory 
oligodendrocyte processes are analogous to the neurites of postmigratory neurons, 
complete with growth cone-like structures (Fox et al., 2006). Oligodendrocyte "growth 
cones" express regulators of cytoskeletal activity and possess the ability to sense and 
avoid nonpermissive substrates, although the precise growth cues appear to be 
different to neurons (Fox et al., 2006). It would seem possible therefore that if NCAM 
can induce process outgrowth in oligodendrocytes similarly to in neurons, then NCAM-
VASE similarly would not induce outgrowth. It is interesting to note that in Chapter 4, the 
cerebellar oligodendrocytes in LT culture appeared to be extending processes out and 
along VASE-positive neurites without any noticeable hindrance (Figure 4.4.4). The most 
likely explanation for this would be that under these culture conditions some factor other 
than NCAM is promoting oligodendrocyte process outgrowth. The significance of the 
oligodendrocyte response to VASE in the monolayer experiments is not entirely clear. 
Previous chapters have shown that VASE is upregulated in oligodendrocytes as they 
adopt a myelinating phenotype (See chapters 4 + 6). Although not stained for myelin 
proteins, the oligodendrocytes on VASE monolayers did not visually appear to be 
undergoing myelination (membrane flattenings) which potentially could have stalled the 
growth of their processes (however further differentiated mature myelinating 
oligodendrocytes would not be expressing 04 so would not have been visible (Levine et 
al., 2001)). VASE expression by the oligodendrocytes on the monolayers was not 
investigated. It appeared that VASE monolayers simply did not induce the process 
outgrowth that NCAM monolayers stimulated. This suggests that what is being 
observed is a more fundamental inhibitory effect of VASE which could possibly be 
applied to all cell types which are sensitive to NCAM-stimulated outgrowth (or possibly 
NCAM-stimulated signalling). 
It is very surprising to find that maximal neurite outgrowth stimulation by NCAM 
only requires 25% of the monolayer (perhaps even less) to be expressing NCAM, and 
that soluble NCAM released from those few cells is sufficient to induce neurite 
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outgrowth in neurons not in contact with the NCAM expressing cells comparable to 
those which are in contact (Figure 7.4.2). It has already been established that NCAM 
can be released from the cell surface and that it plays a role in NCAM-stimulated neurite 
outgrowth, although some have proposed a positive role (Hubschmann et al., 2005; 
Kalus et al., 2006) and others a negative role (Hinkle et al., 2006). The data presented 
in this chapter supports the view that soluble released NCAM is a positive inducer of 
neurite outgrowth. 
Building upon this finding, adding NCAM conditioned media to neurons growing 
on an NCAM-VASE expressing monolayer was found to be able to overcome the 
outgrowth inhibitory effect of the monolayer (Figure 7.5.2). Similarly, NCAM-VASE 
conditioned media was able to overcome the outgrowth promoting effects of an NCAM 
monolayer. This suggests that in vivo, there could be competition between NCAM and 
NCAM-VASE levels for the promotion or inhibition of neurite outgrowth or 
oligodendrocyte process growth. Alternatively, the soluble NCAM in the conditioned 
medium could be preferentially binding to the cerebellar granule neuron NCAM (which 
would be predominantly non-VASE at this age and so presumably favour a non-VASE 
NCAM interaction) and so displace the VASE interactions of the underlying monolayer. 
This would "free" the neuron from the inhibitory effects of the VASE monolayer. Soluble 
VASE would not be able to preferentially bind to the mostly non-VASE NCAM-
containing cerebellar granule neurons and so would require another mechanism to 
inhibit NCAM-stimulated neurite outgrowth. This could be provided by VASE binding to 
the FGFR binding site in NCAM FNIII-1 and blocking a neurite outgrowth promoting 
interaction between the two (in a similar situation to the proposed action of a VASE 
peptide (Saffell et al., 1994)).This is particularly relevant in light of the findings of Vawter 
etal, that elevated levels of soluble VASE have been correlated with neuropsychiatric 
disorders such as schizophrenia (Vawter, 2000; Vawter et al., 2000; Vawter et al., 
1998). A feature of schizophrenia is the reduction of neurogenesis, with several genes 
associated with schizophrenia found to negatively affect adult neurogenesis (Reif et al., 
2007). As discussed in chapter 5, perhaps VASE could also play a role in this process. 
Another study has found elevated levels of VASE in the dorsal hippocampus of 
senescence accelerated mice (Alzheimer's model) that have impaired in spatial memory 
(Arai et al., 2004). Again, VASE possibly could be having an inhibitory role in 
neurogenesis or synaptic plasticity. If the VASE sequence exerts its effects by binding 
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to the FGFR1 activation sequence in NCAM-FNIII-1 thus preventing NCAM stimulated 
FGFR1 neurite outgrowth signalling, perhaps it is the balance of NCAM without VASE, 
to NCAM with VASE which dictates whether NCAM contributes favourably or adversely 
to these conditions. If this turned out to be the case, it might be advantageous to these 
disorders to increase the ratio of NCAM without VASE to NCAM with VASE in the CNS, 
possibly by introducing recombinant NCAM without VASE therapeutically. This is 
indirectly supported by the results of by Bock and coworkers who found that the FGL 
peptide (derived from a sequence in NCAM FNIII2 which can activate FGFR signalling) 
can improve spatial learning and memory in normal rats (Cambon et al., 2004) and 
reduce the cognitive impairment and pathology of a rat Alzheimer's model (Klementiev 
et a!., 2007), and also the observation that the FRM peptide (derived from a sequence 
in NCAM FNIII1 which can activate FGFR signalling (Anderson et al., 2005)) similarly 
enhances spatial memory in rats (Seymour, Regan and Saffell, unpublished 
observation). An alternative approach to take could be to reduce the amount of NCAM-
VASE in the CNS. This could be achieved perhaps by masking the VASE epitope on 
NCAM-VASE in the brain with a VASE antibody. This approach might not be possible 
as suggested by the inability of the VASE antibody to bind live to 3T3 cells transfected 
for NCAM-VASE at 37°C (see Figure 3.5.1). Alternatively, if the failure of the VASE Ab 
to bind live is indicative of the removal NCAM-VASE from the surface of the cell (by 
inducing endocytosis or proteolysis) then this approach to reduce VASE on the cell 
could work well, although it is not yet know what side-effects may be caused by 
reducing the amount of VASE in the CNS. 
The finding that transfected 3T3 cells release soluble NCAM and NCAM-VASE 
also has important implications for the study of NCAM action. NCAM binding leading to 
neurite outgrowth has been described in terms of cis (on the cell) and trans (between 
cells) interactions. In practical terms, it has been shown that NCAM-VASE does not 
stimulate neurite outgrowth when presented in a monolayer (trans) (Doherty et al., 
1992) and interferes with NCAM-stimulated neurite outgrowth when transfected into 
PC12 cells {cis) (Saffell et al., 1994). This chapter shows that NCAM and NCAM-VASE 
expressed by the 3T3 monolayer can be released into the growth medium (although 
some must remain otherwise the cells would not stain for NCAM - see figure 7.4.1) and 
that the released NCAM and NCAM-VASE can have exactly the same effects as their 
respective monolayers (Figure 7.5.2). This somewhat blurs the boundary between cis 
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and trans NCAM interactions as soluble NCAM could bind in either mode to NCAM or 
other effector proteins at the neuron cell surface. Therefore it is unclear whether VASE 
can exert its inhibitory effects both in trans and cis. If the action of VASE is to bind to the 
FRM sequence in NCAM FNIII-1 and so block NCAM-FGFR interactions and signalling, 
this would greatly be helped by VASE being a soluble protein rather than fixed to the 
membrane and having to bend to bring the two domains into contact. 
The findings of this chapter have given new clues and raised new questions as to 
the mechanism of action of NCAM-VASE. 
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Chapter 8 
General Discussion 
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8.0 General Discussion 
The insertion of 10aa comprising the VASE exon into the fourth Ig domain of NCAM is 
sufficient to convert NCAM from a neurite outgrowth promoting molecule to an 
outgrowth inhibitory molecule (Doherty et al., 1992). The functional significance of 
VASE is unknown, but its importance is inferred by its complete conservation in 
mammals and birds, and partial conservation in fish and amphibians. Coupled to its 
inhibitory role in NCAM stimulated neurite outgrowth, VASE mRNA has been found be 
developmentally upregulated in the CNS but is virtually excluded from areas of the brain 
which remain plastic, such as the olfactory bulb, and areas with regenerative capacity, 
such as the PNS (Small and Akeson, 1990). Taken together, it has been proposed that 
VASE could be involved in the developmental loss of plasticity in the CNS and its 
persistence in adulthood (Doherty et al., 1992; Saffell et al., 1994; Small and Akeson, 
1990), but the mechanism for this is not known. 
This project has aimed to shed light on the function of VASE by, for the first time, 
localising NCAM-VASE protein expression both spatially and temporally in the rat 
nervous system and muscle. The approach taken was to purify a VASE isoform-specific 
antibody, for use in identifying which cells express NCAM-VASE protein both in culture 
and tissue sections, and sub-cellular distribution. In addition, the effect of NCAM and 
NCAM-VASE presented to neurons and oligodendrocytes in a cellular context was 
investigated. 
8.1 Why study NCAWI-VASE? 
Although NCAM KO mice are viable, it would appear that NCAM is involved in fine-
tuning developmental processes in the nervous system (Cremer et al., 1994) and 
muscle (Peck and Walsh, 1993), plays a role in the revisitation of these processes 
during regeneration (Franz et al., 2005), and is involved in learning and memory 
(Bonfanti, 2006; Muller et al., 2000; Stoenica et al., 2006). NCAM is extensively 
alternatively spliced and can be postranslationally modified, with NCAM isoforms being 
differently expressed in different cell types and at different points during development 
(Bonfanti, 2006; Reyes et al., 1993). Functions have been described or proposed for 
some NCAM isoforms. For example, the 180kDa isoform of NCAM has been localised 
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to the synapse and is thought to play role in synapse formation and stabilisation (Sytnyk 
et al., 2004), and the PSA modification of NCAM has been found to be essential for long 
term potentiation (LTP), promotion of the survival of neural progenitors (Bonfanti, 2006; 
Vutskits et al., 2006) and inhibition of myelination (Charles et al., 2000; Fewou et al., 
2007). 
Up until this report, little has been known about VASE, except that it is inhibitory 
to NCAM-stimulated neurite outgrowth (Doherty et al., 1992), and that its mRNA is 
developmentally upregulated but excluded from areas of synaptic plasticity (Small and 
Akeson, 1990). Having established that NCAM is involved in processes as important as 
neurogenesis and neurite outgrowth, it would seem logical to characterise further an 
isoform of NCAM which would appear to inversely or negatively correlate with these 
processes, especially as there are many neurological conditions in which neurogenesis, 
synaptic connectivity, or memory formation are perturbed, such as schizophrenia (Pillai-
Nair et al., 2005) and Alzheimer's disease (Klementiev et al., 2007). 
8.2 Major findings of this study 
VASE is highly expressed by oligodendrocytes in correlation with myelination 
One of the most surprising findings of this study is that the major site of VASE 
expression in the adult rat brain and cerebellum appears to be myelin (Figure 6.2.1 + 
6.25). VASE expression by oligodendrocytes has never before been properly 
characterised, with most of the focus of VASE research being directed towards neurons 
(Doherty et al., 1992; Saffell et al., 1994). This study has shown that: 
1. VASE is highly expressed in adult rat brain myelin 
2. During rat postnatal cerebellar development, VASE expression mirrors that of the 
myelin marker MOG 
3. Cultured purified cortical oligodendrocyte VASE upregulation is coincident with 
MOG expression and differentiation into a mature myelinating phenotype 
4. Cultured purified cortical oligodendrocytes do not elaborate processes on a 
VASE expressing cellular monolayer 
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The fact that VASE expression correlates with myelination and persists in adult brain 
and cerebellum myelin suggests perhaps a role for VASE in myelin formation and 
maintenance. PSA has been shown to have the opposite effect, being expressed on 
both the developing axon and oligodendrocyte, but must be downregulated for efficient 
myelination to occur. If it is aberrantly expressed in adult myelin, PSA causes abnormal 
myelin formation and axonal degeneration (Charles et al., 2000; Fewou et al., 2007). 
Two hypotheses for the negative effect of PSA on myelination have been proposed 
(Charles et al., 2000; Fewou et al., 2007). Firstly, it has been suggested that PSA acts 
as a modulator of oligodendrocyte signalling pathways involved in myelination, 
evidenced by the fact that removal of PSA has been observed to affect other signalling 
pathways, such as the migration of oligodendrocyte precursors towards sources of 
PDGF (Zhang et al., 2004), and in neurons, affects BDNF signalling (Vutskits et al., 
2001). Secondly, PSA could be exerting its effect purely through stearic hindrance and 
electrochemical repulsion of axon and oligodendrocyte membranes, possibly preventing 
cell adhesion molecules involved in myelination, such as myelin-associated glycoprotein 
(MAG) (Card et al., 1996) and integrin a6(31 (Olsen and Ffrench-Constant, 2005) from 
being able to interact with their binding partners. This could interfere with myelination 
both by reducing oligodendrocyte-axon interactions - preventing initial stages of 
myelination, or reduce oligodendrocyte-oligodendrocyte interactions -
interfering with axon ensheathing. 
What could VASE be doing in the myelin? If VASE function in myelin is opposite 
to PSA, then perhaps it acts in an opposite manner. This too could involve either 
affecting NCAM signalling pathways involved in myelination/myelin maintenance, or 
modulating NCAM-mediated cell-cell interactions, for example by increasing cell-cell 
adhesion. An NCAM-VASE expressing monolayer has been shown to be not able to 
promote NCAM-stimulated neurite outgrowth and a VASE sequence peptide actually 
inhibits NCAM-stimulated neurite outgrowth (Saffell et al., 1994; Walsh et al., 1992). 
One possibility is that the VASE sequence prevents the FGFR-binding site on NCAM 
from interacting with its target site on the FGFR (Saffell et al., 1994). FGFR signalling in 
oligodendrocytes in response to FGF-2 has been shown to cause dedifferentiation of 
oligodendrocytes, leading to loss of myelin (Fortin et al., 2005). Perhaps if NCAM 
(without VASE) was expressed in myelin, this FGFR signalling pathway would be active 
and cause degeneration of myelin. Expression of the VASE isoform would allow NCAM 
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to be present (and provide an adhesive role or interact with heterophilic partners), whilst 
not causing deleterious signalling. This is purely speculative, as there is no evidence to 
suggest that NCAM-mediated FGFR activation causes oligodendrocytes to 
dedifferentiate like FGF-2, and indeed, NCAM appears to stimulate enhanced 
oligodendrocyte process outgrowth, which could be a sign of enhanced differentiation 
(Figure 7.3.2). 
If VASE has the opposite physiological role to PSA, it may be that VASE is a 
promoter of myelination and is involved in its ongoing maintenance. Whilst this study 
correlates VASE expression with myelination, it does not provide evidence to show that 
VASE could be a trigger, or promoter of myelination. Indeed, a VASE expressing 
monolayer has been shown to not induce an increase in oligodendrocyte differentiation 
(process area spreading) whereas an NCAM (without VASE monolayer) did (Figure 
7.3.2). This however does not rule out a role for VASE in the later stages of 
oligodendrocyte differentiation and myelination, as this was not investigated. Also, this 
experiment investigates VASE presented to the oligodendrocyte and does not take 
account of the possible effect of VASE expressed by the oligodendrocyte. 
As alternatively proposed, PSA could be inhibitory to myelin 
formation/maintenance due to its anti-adhesive properties (Fewou et al., 2007), 
therefore perhaps VASE is permissive to myelin formation/maintenance due to its 
adhesive properties. However, it is currently not directly known if VASE increases 
NCAM-mediated adhesion. What is known is that VASE conveys increased specificity of 
binding, with cells expressing VASE preferring to bind to other NCAM-VASE expressing 
cells rather than NCAM without VASE cells (Chen et al., 1994). Oligodendrocytes form 
myelin sheaths by wrapping their membrane around axons in concentric rings up to a 
hundred times (Arroyo and Scherer, 2000). As observed in the developmental 
cerebellum tissue sections, VASE did not seem to be visibly present on axons, but 
intensely stained myelinating oligodendrocytes (Figure 6.4.1). Perhaps VASE 
expressed by oligodendrocytes could help in the axon ensheathing process by 
promoting preferential association of VASE-positive oligodendrocyte membranes rather 
than their association with VASE-negative membranes of surrounding cells. Myelin 
basic protein (MBP) is thought to play a similar role, bringing oligodendrocyte 
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membranes into tight association, and is absolutely essential for the formation of intact 
myelin (Fitzner et al., 2006). 
In adult myelin, perhaps VASE has a stabilising role. Its localisation throughout 
the compact myelin of the CNS would suggest layers of myelin membrane presenting 
VASE to each other in an arrangement favourable to NCAM-VASE hemophilic 
adhesion. As discussed in previous chapters, if NCAM-VASE homophilic binding is 
stronger, this could facilitate formation of cell-cell junctions such as tight and gap 
juctions. In the PNS, Schwann cells form "reflexive" gap junctions between the layers of 
compact myelin, providing a substantially shorter route for nutrients and signalling 
molecules to travel between the outer and inner myelin (Scherer et al., 1995), however, 
VASE was not found to localise to PNS compact myelin (Figure 5.5.6 + 5.5.8). Although 
essential for proper CNS myelin formation (Menichella et al., 2003), connexins are only 
sparsely distributed in the compact myelin (where VASE is located) (Li et al., 1997; Li et 
al., 2004) and oligodendrocyte "reflexive" gap junctional coupling, whilst theoretically 
possible has not been yet definitively observed (Menichella et al., 2003). Taken 
together, both in the CNS and PNS, it would not seem likely that VASE has the 
appropriate localisation to enhance gap junction formation. Another junctional type 
found in myelin is the tight junction, found in CNS compact myelin and concentrated in 
myelin radial components (Debruin and Harauz, 2007). Tight junctions are adhesive 
structures containing occludin and the claudin family proteins, which act to restrict both 
the paracellular transport of solutes and the lateral diffusion of proteins within the 
membrane (Bronstein et al., 2000). Perhaps VASE contributes to the general adhesion 
of compact myelin and aids formation and association of tight junctions. 
Compared to the CNS, VASE expression in the PNS was very restricted, forming 
punctate patches around the compact myelin (Figure 5.5.8). Whilst functionally similar, 
CNS and PNS myelin is produced by different cells and contains both common and 
different proteins. In the CNS, oligodendrocytes myelinate multiple axons, whilst in the 
PNS, Schwann cells myelinate only one axon (Arroyo and Scherer, 2000). The protein 
MBP is common to both CNS and PNS myelin, whilst the functionally similar PLP and 
PO predominate in the CNS and PNS respectively (Quarles, 2005). It is therefore 
conceivable that VASE could play a role in CNS myelin maintenance, whilst being less 
significant in PNS myelin. Also, VASE could be contributing to the neurite outgrowth 
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inhibitory effects of CNS myelin, whilst its low abundance in PNS myelin could help 
facilitate PNS myelin neurite outgrowth permissive properties (see later). 
VASE monolayer neurite outgrowth experiments show that VASE is inhibitory to 
NCAM-stimulated neurite outgrowth (Figure 7.3.1; (Doherty et al., 1992; Saffell et al., 
1994)). CNS myelin is known to contain other molecules found to be inhibitory to axonal 
growth, thought to be important mediators in the failure of axonal regeneration in the 
CNS. The three major proteins involved are: oligodendrocyte-myelin glycoprotein 
(OMgp - not to be confused with myelin oligodendrocyte glycoprotein (MOG)), nogo, 
and myelin-associated glycoprotein (MAG) (Vourc'h et al., 2003). It is thought that these 
inhibitory cues act to stabilise the nervous system, preventing aberrant axonal sprouting 
and so protecting and maintaining the complex and ordered neural pathways necessary 
for brain function (Yiu and He, 2006). It is possible that NCAM-VASE could also 
therefore contribute to the axon inhibitory properties of myelin. 
VASE is highly expressed in ependymal cells 
Another novel finding of this study is that ependymal cells strongly express VASE, 
except those of the lateral ventricle, which are NCAM-negative (Figure 5.6.1 + 5.6.2). 
Ependymal cells are ciliated cells lining brain ventricles which aid the flow of CSF 
through the ventricles by beating their cilia, and which possibly also have stem cell-like 
properties (Introduction section 1.40 and Chapter 5 discussion). Regulated and 
controlled cilia beating has been shown to be vital in maintaining a normal brain, with 
mutations in cilia proteins causing hydrocephalus (abnormally high volumes of ventricle 
fluid, resulting in fluid compression of brain tissue) (Banizs et al., 2005). The frequency 
of cilia beating increases in response to an elevation in intracellular Ca^ "" ion 
concentration and decreases in response to an elevation in cAMP (Nguyen et al., 2001). 
Ependymal cells are extensively coupled to one another by gap junctions (Bouille et al., 
1991), and so second messengers regulating cilia beating would be free to pass 
between cells through the junctions, thus enabling organised and coordinated beating. 
As discussed in Chapter 5, perhaps VASE increases cell-cell adhesion, facilitating gap 
and tight junction formation between ependymal cells which, as well as serving a 
mechanical purpose to anchor the cells together, could also enhance communication 
between neighbouring cells. 
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Interestingly, PSA has been found by a number of reports to localise to 
ependymal cells in the adult brain (Bonfanti et al., 1992; Oumesmar et al., 1995; Seki 
and Arai, 1993). This raises the possibility of NCAM-VASE actually being able to be 
polysialylated in vivo, confirming in vitro recombinant studies (Oka et al., 1995). The 
significance of this is unclear, but perhaps the balance of PSA and VASE within 
ependymal cells acts to regulate the normal functioning of the ependymal cell layer. 
The function of VASE in ependymal cells is given an extra layer of complexity by 
the fact that it is absent from ependymal cells of the lateral ventricle. In Chapter 5, it is 
proposed that it could be desirable for the lateral ventricle ependymal cells not to 
express VASE, as reduced cell-cell adhesion could facilitate the migration of neural 
precursor cells from the SVZ onto the surface of the ventricular ependymal wall. The 
difficulty with this hypothesis is that to presumably be of any use, the neural precursors 
must then migrate back out of the ventricle when they reach their destination, which 
would mean migrating through VASE-positive ependymal cells. Alternatively, VASE 
presented to the neural precursors by the ependymal cells could act to prevent neurite 
outgrowth, and so maintain the precursor in an immature state until it finishes its 
migration and begins to integrate into the surrounding tissue. 
VASE is highly expressed in the heart 
This study has shown that VASE protein is highly expressed in cardiac muscle, whilst is 
absent from skeletal muscle (Figure 5.7.1). VASE transcripts are present at El 5 in rat 
heart, well before it is upregulated in the brain (Small and Akeson, 1990). Adhesion 
proteins are of critical importance to the normal functioning of the heart (Saffitz, 2006). 
N-Cadherin has been found to be particularly important, as in mice its selective deletion 
from the heart leads to aberrant intercalated disc structure, cardiomyopathy, impaired 
cardiac function, and death within 2 months (Li et al., 2006). Death is caused by heart 
failure due to the N-Caherin-dependent loss of gap junctions from intercalated sdiscs 
between cardiomyocytes causing a slowing and erratic electrical conduction between 
cells (Li et al., 2006). 
The role of VASE in cardiac tissue has never been explored. NCAM hemophilic 
binding blocking antibodies have been found to slightly reduce gap junction 
communication between embryonic cardiomyocytes, and endoN removal of PSA found 
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to increase communication, leading to the suggestion that NCAM plays a small role in 
gap junction coupling in the heart (Watanabe, 1998). As proposed for other areas, if 
PSA reduces gap junctional coupling, then VASE may enhance it. There have not been 
any published reports of tight junctions in the heart, and so VASE cannot be contributing 
to their formation or maintenance. After ischemic insult to the heart, cardiomyocytes in, 
and around the areas of damage greatly upregulate their expression of NCAM 
(Gattenlohner et al., 2003). It is not commented upon whether the upregulation is NCAM 
with or without VASE, but it would make sense that damaged areas would require 
stronger cell-cell adhesion to maintain structural integrity. 
VASE is excluded from sites of plasticity 
This study has shown that VASE protein is absent or very low from NCAM-expressing 
cells at areas of plasticity such as the dentate gyrus, SVZ and olfactory bulb (Figure 
5.6.2). There could be two possible explanations for this. The simplest being that VASE 
could just not be expressed at high levels in neurons, and so is naturally not present in 
areas of synaptic plasticity. Staining of the adult brain would seem to show that VASE is 
only expressed at very low levels in neurons (although neurons in culture did upregulate 
VASE expression), and certainly does not seem to be expressed in all neurons. The 
second possibility is that VASE is inhibitory to plasticity and is therefore kept to a 
minimum in plastic areas. In support of this, it was also found that VASE is transiently 
expressed in the Purkinje cell layer of the cerebellum and is downregulated coinciding 
with the commencement of Purkinje cell dendritic arborisation, suggesting that VASE 
could be a negative modulator of dendritic outgrowth (Figure 6.3.1, 6.3.2 + 6.3.4). 
Contrastingly to VASE, PSA remains high in areas of plasticity (Hildebrandt et al., 
1998), and has been found to promote plasticity (Becker et al., 1996; Ono et al., 1994), 
suggesting again, perhaps an opposing role for VASE. PSA is thought to promote 
plasticity, at least in part, through a reduction of cell-cell adhesion (Bonfanti, 2006), and 
so VASE could be inhibitory to plasticity possibly by increasing cell-cell adhesion. 
Plasticity in the brain relies on the ability of neurons to reorganise their connections or 
generate new neurons to make new connections (Abrous et al., 2005; Bonfanti, 2006; 
Ming and Song, 2005; Sohur et al., 2006). Reorganisation implies cellular movement or 
rearrangement, and an increase in cell-cell adhesion would presumably hinder this. 
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VASE is expressed by reactive astrocytes 
Interestingly, VASE was found to be expressed in reactive astrocytes (Figure 4.5.3). As 
discussed in Chapter 5, astrocytes form an interconnected syncytium throughout the 
CMS, sharing metabolites and second messengers through gap junctions (Theriault et 
al., 1997). This coupling is transiently broken and rearranged after injury to contain toxic 
factors at the lesion site and prevent their spreading throughout the CNS (Ochalski et 
al., 1995). Perhaps the upregulation of VASE by reactive astrocytes is involved in the 
gap junction remodelling process after injury. Increased VASE expression could 
promote preferential adhesion of reactive astrocytes to one another, thus connecting 
astrocytes at the lesion site together but facilitating its isolation from the global astrocyte 
syncytium. As well as CNS myelin, reactive astrocytes are also inhibitory to neuronal 
plasticity and regeneration (Yiu and He, 2006). Perhaps VASE expression by reactive 
astrocytes contributes to their inhibitory effect, and that this could be a side-effect of the 
physiological role of VASE in reactive astrocytes. 
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Speculation Evidence for Evidence against 
VASE is involved in myelin 
formation/maintenance 
Upregulated with 
myelin marker in CNS 
oligodendrocytes 
Highly expressed in 
adult CNS compact 
myelin 
VASE presented by a 
monolayer does not 
induce process 
elaboration 
(differentiation) in 
oligodendrocytes 
Low expression in 
spinal cord and PNS 
myelin 
VASE is involved in gap or 
tight junction 
formation/maintenance 
VASE is highly 
expressed in heart -
where NCAM has been 
shown to affect gap 
junctional 
communication 
Both VASE and 
connexins are absent 
from adult skeletal 
muscle 
VASE upregulated in 
reactive astrocytes -
gap junction 
remodelling critical in 
reactive response to 
injury 
VASE highly expressed 
by ependymal cells 
which are motile and 
require adhesive 
junctions for mechnical 
stability 
VASE myelin 
expression does not 
mirror gap junction 
myelin expression -
plays role in tight 
junctions only here? 
Does not appear to be 
localised only to sites of 
cell-cell contact 
VASE has an anti-plasticity 
role 
Inhibits NCAM-
stimulated neurite 
outgrowth 
Excluded from sites of 
adult neurogenesis and 
plasticity 
Highly expressed by 
CNS myelin and 
reactive astrocytes -
both which are known 
inhibitors of neuronal 
regeneration 
Could be absent from 
sites of adult 
neurogenesis simply 
because VASE might 
not be expressed by 
neurons. 
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8.3 Summary of hypotheses of VASE function 
VASE 
A S W T R P E K Q E 
Hypothesis 
Speculated 
Modes of action 
Problems 
1. Exer ts ef fects on 
s ignal l ing pa thways? 
2. Exerts effects by 
adhes ion? 
Homology to FGFR CHD 
- inhibits NCAM-FGFR 
signalling through 
competitive binding? 
Sequence highly 
consen/ed so must 
be important "\^ 
/ 
Uncouples NCAM signalling 
properties from NCAM 
adhesion/heterophilic binding 
properties 
Functional Consequences 
Experimental evidence sugests 
that NCAM does not activate 
all FGFR signalling pathways, so this 
could perhaps only apply to neurits 
outgrowth-type signalling 
Promotes preferential 
binding to other 
NCAM-VASE molecules 
VASE mediates 
binding to another 
protein? 
Promotes cell-cell adhesion, 
stabilising contact and 
promoting junctional 
formation 
Increases NCAM 
homophilic binding 
strength 
No experimental evidence 
to show VASE increases 
adhesion 
Myelin formation/ 
maintenence? 
Inhibition of 
neurite outgrowth/ 
(regeneration?) 
Gap + tight junction 
formation/maintenance? 
Throughout this report, two hypotheses have predominated based on the cell type 
expression of VASE and its distribution: 1. That VASE could be exerting its effects 
through altering cellular signalling; 2. That VASE could be exerting its effects through 
enhancing cell-cell adhesion. Whilst this report does not definitively confirm either, it 
does provide direction for further experiments to test these hypotheses. 
8.4 Further Work 
Is VASE required for myelination? 
Although NCAM KO mice have not been reported to have defects in myelination, it 
would be interesting to test whether blocking the VASE sequence could delay or perturb 
myelination in a similar way to prolonging PSA addition (Fewou et al., 2007). This could 
perhaps be achieved in vitro by culturing purified oligodendrocytes in the presence and 
absence of aVASE (if it can bind live) and probing their expression of myelin markers 
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over time by cell staining and western blotting. Neuron-oligodendrocyte coculture 
assays could also be explored to observe more physiologically accurate myelination of 
axons 
What is the localisation of VASE by EM? 
It would be particularly interesting to look at the distribution of VASE in both CNS and 
PNS myelin at the EM level. In the CNS, this could answer the question as to whether 
VASE is expressed solely in the compact myelin, or if it is expressed by the axon as 
well. In the PNS, EM investigations could shed light onto the nature of the punctate 
VASE expression surrounding the compact myelin. 
Does VASE bind heterophilically to some other protein? 
In a similar approach to affinity purifying aVASE, NCAM-VASE-Fc and NCAM-Fc 
coupled columns could be produced. Cell homogenates of adult brain or perhaps heart 
muscle could be passed through the NCAM-Fc column to adsorb proteins which bind to 
NCAM. The NCAM binding partner-depleted homogenates could then be passed 
through the NCAM-VASE-Fc column to collect VASE-specific binding partners which 
could then be eluted and identified by mass spectrometry or western blotting. 
Alternatively, recombinant a IglV+VASE domain could be constructed and put to a 
similar purpose. 
What is the expression pattern of non-VASE NCAM isoforms? 
This study has relied on comparing VASE antibody staining to that of an NCAM 
antibody which recognises both VASE and non-VASE isoforms. This has prevented the 
observation of whether cell express solely NCAM or NCAM-VASE, or whether they 
express a mixture. For example, both myelin and ependymal cells highly stain for 
VASE. It would be interesting to see if they only express the VASE isoform. A non-
VASE antibody could be produced by constructing a peptide comprising the two joined 
flanking regions of the VASE splice site in NCAM IglV. This could be used to create 
monoclonal antibodies that only recognise IglV without VASE, and allow costains with 
the polyclonal aVASE. 
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What is the effect of knocking out/constitutively expressing VASE exon? 
Deleting both siaiyltransferase enzymes and thus preventing PSA addition to NCAM 
produces a harsh phenotype in mice giving postnatal growth retardation, abnormalities 
in brain fibre tracts, massive hydrocephalus and precocious death (Weinhold et al., 
2005). These symptoms are removed if the NCAM gene is also deleted, indicating that 
PSA removal "unmasks" a gain of function in NCAM (Weinhold et al., 2005). Removing 
the VASE exon from the NCAM gene and fusing exons 7 and 8 together (encoding IglV) 
would result in only NCAM without VASE ever being produced. This would eliminate the 
developmental switch to splicing in the VASE exon from occurring, allowing the 
investigation of whether VASE plays a vital role in processes such as myelination during 
development and maturation of the nervous system, and also if VASE is important for 
heart function. 
Unlike the complete NCAM KO, which has a relatively mild phenotype (Cremer et 
al., 1994), it would be interesting to see if the VASE KO possesses a severe, possibly 
lethal phenotype like the PSA double KO by allowing a similar NCAM gain of function. 
This would be assuming that VASE splicing prevents NCAM activating FGFR signalling. 
Knocking out VASE splicing could allow NCAM-activated FGFR signalling to occur 
uncontrolled in all NCAM expressing tissues. If VASE increases NCAM adhesion rather 
than inhibits NCAM-FGFR signalling, then the phenotype of the VASE KO might be less 
severe. Unlike the PSA double KO in which mice were born with severe defects, a 
VASE KO might not start to display an aberrant phenotype until after birth when VASE 
splicing is normally upregulated. A possible outcome could be that myelination is 
compromised in some manner, and there would be some sort of defect in ependymal 
cells, possibly causing hydrocephalus or perturbing neural precursors in the SVZ. There 
also could be disruption to the layering of the cerebellum. The splicing of VASE into 
NCAM in heart muscle occurs in the embryo (Small and Akeson, 1990). If VASE is 
essential for heart function, or if an NCAM gain of function has deleterious effects in the 
heart, then perhaps VASE KO mice would be embryonic lethal. However, complete 
NCAM KO has been shown only lead to a smaller, weaker heart, rather then lethality 
(Watanabe, 1998). 
An equally interesting transgenic mouse to create would be a VASE knock-"in" 
(Kl). This would involve removing the VASE exon, and exons 7 and 8 from the NCAM 
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gene, and replacing them with fused exons 7+VASE+8. This would mean that all NCAM 
expressed would contain VASE. This might give a severe developmental phenotype, as 
NCAM expression is widespread throughout early development, important for neural 
migration and neurite outgrowth. As VASE is inhibitory to NCAM-stimulated neurite 
outgrowth, then a VASE knock-in mouse might have severe neuronal patterning defects 
in the nervous system. For example, the transient expression of VASE in the developing 
cerebellar Purkinje layer would be replaced with constant VASE expression, perhaps 
causing a failure of Purkinje cell dendritic arborisation, resulting in severe defects in 
cerebellar-controlled motor coordination. Possibly this could be rescued by injection of 
aVASE into the cerebellum at an appropriate developmental timepoint? 
Is VASE inhibitory to axonai regeneration in vivo after injury? 
As VASE as been localised to astrocytes of the DREZ and reactive astrocytes, it would 
be important to observe if there is an upregulation in reactive astrocytes in vivo at lesion 
sites. This is being initially investigated by immunostaining rat hemisectioned spinal 
cords for VASE at different timepoints after surgery in collaboration with Professor John 
Priestley. The hypothesis would be that VASE may be upregulated in reactive 
astrocytes surrounding the lesion. At time of printing, the results of this experiment have 
not been obtained. Perhaps injecting a VASE into the lesion site would block VASE and 
aid axonai regeneration? 
Is VASE unable to activate FGFR signalling? 
This is crucial to one of the hypotheses presented, but could be tested quite simply. 3T3 
cells transfected for NCAM or NCAM-VASE could be treated with recombinant NCAM 
and NCAM-VASE (or perhaps NCAM and NCAM-VASE extracellular domains purified 
from the conditioned media) and the degree of endogenous FGFR phosphorylation 
observed (indicative of activation of signalling). The NCAM FN1111-derived FRM peptide 
causes 3T3 FGFR phosphorylation (Anderson et al., 2005), and so perhaps NCAM 
ECD would act in a similar manner. If VASE does not activate FGFR signalling (or 
perhaps is less efficient) then it should be possible to observe less FGFR 
phosphorylation in the VASE-treated cells. It as been shown previously that NCAM-
VASE can coprecipitate FGFR in pull down assays (Sanchez-Heras et al., 2006), 
although this does not necessarily mean that the binding conformation activates FGFR 
signalling. 
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Does VASE bind to the FGFR activation region o1 NCAM? 
This question is vital for understanding the physical mechanism of the action of VASE. It 
could be tested by creating recombinant NCAM IglV domains with or without VASE, and 
recombinant NCAM FNIII-1+2. The NCAM FNIII-1+2 could be coupled to a surface 
plasmon resonance (SPR) chip and the recombinant IglV domains passed over the top. 
SPR works on the principle that protein binding to an immobilised partner on the SPR 
chip causes detectable changes in chip surface plasmons which can be used to 
calculate binding affinity. If VASE binds to NCAM FNIII-1+2, there should be an 
observable increase in the binding affinity of IglV-VASE compared to IglV-non VASE. 
This could be investigated further by preabsorbing the IglV-VASE domain against the 
affinity purified VASE antibody to see if it blocks binding. Mutagenic studies on the 
VASE sequence could also be carried out to see which amino acid residues are most 
important for binding. 
Recombinant NCAM IglV with or without VASE could also be with NCAM FNIII-
1+2 domains to a SPR chip coated with FGFR. If VASE blocks the FNIII-1+2 FGFR 
binding site then this should be observable. 
Does VASE increase the adhesive properties of NCAM? 
Measurements of the binding strength of NCAM with or without VASE could be taken 
using surface force apparatus as demonstrated by Weinhold et al (Wieland et al., 
2005). This would give a value as to the relative binding strength of single NCAM or 
NCAM-VASE molecules. A potential problem with this could arise if VASE exerts 
binding effects through multimerisation rather than single molecule interactions, or if 
VASE is binding to another protein entirely. 
Does VASE promote gap junction formation? 
This could be investigated by observing gap junctional communication in the NCAM and 
NCAM-VASE transfected 3T3 cell lines. NIH-3T3 cells have been demonstrated to 
express endogenous connexin-43 (Theiss et al., 2007). Immunostaining could be 
performed to observe gap junctions in the cell lines and look for differences in the size 
or quantity of the junctions. A western blot could be performed to observe whether the 
NCAM or NCAM-VASE promotes an increase in connexin expression. Finally, dye 
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loading experiments could be carried out to observe if VASE promotes better gap 
junction connectivity than NCAM. This would involve culturing monolayers of cells and 
then injecting a fluorescent dye such as Lucifer yellow, which is small enough to pass 
through gap junctions, into a cell and observing its transmission over a fixed length of 
time. If VASE is a better promoter of gap junction connectivity, then the dye should 
travel between cells faster with the VASE expressing monolayer. 
8.5 Significance of findings 
Through use of an affinity purified antibody specific for VASE, this study has for the first 
time been able to localise VASE expression to specific cell types throughout the 
nervous system, rather than general tissue areas. The CNS is a highly ordered 
structure, that once developed, requires a relatively static environment to maintain the 
correct connectivity and structures necessary to function normally. The adverse side-
effect of this is that if the CNS is damaged, the same static environment becomes a 
barrier to repair and regeneration (Fitch and Silver, 2007). VASE has been previously 
been proposed to be a promoter of stability and reduce plasticity, presumably through 
its expression in neurons (Doherty et al., 1992; Saffell et al., 1994; Small and Akeson, 
1990). This study has most notably found that VASE appears to be primarily expressed 
by non-neuronal cells and so could be exerting stabilising, antiplasticity effects through 
non-neuronal cells such as oligodendrocytes. 
The significance of the data presented in this report lies in the fact that now 
VASE expression has been mapped in the brain and muscle, target areas and systems 
can be identified to home-in on and identify the mechanism of action and functional 
consequences of the VASE exon. 
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